data_1ehx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ehx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.744 0.307 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.552 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 7' ' ' ASN . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 86' ' ' LEU . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG23 ' ND2' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.471 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' CD2' ' CG ' ' A' ' 32' ' ' PHE . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.798 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.534 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 4.8 t-20 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 55' ' ' SER . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CD1' ' HG2' ' A' ' 66' ' ' LYS . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.798 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.549 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.473 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 4.8 p-10 -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.435 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.499 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.571 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.839 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.839 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 11' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' CB ' HG22 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.57 ' H ' ' C ' ' A' ' 16' ' ' GLY . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 19' ' ' ALA . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.529 ' OE2' ' CG2' ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.551 ' CB ' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.551 ' CG ' ' CB ' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.552 ' HA ' ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HD2' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.529 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HA ' HG22 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.493 ' CB ' ' OE2' ' A' ' 37' ' ' GLU . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' THR . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.573 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.462 ' CD2' ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.482 HG22 ' CB ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.648 0.261 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.488 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 79' ' ' PRO . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.803 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.803 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.444 ' N ' HD21 ' A' ' 81' ' ' LEU . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.428 ' HA ' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.721 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 16' ' ' GLY . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' N ' ' HB3' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.543 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.551 ' N ' ' O ' ' A' ' 50' ' ' VAL . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 38' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.643 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.543 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.556 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.65 HD21 ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 83' ' ' ILE . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 37' ' ' GLU . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.577 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 31' ' ' THR . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 75' ' ' GLY . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 67' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' LYS . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.721 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.643 HG12 ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.643 ' ND2' HG12 ' A' ' 6' ' ' ILE . 3.2 p30 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.452 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 84' ' ' THR . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 86' ' ' LEU . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 16' ' ' GLY . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.632 HD13 ' ND2' ' A' ' 7' ' ' ASN . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.595 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.589 ' C ' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.61 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.553 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD22 ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' CD ' HD23 ' A' ' 60' ' ' LEU . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.4 m-80 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.64 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.634 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' CD1' ' A' ' 35' ' ' ILE . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CE1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 78' ' ' ASN . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG3' HD11 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 68' ' ' LEU . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 1.2 pp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.585 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.518 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.63 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.925 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.925 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' CG2' HG12 ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.475 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 16' ' ' GLY . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HG21 ' A' ' 23' ' ' ILE . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 68' ' ' LEU . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' OE1' ' OG1' ' A' ' 69' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.567 ' CD2' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.581 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.8 m120 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 60' ' ' LEU . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HG ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.553 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 68' ' ' LEU . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.617 HG12 ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.679 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.679 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.479 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CE2' HG11 ' A' ' 85' ' ' VAL . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.609 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 18.4 mm-40 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG2' ' CD1' ' A' ' 43' ' ' TYR . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' A' ' 23' ' ' ILE . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HB3' ' CG2' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 35' ' ' ILE . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 32' ' ' PHE . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' THR . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.444 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' CB ' HD13 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 67' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.886 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.886 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.472 ' CD1' HD12 ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' N ' ' HG2' ' A' ' 14' ' ' LYS . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.56 ' O ' ' CB ' ' A' ' 54' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 23' ' ' ILE . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.606 HD12 ' CG ' ' A' ' 70' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.536 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.703 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.703 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.598 ' O ' ' CB ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' GLY . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 62' ' ' GLU . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.639 ' H ' HD11 ' A' ' 81' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.441 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CG ' HD12 ' A' ' 25' ' ' LEU . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.65 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.452 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.538 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.609 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.879 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.879 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' CB ' ' CG2' ' A' ' 85' ' ' VAL . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' H ' ' C ' ' A' ' 16' ' ' GLY . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' N ' ' HB3' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' N ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.639 ' CG2' ' CE1' ' A' ' 43' ' ' TYR . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.617 ' HG2' ' CG1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.749 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.55 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 57' ' ' LEU . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 62' ' ' GLU . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.764 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.609 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG2' ' OD1' ' A' ' 78' ' ' ASN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.609 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' CG2' ' CB ' ' A' ' 15' ' ' ALA . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.8 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.52 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 79' ' ' PRO . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.732 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 82' ' ' THR . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG1' ' N ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' CB ' ' CG2' ' A' ' 85' ' ' VAL . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 16' ' ' GLY . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.532 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.461 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.513 HD12 ' CD2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.628 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HB ' HD12 ' A' ' 38' ' ' LEU . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.628 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.552 ' CE1' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.401 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 32' ' ' PHE . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.532 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 42' ' ' GLN . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 66' ' ' LYS . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.582 ' CE ' ' OE2' ' A' ' 37' ' ' GLU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 4' ' ' PRO . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' THR . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.5 p-10 -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.498 ' CG2' ' HG3' ' A' ' 66' ' ' LYS . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.508 ' CG2' ' CB ' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 16.5 p30 . . . . . 0 C--O 1.229 -0.025 0 CA-C-O 121.023 0.439 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.598 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' CG1' ' HB3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.758 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.557 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB2' ' A' ' 17' ' ' SER . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.49 ' HB2' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 16' ' ' GLY . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 19' ' ' ALA . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 ' CG2' ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ASN . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.598 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.625 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.553 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.524 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.595 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HG ' ' CD2' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.509 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' CD2' ' CG1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.472 ' CG2' ' HE2' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB3' ' CG1' ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' CG1' ' CD2' ' A' ' 68' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.439 ' N ' HD23 ' A' ' 81' ' ' LEU . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 82' ' ' THR . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB1' ' CG2' ' A' ' 85' ' ' VAL . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 16' ' ' GLY . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' VAL . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.586 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' OH ' ' A' ' 43' ' ' TYR . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.1 mm-40 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.555 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.554 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.49 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 60' ' ' LEU . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.73 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.503 ' N ' ' HG2' ' A' ' 62' ' ' GLU . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 75' ' ' GLY . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA2' ' ND2' ' A' ' 78' ' ' ASN . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 9' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.986 0.422 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.618 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.957 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 9' ' ' THR . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.523 ' CG2' HG12 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 57' ' ' LEU . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ASN . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.534 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.521 ' CD ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.56 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.55 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 35' ' ' ILE . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG22 ' CE ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB3' ' CB ' ' A' ' 6' ' ' ILE . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' O ' ' CG2' ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' CD1' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.275 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.8 p30 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' CG2' ' HB ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HG3' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HA ' HG11 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.676 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.621 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.634 ' N ' ' O ' ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 5' ' ' THR . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG2' ' CG ' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.637 ' HB2' ' CG ' ' A' ' 42' ' ' GLN . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.637 ' CG ' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' GLY . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 38' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.647 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.481 ' CB ' ' OE1' ' A' ' 37' ' ' GLU . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' THR . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HD2' ' CG2' ' A' ' 69' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.973 0.416 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.908 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 9' ' ' THR . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.411 ' HA ' HG22 ' A' ' 82' ' ' THR . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.554 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 83' ' ' ILE . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' ALA . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.58 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.509 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.496 ' HB3' HD22 ' A' ' 38' ' ' LEU . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.656 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD23 ' CG ' ' A' ' 18' ' ' PHE . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG12 ' CE ' ' A' ' 77' ' ' LYS . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.592 ' CG2' ' HG3' ' A' ' 66' ' ' LYS . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 24' ' ' THR . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.501 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.494 ' CG2' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 16' ' ' GLY . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.656 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.698 HG22 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.791 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.791 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 46' ' ' GLY . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.597 ' CD1' ' HG2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' GLU . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.779 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.487 ' HB ' ' CD ' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 35' ' ' ILE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.477 ' CG2' ' ND2' ' A' ' 78' ' ' ASN . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 25' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 75' ' ' GLY . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.475 ' HA2' ' ND2' ' A' ' 78' ' ' ASN . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' ND2' ' CG2' ' A' ' 69' ' ' THR . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.504 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.5 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.525 ' CG2' ' CG2' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.543 ' CG2' ' CB ' ' A' ' 79' ' ' PRO . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.78 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.467 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.524 ' CG1' ' HB ' ' A' ' 83' ' ' ILE . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE3' ' CD1' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' CA ' HG11 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.693 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 19' ' ' ALA . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.522 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.525 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB2' HG21 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.759 HG23 ' CZ ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HG2' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.759 ' CZ ' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.558 HG23 ' HB ' ' A' ' 51' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.558 ' HB ' HG23 ' A' ' 44' ' ' THR . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 42' ' ' GLN . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.693 ' CD2' ' CG ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.575 ' CG ' HG22 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.424 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.56 ' CB ' ' HG ' ' A' ' 81' ' ' LEU . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 75' ' ' GLY . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 68' ' ' LEU . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.575 HG22 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG11 ' CA ' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 2.5 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 25' ' ' LEU . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.723 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.723 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 9' ' ' THR . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.521 ' HA ' HG22 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HA ' HG11 ' A' ' 85' ' ' VAL . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' GLY . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.43 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' CD1' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.712 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.712 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HE2' ' CD2' ' A' ' 32' ' ' PHE . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 18' ' ' PHE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.6 t-20 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.468 ' ND2' ' CD2' ' A' ' 86' ' ' LEU . 3.1 t-20 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.579 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.457 ' CB ' ' OE1' ' A' ' 37' ' ' GLU . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 75' ' ' GLY . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 ' O ' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.547 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 9' ' ' THR . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CD1' HD11 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 57' ' ' LEU . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' CD ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD11 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.695 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.696 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.695 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 46' ' ' GLY . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.432 ' OG1' ' CD ' ' A' ' 22' ' ' LYS . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.448 HD23 ' CG ' ' A' ' 66' ' ' LYS . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HB2' ' CG2' ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.512 ' CD ' ' OH ' ' A' ' 56' ' ' TYR . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' HD12 ' A' ' 35' ' ' ILE . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.552 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' CG ' ' CG2' ' A' ' 67' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' ' CG2' ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' LYS . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 110.976 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.597 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 9' ' ' THR . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.443 HG12 ' CD1' ' A' ' 81' ' ' LEU . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' CB ' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 16' ' ' GLY . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.597 HG12 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 70' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 5' ' ' THR . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HG2' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.537 ' C ' ' O ' ' A' ' 46' ' ' GLY . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.2 m120 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 43' ' ' TYR . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' LEU . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HG2' ' CG2' ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 23' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.643 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 75' ' ' GLY . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.46 ' CG2' ' CB ' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 12.8 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 7.8 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.874 0.368 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 24' ' ' THR . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.6 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.433 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 19' ' ' ALA . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 7' ' ' ASN . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD23 ' CD1' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 5' ' ' THR . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 43' ' ' TYR . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' N ' HD11 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG2' ' CD1' ' A' ' 43' ' ' TYR . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HB3' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.488 ' CD2' ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CD1' HD23 ' A' ' 25' ' ' LEU . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 75' ' ' GLY . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.48 HG21 ' HB3' ' A' ' 66' ' ' LYS . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.871 0.367 . . . . 1.0 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 12.0 mm-40 -107.58 178.6 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 -124.92 49.46 3.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.292 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.552 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 7' ' ' ASN . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG23 ' ND2' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.471 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' CD2' ' CG ' ' A' ' 32' ' ' PHE . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.798 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.534 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.51 ' CD2' ' HB3' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 4.8 t-20 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 55' ' ' SER . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CD1' ' HG2' ' A' ' 66' ' ' LYS . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.481 ' ND2' ' HE2' ' A' ' 88' ' ' LYS . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.589 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.798 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.549 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.423 HG13 ' CG ' ' A' ' 2' ' ' GLN . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 4.8 p-10 -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -123.9 86.63 53.41 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 15' ' ' ALA . 41.6 Cg_endo -68.7 -27.82 31.56 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 122.589 2.192 . . . . 0.0 111.679 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HE2' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.15 136.27 56.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' O ' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -78.98 114.63 18.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.619 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 1.7 mt -161.1 -62.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.408 0.623 . . . . 0.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 90' ' ' ILE . 60.9 Cg_endo -76.42 167.85 24.92 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.801 3.001 . . . . 0.0 112.406 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.15 22.51 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.54 78.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.687 0.279 . . . . 1.0 111.498 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 7.0 mt-30 -96.84 158.0 15.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -135.48 76.31 55.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.499 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.571 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.839 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.839 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 11' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' CB ' HG22 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.57 ' H ' ' C ' ' A' ' 16' ' ' GLY . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 19' ' ' ALA . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.595 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.529 ' OE2' ' CG2' ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' CD2' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.551 ' CB ' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 23' ' ' ILE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.551 ' CG ' ' CB ' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.552 ' HA ' ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HD2' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.529 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HA ' HG22 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.493 ' CB ' ' OE2' ' A' ' 37' ' ' GLU . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' THR . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.573 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' CD2' ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.482 HG22 ' CB ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt -85.15 154.52 60.35 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.44 129.51 18.06 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.31 140.15 1.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -158.13 153.83 26.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -110.42 164.28 15.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 53.7 Cg_endo -69.83 158.45 56.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.676 2.251 . . . . 0.0 112.239 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.76 33.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.94 -157.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.782 0.325 . . . . 0.0 110.76 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.863 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mtm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.775 0.321 . . . . 1.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 1.2 mp0 -136.05 146.07 46.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 -113.9 73.16 2.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.488 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 79' ' ' PRO . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.803 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.803 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.444 ' N ' HD21 ' A' ' 81' ' ' LEU . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.428 ' HA ' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.721 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 16' ' ' GLY . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' N ' ' HB3' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.543 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.551 ' N ' ' O ' ' A' ' 50' ' ' VAL . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 38' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.643 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.643 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.556 ' O ' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.65 HD21 ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 6.0 p30 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 83' ' ' ILE . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 37' ' ' GLU . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 31' ' ' THR . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 2' ' ' GLN . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 67' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' LYS . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.721 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -90.35 157.08 45.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 63' ' ' ASN . 5.9 Cg_endo -49.18 115.11 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.111 2.541 . . . . 0.0 112.814 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -45.88 112.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.806 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -112.9 176.48 5.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.8 mm -144.65 73.47 15.32 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.223 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HB2' ' CD2' ' A' ' 93' ' ' LEU . 53.0 Cg_endo -69.93 122.68 9.31 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.28 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.98 -26.11 42.42 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.628 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 91' ' ' PRO . 3.2 mm? 62.15 94.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.882 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.875 0.369 . . . . 1.0 111.255 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 1.7 mp0 -117.02 166.44 12.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -140.22 78.51 23.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.643 HG12 ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.643 ' ND2' HG12 ' A' ' 6' ' ' ILE . 3.2 p30 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.452 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 84' ' ' THR . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 87' ' ' PRO . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 16' ' ' GLY . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.632 HD13 ' ND2' ' A' ' 7' ' ' ASN . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.589 ' C ' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.61 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.553 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD22 ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' CD ' HD23 ' A' ' 60' ' ' LEU . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.4 m-80 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.64 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.634 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.595 ' CD2' ' CD1' ' A' ' 35' ' ' ILE . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CE1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 78' ' ' ASN . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG3' HD11 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' CD2' ' A' ' 68' ' ' LEU . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 1.2 pp -124.1 84.19 55.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 56.0 Cg_endo -75.22 -26.98 10.06 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.535 2.157 . . . . 0.0 111.703 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HE3' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -48.41 140.77 7.41 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.22 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -166.8 0.12 Allowed 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.941 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.437 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 29.3 mm -139.57 137.57 18.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.09 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.78 132.41 23.23 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.632 2.222 . . . . 0.0 112.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.84 -31.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' O ' ' CD1' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -159.45 88.27 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.916 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.782 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.824 0.345 . . . . 1.0 111.165 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.43 ' HG3' ' CG1' ' A' ' 74' ' ' VAL . 2.8 mt-30 -104.91 164.03 12.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.843 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 -132.53 70.26 79.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.585 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.63 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.925 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.925 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' CG2' HG12 ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 16' ' ' GLY . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HG21 ' A' ' 23' ' ' ILE . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 68' ' ' LEU . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' OE1' ' OG1' ' A' ' 69' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.567 ' CD2' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.581 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.8 m120 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.43 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' TYR . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 60' ' ' LEU . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.664 ' HG ' HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.553 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.43 ' CG1' ' HG3' ' A' ' 2' ' ' GLN . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 68' ' ' LEU . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? -61.36 164.99 7.58 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 63' ' ' ASN . 94.8 Cg_endo -79.07 137.35 13.62 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.073 2.516 . . . . 0.0 112.585 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.16 144.69 57.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.88 94.06 1.03 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 ' CG1' ' HD2' ' A' ' 91' ' ' PRO . 4.7 tt -132.66 137.02 28.85 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' CG1' ' A' ' 90' ' ' ILE . 55.2 Cg_endo -70.01 117.07 4.88 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.6 2.2 . . . . 0.0 112.296 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.91 -22.96 4.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' CG ' ' A' ' 93' ' ' LEU . 1.5 pp -146.17 101.85 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 110.8 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.834 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.852 0.358 . . . . 1.0 111.209 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 35.4 mm-40 -78.27 176.83 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 -129.03 84.47 62.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.617 HG12 ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.679 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.679 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.479 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CE2' HG11 ' A' ' 85' ' ' VAL . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.609 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 18.4 mm-40 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG2' ' CD1' ' A' ' 43' ' ' TYR . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' A' ' 23' ' ' ILE . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HB3' ' CG2' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.52 ' N ' HG21 ' A' ' 35' ' ' ILE . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE2' ' CD1' ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 32' ' ' PHE . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.456 ' CG1' ' HB2' ' A' ' 2' ' ' GLN . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.444 ' HB2' ' CA ' ' A' ' 75' ' ' GLY . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' CB ' HD13 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 67' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.58 168.57 20.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 60.1 Cg_endo -73.44 130.47 15.05 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.495 2.13 . . . . 0.0 112.333 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.93 164.35 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -69.94 162.61 27.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 89' ' ' ASP . 37.5 mm -148.6 66.58 9.11 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.29 168.08 21.99 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.583 2.189 . . . . 0.0 112.504 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.1 1.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.578 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.85 32.06 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.038 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.817 0.342 . . . . 1.0 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -77.95 179.66 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 -143.15 72.47 18.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.004 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.886 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.886 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.472 ' CD1' HD12 ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HB2' ' HG3' ' A' ' 87' ' ' PRO . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.56 ' O ' ' CB ' ' A' ' 54' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 23' ' ' ILE . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.606 HD12 ' CG ' ' A' ' 70' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.536 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 70' ' ' PHE . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.703 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.703 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' O ' ' CB ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 46' ' ' GLY . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.639 ' H ' HD11 ' A' ' 81' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.441 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CG ' HD12 ' A' ' 25' ' ' LEU . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.431 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.65 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.452 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.662 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.05 75.26 10.81 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.598 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 21.1 Cg_exo -64.91 -148.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 112.433 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.45 132.29 48.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.29 30.83 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.498 HD13 HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -130.56 130.81 23.01 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.122 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 114.63 3.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.634 2.222 . . . . 0.0 112.223 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -119.87 -31.6 1.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER 61.75 63.39 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.755 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.946 0.403 . . . . 1.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 7.8 mt-30 -147.59 -179.78 7.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -142.56 74.27 19.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.538 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.609 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.879 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.879 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' H ' ' C ' ' A' ' 16' ' ' GLY . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' N ' ' HB3' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' N ' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.522 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.639 ' CG2' ' CE1' ' A' ' 43' ' ' TYR . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' HG2' ' CG1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.749 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.538 ' CG1' ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.55 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 ' HA ' ' A' ' 57' ' ' LEU . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.567 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.764 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.568 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.609 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG2' ' OD1' ' A' ' 78' ' ' ASN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.609 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB3' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.549 ' CG2' ' HD3' ' A' ' 87' ' ' PRO . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.8 mt -106.65 69.15 0.23 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.751 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.1 Cg_endo -62.65 -156.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.121 2.548 . . . . 0.0 112.177 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 163.82 14.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 6.5 t0 -84.34 128.64 34.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.432 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 41.1 mm -149.3 137.64 11.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 53.3 Cg_endo -70.01 114.82 3.87 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.541 2.161 . . . . 0.0 112.206 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.92 33.73 2.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.73 81.07 8.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.805 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 1.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' CG ' HG12 ' A' ' 74' ' ' VAL . 1.5 mm100 -70.06 150.81 46.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.787 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -124.53 82.39 59.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.52 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 79' ' ' PRO . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.732 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 82' ' ' THR . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG1' ' N ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' CB ' ' CG2' ' A' ' 85' ' ' VAL . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 16' ' ' GLY . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.532 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG12 ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.461 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.513 HD12 ' CD2' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.628 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.628 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HB ' HD12 ' A' ' 38' ' ' LEU . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.628 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.552 ' CE1' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.401 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 32' ' ' PHE . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.532 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 42' ' ' GLN . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD21 ' CG ' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 66' ' ' LYS . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.582 ' CE ' ' OE2' ' A' ' 37' ' ' GLU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 4' ' ' PRO . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG12 ' CG ' ' A' ' 2' ' ' GLN . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.5 p-10 -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' CD ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.498 ' CG2' ' HG3' ' A' ' 66' ' ' LYS . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' CG2' ' CB ' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -140.38 95.14 8.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 57.7 Cg_endo -73.55 -43.87 0.6 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.41 2.074 . . . . 0.0 112.075 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -65.27 163.27 15.69 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.995 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.59 165.33 12.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.433 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 3.5 mp -70.01 137.69 87.32 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 55.3 Cg_endo -69.94 134.23 27.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.63 2.22 . . . . 0.0 112.319 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -104.18 -21.71 9.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.19 102.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 110.956 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.826 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.831 0.348 . . . . 1.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.424 ' HG3' ' CG1' ' A' ' 74' ' ' VAL . 2.0 mm100 -118.31 151.59 37.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.774 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 16.5 p30 -134.01 75.57 66.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.243 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.598 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' CG1' ' HB3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.758 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.557 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' N ' ' HB2' ' A' ' 17' ' ' SER . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 87' ' ' PRO . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.49 ' HB2' ' N ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 16' ' ' GLY . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 19' ' ' ALA . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 ' CG2' ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.518 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ASN . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.598 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.625 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.553 ' CE2' ' CD1' ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.524 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.595 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.518 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.546 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.625 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.53 ' HG ' ' CD2' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.509 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.445 ' CB ' ' HE2' ' A' ' 88' ' ' LYS . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' CD2' ' CG1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.603 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.472 ' CG2' ' HE2' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB3' ' CG1' ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' CG1' ' CD2' ' A' ' 68' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -136.5 103.02 9.48 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.476 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -75.3 -31.84 5.52 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.696 2.264 . . . . 0.0 112.093 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HE2' ' CB ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.29 138.02 57.93 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.823 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.08 164.72 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.061 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 30.2 mm -98.48 137.68 20.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.168 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 52.2 Cg_endo -69.62 114.39 3.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 0.0 112.188 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.99 31.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 69.97 37.05 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LEU . 11.3 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.041 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.821 0.343 . . . . 1.0 111.38 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' NE2' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -69.91 -105.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -170.46 47.94 0.1 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.439 ' N ' HD23 ' A' ' 81' ' ' LEU . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.469 ' HA ' HG21 ' A' ' 82' ' ' THR . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 16' ' ' GLY . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' VAL . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.586 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' OH ' ' A' ' 43' ' ' TYR . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HB3' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.1 mm-40 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.555 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.554 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.49 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.503 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.777 ' HA ' ' CG ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.618 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.475 ' CG1' ' NE2' ' A' ' 2' ' ' GLN . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA2' ' ND2' ' A' ' 78' ' ' ASN . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 9' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.55 ' CG2' ' HD3' ' A' ' 87' ' ' PRO . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt -104.39 71.37 0.18 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.777 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 36.4 Cg_endo -66.37 -155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.33 -0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 111.905 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 132.12 48.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.243 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CB ' ' HD2' ' A' ' 91' ' ' PRO . 1.3 t0 -120.91 148.42 44.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.752 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -84.68 -26.5 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 90' ' ' ILE . 84.5 Cg_endo -86.34 132.81 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.398 2.732 . . . . 0.0 112.461 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.35 32.24 7.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.537 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.26 119.92 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.939 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.779 0.324 . . . . 1.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 7.8 mt-30 -142.37 157.39 44.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 -134.01 77.59 61.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.99 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.618 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.957 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 9' ' ' THR . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.523 ' CG2' HG12 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CD1' HD22 ' A' ' 57' ' ' LEU . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ASN . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.62 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.552 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.534 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.521 ' CD ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.514 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.56 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.55 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.59 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 35' ' ' ILE . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG22 ' CE ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' CE ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB3' ' CB ' ' A' ' 6' ' ' ILE . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' O ' ' CG2' ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' CD1' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? -76.35 159.4 79.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 54.8 Cg_endo -70.25 163.77 37.45 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.668 2.245 . . . . 0.0 112.345 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -64.93 167.87 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.013 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.29 160.7 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 4.5 mp -109.89 137.61 20.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 54.1 Cg_endo -69.88 147.42 62.07 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.176 . . . . 0.0 112.239 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.93 -39.97 2.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.291 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 tp 174.41 140.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.691 0.281 . . . . 0.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.652 0.263 . . . . 1.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 2.3 mm-40 -105.51 164.28 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.69 84.34 15.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.119 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.8 p30 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' CG2' ' HB ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HG3' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HA ' HG11 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.676 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.621 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.634 ' N ' ' O ' ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 5' ' ' THR . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.609 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG2' ' CG ' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.637 ' HB2' ' CG ' ' A' ' 42' ' ' GLN . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.637 ' CG ' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' GLY . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.621 ' CD2' ' CG ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.443 ' HB2' ' HD3' ' A' ' 87' ' ' PRO . 10.1 t-20 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 38' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.647 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.481 ' CB ' ' OE1' ' A' ' 37' ' ' GLU . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' THR . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HD2' ' CG2' ' A' ' 69' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -75.99 173.58 6.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 88.3 Cg_endo -83.83 168.39 12.43 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.44 2.094 . . . . 0.0 112.457 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.0 167.88 7.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -171.11 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.879 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 90' ' ' ILE . 1.3 mp -147.82 136.19 11.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 57.2 Cg_endo -70.97 154.78 62.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 0.0 112.344 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 155.8 -32.24 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.325 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tt -162.53 94.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.903 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.939 0.399 . . . . 1.0 111.135 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HG3' ' CG1' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -103.34 166.23 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -127.75 61.66 51.91 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.908 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 9' ' ' THR . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.411 ' HA ' HG22 ' A' ' 82' ' ' THR . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HA ' HG11 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 83' ' ' ILE . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' ALA . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.58 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.509 ' CD1' ' CE2' ' A' ' 43' ' ' TYR . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.496 ' HB3' HD22 ' A' ' 38' ' ' LEU . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.656 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD23 ' CG ' ' A' ' 18' ' ' PHE . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' CG1' ' HG3' ' A' ' 2' ' ' GLN . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.592 ' CG2' ' HG3' ' A' ' 66' ' ' LYS . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 1.2 mt -73.78 159.46 84.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 37.8 Cg_endo -66.93 127.48 17.01 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.437 2.091 . . . . 0.0 112.288 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.38 142.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 8.6 t70 -134.62 145.23 48.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.475 HD13 HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -113.41 93.62 27.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.88 147.95 63.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.659 2.239 . . . . 0.0 112.503 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 38.98 57.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.412 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.29 60.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.963 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.738 0.304 . . . . 1.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 4.8 mt-30 -128.65 -176.4 3.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -122.6 48.92 2.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.395 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 24' ' ' THR . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.501 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.494 ' CG2' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 16' ' ' GLY . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.656 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.698 HG22 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.791 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.791 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 46' ' ' GLY . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG1' ' CD1' ' A' ' 43' ' ' TYR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.631 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.597 ' CD1' ' HG2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 62' ' ' GLU . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.432 ' N ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.779 ' HA ' ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.487 ' HB ' ' CD ' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HA ' HD11 ' A' ' 35' ' ' ILE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 ' CG2' ' ND2' ' A' ' 78' ' ' ASN . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 25' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 2' ' ' GLN . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.475 ' HA2' ' ND2' ' A' ' 78' ' ' ASN . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' ND2' ' CG2' ' A' ' 69' ' ' THR . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.504 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.5 mt -94.16 161.72 28.71 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 71.2 Cg_endo -77.98 -32.66 2.46 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 122.634 2.223 . . . . 0.0 112.08 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HE2' ' CD1' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -42.35 164.16 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.184 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -160.15 145.03 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG23 ' CD2' ' A' ' 93' ' ' LEU . 9.3 mm -118.59 77.01 13.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.16 153.97 66.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.796 2.331 . . . . 0.0 112.263 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.23 42.49 41.2 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.496 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' CD2' HG23 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -50.18 93.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 111.037 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' N ' ' HB ' ' A' ' 74' ' ' VAL . 34.9 ttp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.825 0.345 . . . . 1.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 24.9 mm-40 -137.76 -179.35 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 -113.53 61.5 0.87 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.525 ' CG2' ' CG2' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.543 ' CG2' ' CB ' ' A' ' 79' ' ' PRO . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.78 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.467 ' HA ' ' CB ' ' A' ' 81' ' ' LEU . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 ' CG1' ' HB ' ' A' ' 83' ' ' ILE . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HE3' ' CD1' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' CA ' HG11 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.693 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 19' ' ' ALA . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.522 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.441 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.525 ' CG2' ' CG2' ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HB2' HG21 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.759 HG23 ' CZ ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' CB ' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HG2' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.759 ' CZ ' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.558 HG23 ' HB ' ' A' ' 51' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.558 ' HB ' HG23 ' A' ' 44' ' ' THR . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' CD2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 42' ' ' GLN . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.693 ' CD2' ' CG ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.575 ' CG ' HG22 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.424 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.56 ' CB ' ' HG ' ' A' ' 81' ' ' LEU . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' ' OE1' ' A' ' 37' ' ' GLU . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 2' ' ' GLN . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 68' ' ' LEU . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.575 HG22 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG11 ' CA ' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 2.5 mt -84.05 161.68 54.4 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 9.9 Cg_endo -53.58 117.93 4.35 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.554 2.169 . . . . 0.0 112.346 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 142.62 11.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.695 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 31.59 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 110.661 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 4.3 tt -105.58 94.34 8.43 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.99 143.89 51.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.703 2.268 . . . . 0.0 112.243 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.58 22.52 23.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.543 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.02 109.92 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.868 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.763 0.316 . . . . 1.0 111.151 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -127.97 144.95 51.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -118.58 62.47 5.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.817 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 25' ' ' LEU . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.723 ' HB2' ' CD ' ' A' ' 8' ' ' PRO . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.723 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 9' ' ' THR . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.521 ' HA ' HG22 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.537 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 87' ' ' PRO . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' GLY . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.43 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' CD1' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 70' ' ' PHE . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.712 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.712 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HE2' ' CD2' ' A' ' 32' ' ' PHE . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 18' ' ' PHE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.6 t-20 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.468 ' ND2' ' CD2' ' A' ' 86' ' ' LEU . 3.1 t-20 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.579 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.507 HG23 ' HG2' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.457 ' CB ' ' OE1' ' A' ' 37' ' ' GLU . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.438 ' CG1' ' HG2' ' A' ' 2' ' ' GLN . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' O ' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.04 91.61 43.74 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.475 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 60.2 Cg_endo -72.8 -31.17 10.64 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.098 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -64.93 123.08 18.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.72 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -97.68 31.67 2.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.332 0.587 . . . . 0.0 110.743 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 89' ' ' ASP . 38.0 mm -148.99 92.59 4.33 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.061 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 164.84 33.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.61 43.51 85.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' O ' ' NZ ' ' A' ' 88' ' ' LYS . 5.1 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.778 0.323 . . . . 1.0 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 3.5 mm100 -116.45 178.58 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -133.04 68.03 78.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.547 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.802 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 9' ' ' THR . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CD1' HD11 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 57' ' ' LEU . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' CD ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' CD2' ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD11 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.695 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.696 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.695 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 46' ' ' GLY . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.432 ' OG1' ' CD ' ' A' ' 22' ' ' LYS . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.696 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.448 HD23 ' CG ' ' A' ' 66' ' ' LYS . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HB2' ' CG2' ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' CD ' ' OH ' ' A' ' 56' ' ' TYR . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' HD12 ' A' ' 35' ' ' ILE . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.552 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' CG ' ' CG2' ' A' ' 67' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' ' CG2' ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 66' ' ' LYS . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -106.35 163.64 16.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HD2' ' CD2' ' A' ' 86' ' ' LEU . 58.8 Cg_endo -71.76 137.14 29.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.474 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.06 111.67 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.647 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -160.48 164.62 32.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 90' ' ' ILE . 5.0 tp -129.05 58.78 39.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.19 132.82 23.4 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.809 2.339 . . . . 0.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.51 -21.38 77.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.53 80.57 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 0.0 110.964 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.842 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' N ' ' OE1' ' A' ' 2' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.77 0.319 . . . . 1.0 111.229 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.457 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 1.7 mm100 -102.19 160.34 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -132.84 73.42 75.87 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 70' ' ' PHE . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.597 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 9' ' ' THR . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.443 HG12 ' CD1' ' A' ' 81' ' ' LEU . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' CB ' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.583 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 16' ' ' GLY . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.597 HG12 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 70' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 5' ' ' THR . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HG2' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.537 ' C ' ' O ' ' A' ' 46' ' ' GLY . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.2 m120 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 43' ' ' TYR . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.458 HG23 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' LEU . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HG2' ' CG2' ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 23' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.643 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.457 ' CG1' ' CG ' ' A' ' 2' ' ' GLN . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.46 ' CG2' ' CB ' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 12.8 mt -92.52 164.17 23.59 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 86' ' ' LEU . 59.3 Cg_endo -72.18 170.37 19.23 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 0.0 112.404 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 167.76 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -127.19 144.92 50.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.065 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mm -102.25 93.08 3.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.38 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.62 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.78 2.32 . . . . 0.0 112.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -110.63 33.91 5.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tt 69.85 84.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.354 . . . . 1.0 111.225 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' OE1' ' CE ' ' A' ' 77' ' ' LYS . 2.7 mp0 -140.14 154.02 46.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 7.8 p30 -121.61 55.13 5.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.28 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 24' ' ' THR . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.6 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.433 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 54' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 19' ' ' ALA . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 HG21 ' HB3' ' A' ' 7' ' ' ASN . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD23 ' CD1' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 5' ' ' THR . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 43' ' ' TYR . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.603 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' N ' HD11 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG2' ' CD1' ' A' ' 43' ' ' TYR . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HB3' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.488 ' CD2' ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CD1' HD23 ' A' ' 25' ' ' LEU . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 32' ' ' PHE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 75' ' ' GLY . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' CE ' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.48 HG21 ' HB3' ' A' ' 66' ' ' LYS . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 7.0 mt -78.2 159.43 75.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 61.0 Cg_endo -73.62 130.29 14.63 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.71 2.273 . . . . 0.0 112.411 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.3 160.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -69.86 112.51 6.34 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.127 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -110.12 163.32 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.32 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.74 121.21 7.91 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.043 2.495 . . . . 0.0 112.274 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.43 24.63 4.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.423 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pp -97.78 102.31 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.744 0.307 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 25' ' ' LEU . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.693 ' CG ' HD13 ' A' ' 23' ' ' ILE . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.603 HG12 HD11 ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.77 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.059 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.885 ' HB ' HD21 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 50' ' ' VAL . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' A' ' 26' ' ' THR . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD11 ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.795 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.741 ' CB ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.734 ' CD2' HD12 ' A' ' 35' ' ' ILE . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 25' ' ' LEU . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.885 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE1' HD21 ' A' ' 60' ' ' LEU . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 40.0 t30 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 56' ' ' TYR . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.626 ' CB ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.936 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.739 ' C ' HG23 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CZ ' HD23 ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.509 HG22 ' HE3' ' A' ' 77' ' ' LYS . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 76' ' ' THR . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.95 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.032 ' N ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.872 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.492 ' N ' HD23 ' A' ' 81' ' ' LEU . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 83' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.987 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD2' HD23 ' A' ' 53' ' ' LEU . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.898 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.021 HD22 ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.032 HD22 ' N ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.095 HD11 ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.782 ' OE2' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.645 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.558 HE22 ' HB3' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.1 m-20 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 70' ' ' PHE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 66' ' ' LYS . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.634 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.549 HG23 ' ND2' ' A' ' 78' ' ' ASN . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.095 ' CE1' HD11 ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.021 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' THR . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CG ' HD21 ' A' ' 25' ' ' LEU . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.808 HD21 ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 65' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.648 0.261 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.447 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.857 HD11 HG21 ' A' ' 23' ' ' ILE . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.89 ' ND2' ' H ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 80' ' ' LYS . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.744 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.587 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.861 ' HB ' HD21 ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 6' ' ' ILE . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.89 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.045 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 28' ' ' ASN . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 68' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.895 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.917 HD22 ' HE3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.677 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.842 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.861 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.8 ' O ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 63' ' ' ASN . 5.7 p-10 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.917 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HD3' ' A' ' 80' ' ' LYS . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.955 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 78' ' ' ASN . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.045 ' CD2' HD11 ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HE1' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' GLY . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.784 ' O ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 11' ' ' ILE . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' ILE . 7.6 p-10 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.869 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.473 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD23 ' A' ' 57' ' ' LEU . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.598 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.485 HD13 ' HZ ' ' A' ' 70' ' ' PHE . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.076 HD11 ' CE2' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.043 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.776 ' CD1' HG13 ' A' ' 50' ' ' VAL . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.833 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.477 ' CB ' ' HA2' ' A' ' 16' ' ' GLY . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.854 HD13 ' HG3' ' A' ' 66' ' ' LYS . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.4 m-80 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 82' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.854 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.646 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.867 HD21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.076 ' CE2' HD11 ' A' ' 25' ' ' LEU . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 72' ' ' PHE . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.869 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.78 HD13 ' HA ' ' A' ' 9' ' ' THR . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.56 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.2 pp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.962 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.962 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 80' ' ' LYS . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.425 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HB3' HD23 ' A' ' 57' ' ' LEU . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG23 HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.113 HD11 ' CE1' ' A' ' 70' ' ' PHE . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.623 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 4.5 m-20 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.818 ' CE1' HD21 ' A' ' 60' ' ' LEU . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.842 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 64' ' ' THR . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.658 ' CE ' HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.838 ' O ' HD21 ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 80' ' ' LYS . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.113 ' CE1' HD11 ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 78' ' ' ASN . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 82' ' ' THR . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.778 ' CG ' HD12 ' A' ' 23' ' ' ILE . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.687 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' LYS . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.414 ' C ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.734 HD11 HD12 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.997 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.778 HD12 ' CG ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 24' ' ' THR . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.917 HD11 ' CE2' ' A' ' 70' ' ' PHE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.808 HD13 ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.755 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.726 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.623 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.658 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 5.1 mm100 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.808 ' CE2' HD13 ' A' ' 35' ' ' ILE . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.726 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 50' ' ' VAL . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.837 ' CD2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HD2' HD23 ' A' ' 60' ' ' LEU . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.848 ' HD2' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.726 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 72' ' ' PHE . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 74' ' ' VAL . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.943 ' O ' HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 67' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.739 HG12 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.634 HG22 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.927 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' THR . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.766 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 58' ' ' ASN . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.035 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' THR . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' OE2' ' A' ' 49' ' ' GLU . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.014 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.634 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 43' ' ' TYR . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.697 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HG2' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 35' ' ' ILE . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.738 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.602 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 47' ' ' THR . 1.7 p30 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 24' ' ' THR . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.788 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.738 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.805 ' CE1' HD21 ' A' ' 60' ' ' LEU . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.887 HD23 ' CG ' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.805 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 62' ' ' GLU . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' OE1' ' A' ' 37' ' ' GLU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 52' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 69' ' ' THR . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE1' HG11 ' A' ' 50' ' ' VAL . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.014 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HG3' HD21 ' A' ' 25' ' ' LEU . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.936 ' C ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.675 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 81' ' ' LEU . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 18' ' ' PHE . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.489 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.901 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 80' ' ' LYS . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.764 ' CG2' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.046 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.88 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 ' CG ' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB2' HG22 ' A' ' 26' ' ' THR . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.884 HD11 ' HA ' ' A' ' 68' ' ' LEU . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.79 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' N ' ' A' ' 20' ' ' ASP . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HB3' HG11 ' A' ' 85' ' ' VAL . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 64' ' ' THR . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.764 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.591 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.009 ' CG ' HD11 ' A' ' 25' ' ' LEU . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.941 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG22 ' OD1' ' A' ' 78' ' ' ASN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' ' 74' ' ' VAL . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.682 ' HG2' HD21 ' A' ' 25' ' ' LEU . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 65' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.88 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 5.8 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.484 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.96 HD11 HD13 ' A' ' 23' ' ' ILE . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.925 HD22 ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.745 ' HD3' ' CB ' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' LYS . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.731 HG23 ' CB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.985 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD2' HD23 ' A' ' 53' ' ' LEU . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.773 ' O ' HD22 ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.96 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.925 ' N ' HD22 ' A' ' 7' ' ' ASN . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.06 HD23 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 50' ' ' VAL . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.622 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 70' ' ' PHE . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.785 ' OE2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.864 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.873 HG23 HD13 ' A' ' 25' ' ' LEU . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 44' ' ' THR . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.547 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.588 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.9 t30 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB3' HG11 ' A' ' 85' ' ' VAL . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.566 ' CB ' HD23 ' A' ' 86' ' ' LEU . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.932 ' HE2' HD23 ' A' ' 38' ' ' LEU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.956 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.858 HG23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.06 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' THR . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 76' ' ' THR . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.731 ' CB ' HG23 ' A' ' 11' ' ' ILE . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.98 ' N ' HD22 ' A' ' 30' ' ' ASN . 16.5 p30 . . . . . 0 C--O 1.229 -0.025 0 CA-C-O 121.023 0.439 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 77' ' ' LYS . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 23' ' ' ILE . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.766 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.587 ' HA ' HD22 ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.671 HD13 HD13 ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 17' ' ' SER . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' NZ ' HD12 ' A' ' 86' ' ' LEU . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.986 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.952 ' HB3' HD23 ' A' ' 57' ' ' LEU . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 51' ' ' THR . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD13 HG23 ' A' ' 50' ' ' VAL . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.98 HD22 ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.778 ' CD2' HD22 ' A' ' 25' ' ' LEU . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.039 HG22 ' HG2' ' A' ' 37' ' ' GLU . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.039 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.636 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.761 ' CE2' HD12 ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.722 HG22 ' O ' ' A' ' 47' ' ' THR . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.836 HG23 HD13 ' A' ' 25' ' ' LEU . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.699 HD22 HD22 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 1.008 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.872 ' OG1' HG22 ' A' ' 82' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.985 HD11 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.602 HG22 ' ND2' ' A' ' 78' ' ' ASN . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.754 ' CE1' HD11 ' A' ' 35' ' ' ILE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.783 HG21 ' CE ' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.783 ' CE ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 69' ' ' THR . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.985 HD12 HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.872 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.774 HD12 HD21 ' A' ' 57' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.577 HG22 ' CD2' ' A' ' 86' ' ' LEU . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' HG22 ' A' ' 84' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.862 HG21 HD23 ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.991 ' HB3' HD12 ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' LYS . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.112 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.112 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.991 HD12 ' HB3' ' A' ' 7' ' ' ASN . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 6' ' ' ILE . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.498 ' CB ' ' HB ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.822 HD11 ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD11 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.582 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.781 ' CD2' HG12 ' A' ' 50' ' ' VAL . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 1.041 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.041 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 60' ' ' LEU . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.73 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.491 ' N ' ' HG2' ' A' ' 62' ' ' GLU . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 38' ' ' LEU . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.018 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HB2' HD11 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HE2' HG21 ' A' ' 67' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.693 ' N ' HG23 ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HD21 ' A' ' 68' ' ' LEU . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.818 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.986 0.422 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.652 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.972 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 80' ' ' LYS . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.983 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.983 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.989 ' HB ' HG13 ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.668 HG23 ' OE2' ' A' ' 49' ' ' GLU . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 79' ' ' PRO . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.042 ' CD1' HD23 ' A' ' 68' ' ' LEU . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.698 ' CE2' HD12 ' A' ' 35' ' ' ILE . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' HG23 ' A' ' 24' ' ' THR . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 52' ' ' LEU . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.568 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.586 HD11 ' HZ2' ' A' ' 66' ' ' LYS . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.844 ' HE2' HD11 ' A' ' 68' ' ' LEU . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.042 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 78' ' ' ASN . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 50' ' ' VAL . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.888 ' CE1' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.592 HG21 ' NZ ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.655 HD21 HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 25' ' ' LEU . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.975 HD11 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 9' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.275 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.832 ' CG ' HD13 ' A' ' 23' ' ' ILE . 11.7 p-10 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 80' ' ' LYS . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.626 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.951 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.68 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CD2' HD11 ' A' ' 83' ' ' ILE . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.991 ' HB ' HG13 ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD21 ' CG ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 28' ' ' ASN . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CG ' HD21 ' A' ' 25' ' ' LEU . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.009 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.009 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.752 HD22 ' HE3' ' A' ' 66' ' ' LYS . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 47' ' ' THR . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' HE1' HD21 ' A' ' 60' ' ' LEU . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.938 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.938 HD12 ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.803 ' HZ3' HD11 ' A' ' 60' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.636 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.825 ' C ' HG23 ' A' ' 35' ' ' ILE . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.747 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.688 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 72' ' ' PHE . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HB2' HD11 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.85 ' O ' HG23 ' A' ' 9' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.046 HD11 ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.973 0.416 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.688 HD12 ' HG ' ' A' ' 25' ' ' LEU . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 80' ' ' LYS . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.674 HG23 ' CB ' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.034 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.034 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.72 ' OD1' HG22 ' A' ' 51' ' ' THR . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.864 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 81' ' ' LEU . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.947 HD11 ' CE2' ' A' ' 70' ' ' PHE . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' CD ' HG23 ' A' ' 67' ' ' THR . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.873 HD22 ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.685 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 35' ' ' ILE . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.817 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.811 HG23 ' C ' ' A' ' 21' ' ' THR . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.827 ' CE1' HD21 ' A' ' 60' ' ' LEU . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 66' ' ' LYS . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.827 HD21 ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.874 ' HG2' HD11 ' A' ' 57' ' ' LEU . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' CD ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.824 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.671 ' C ' HG23 ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.947 ' CE2' HD11 ' A' ' 35' ' ' ILE . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.088 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 75' ' ' GLY . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.685 ' CG ' HD21 ' A' ' 25' ' ' LEU . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.008 HD11 ' CE1' ' A' ' 18' ' ' PHE . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 14' ' ' LYS . 1.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 79' ' ' PRO . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.813 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 80' ' ' LYS . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.542 HG23 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.885 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.981 ' HB3' HD23 ' A' ' 57' ' ' LEU . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.01 HD11 HD12 ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.66 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.982 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.941 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.941 HD23 ' C ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.803 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.982 ' CE2' HG23 ' A' ' 35' ' ' ILE . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' THR . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 51' ' ' THR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.585 ' N ' HG12 ' A' ' 50' ' ' VAL . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.077 HD21 ' HE2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HD2' HG21 ' A' ' 64' ' ' THR . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 3.5 t-20 -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 1.077 ' HE2' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.648 HG22 ' OE1' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.7 HD23 ' CE1' ' A' ' 70' ' ' PHE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.855 ' N ' HD13 ' A' ' 35' ' ' ILE . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.7 ' CE1' HD23 ' A' ' 68' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 75' ' ' GLY . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 74' ' ' VAL . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.885 HG12 ' HB2' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.608 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.5 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HG3' HG21 ' A' ' 74' ' ' VAL . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.715 HG23 ' HB ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.705 HD13 ' HG ' ' A' ' 25' ' ' LEU . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 9' ' ' THR . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 10' ' ' SER . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.975 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' HG22 ' A' ' 51' ' ' THR . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.848 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASN . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.715 ' HB ' HG23 ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CG ' HD22 ' A' ' 25' ' ' LEU . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.052 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.023 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 37' ' ' GLU . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CE2' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 44' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HA ' HG13 ' A' ' 50' ' ' VAL . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 22' ' ' LYS . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.704 HD12 ' H ' ' A' ' 56' ' ' TYR . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' H ' HD12 ' A' ' 53' ' ' LEU . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.847 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD12 ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.834 ' CG ' HG23 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 ' HE2' ' A' ' 66' ' ' LYS . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' HD13 ' A' ' 35' ' ' ILE . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 72' ' ' PHE . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.589 ' O ' HG23 ' A' ' 9' ' ' THR . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 67' ' ' THR . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.834 HG23 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.975 HG12 ' HB2' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.5 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.006 ' N ' HD22 ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD3' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.01 HD12 ' ND2' ' A' ' 7' ' ' ASN . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 1.01 ' ND2' HD12 ' A' ' 6' ' ' ILE . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.731 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 80' ' ' LYS . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.61 HD11 ' HE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.975 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.975 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.863 HD12 ' CG ' ' A' ' 7' ' ' ASN . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.759 ' HA ' HG22 ' A' ' 6' ' ' ILE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.421 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.006 HD22 ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.832 HD12 HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.904 ' CD ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.943 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.943 ' CE1' HD12 ' A' ' 38' ' ' LEU . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.77 HG23 ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.539 HG22 ' OD1' ' A' ' 20' ' ' ASP . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.933 HD21 ' CD1' ' A' ' 83' ' ' ILE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.642 HD13 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 60' ' ' LEU . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.577 ' OD1' HD23 ' A' ' 86' ' ' LEU . 27.3 t30 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.904 HG23 ' CD ' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.832 HD23 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.719 HG23 ' OD1' ' A' ' 78' ' ' ASN . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.708 ' CE2' HG21 ' A' ' 50' ' ' VAL . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.719 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.514 ' HB2' HD11 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.933 ' CD1' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.507 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.859 HD22 ' H ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 80' ' ' LYS . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.017 HD11 HG23 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.045 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.045 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.612 HG22 HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.859 ' H ' HD22 ' A' ' 7' ' ' ASN . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.031 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.625 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.73 HD12 ' CE2' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.835 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.971 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.725 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.94 ' CD2' HD12 ' A' ' 38' ' ' LEU . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' THR . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG12 HG22 ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 50' ' ' VAL . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.766 HD21 ' C ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.725 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 57' ' ' LEU . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HB2' HG21 ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.571 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.936 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 25' ' ' LEU . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 1.031 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 72' ' ' PHE . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HG2' HD21 ' A' ' 25' ' ' LEU . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 9' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.473 HG23 ' OG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.017 HG23 HD11 ' A' ' 11' ' ' ILE . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.571 ' OG1' HG23 ' A' ' 65' ' ' THR . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 60' ' ' LEU . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 110.976 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.612 HD12 ' ND2' ' A' ' 7' ' ' ASN . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.734 ' OD1' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.967 HG23 ' O ' ' A' ' 80' ' ' LYS . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 83' ' ' ILE . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.06 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.06 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.734 HG23 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' CE1' ' A' ' 72' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 28' ' ' ASN . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.057 HD13 HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.817 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.971 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.762 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.537 ' C ' ' O ' ' A' ' 46' ' ' GLY . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.9 m-20 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 45' ' ' LYS . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.762 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 59' ' ' THR . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 55' ' ' SER . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.799 ' HG2' HG21 ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.817 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 35' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.761 ' HB3' HD21 ' A' ' 25' ' ' LEU . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.896 ' CE1' HD23 ' A' ' 25' ' ' LEU . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 75' ' ' GLY . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.865 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.861 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 12.8 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.9 ' N ' HD22 ' A' ' 30' ' ' ASN . 7.8 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.874 0.368 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.676 HG21 ' CE1' ' A' ' 72' ' ' PHE . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.686 ' OD1' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.773 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.003 ' HB ' HG13 ' A' ' 50' ' ' VAL . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 28' ' ' ASN . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.534 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.9 HD22 ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 ' CE1' ' A' ' 70' ' ' PHE . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.758 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.796 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.586 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.831 ' CD1' HG23 ' A' ' 50' ' ' VAL . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' HD21 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.676 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.003 HG13 ' HB ' ' A' ' 23' ' ' ILE . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.1 t30 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.758 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.899 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.753 HG23 HD21 ' A' ' 78' ' ' ASN . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' CE1' HD11 ' A' ' 35' ' ' ILE . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 75' ' ' GLY . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.753 HD21 HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.773 HD11 ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 12.0 mm-40 -107.58 178.6 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 -124.92 49.46 3.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.292 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 25' ' ' LEU . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.693 ' CG ' HD13 ' A' ' 23' ' ' ILE . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG12 HD11 ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.77 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.059 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.885 ' HB ' HD21 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 50' ' ' VAL . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' A' ' 26' ' ' THR . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD11 ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.795 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.741 ' CB ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.734 ' CD2' HD12 ' A' ' 35' ' ' ILE . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 25' ' ' LEU . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.885 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE1' HD21 ' A' ' 60' ' ' LEU . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 40.0 t30 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 56' ' ' TYR . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.5 ' ND2' ' HE2' ' A' ' 88' ' ' LYS . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.626 ' CB ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.936 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.739 ' C ' HG23 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CZ ' HD23 ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG13 ' HG3' ' A' ' 2' ' ' GLN . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.509 HG22 ' HE3' ' A' ' 77' ' ' LYS . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 76' ' ' THR . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.95 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.728 HD13 ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.9 86.63 53.41 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 14' ' ' LYS . 41.6 Cg_endo -68.7 -27.82 31.56 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 122.589 2.192 . . . . 0.0 111.679 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HE2' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.15 136.27 56.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -78.98 114.63 18.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 1.7 mt -161.1 -62.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.408 0.623 . . . . 0.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.728 ' HG3' HD13 ' A' ' 86' ' ' LEU . 60.9 Cg_endo -76.42 167.85 24.92 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.801 3.001 . . . . 0.0 112.406 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.15 22.51 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.54 78.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.687 0.279 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HB2' HG11 ' A' ' 74' ' ' VAL . 7.0 mt-30 -96.84 158.0 15.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -135.48 76.31 55.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.872 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.492 ' N ' HD23 ' A' ' 81' ' ' LEU . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 83' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.987 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD2' HD23 ' A' ' 53' ' ' LEU . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.898 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.021 HD22 ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.095 HD11 ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.782 ' OE2' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.645 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.558 HE22 ' HB3' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.1 m-20 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 70' ' ' PHE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 66' ' ' LYS . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.634 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.549 HG23 ' ND2' ' A' ' 78' ' ' ASN . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.095 ' CE1' HD11 ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.021 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 2' ' ' GLN . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CG ' HD21 ' A' ' 25' ' ' LEU . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.808 HD21 ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 65' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt -85.15 154.52 60.35 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.44 129.51 18.06 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.404 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -42.31 140.15 1.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -158.13 153.83 26.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.907 ' O ' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.42 164.28 15.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 90' ' ' ILE . 53.7 Cg_endo -69.83 158.45 56.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.676 2.251 . . . . 0.0 112.239 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.76 33.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.94 -157.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.782 0.325 . . . . 0.0 110.76 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.863 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mtm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.665 ' OE1' HG12 ' A' ' 74' ' ' VAL . 1.2 mp0 -136.05 146.07 46.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 -113.9 73.16 2.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.447 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.857 HD11 HG21 ' A' ' 23' ' ' ILE . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.89 ' ND2' ' H ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 80' ' ' LYS . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.744 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.587 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.861 ' HB ' HD21 ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 6' ' ' ILE . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.89 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.045 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 28' ' ' ASN . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 68' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.895 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.917 HD22 ' HE3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.677 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.842 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.861 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.8 ' O ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 63' ' ' ASN . 5.7 p-10 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.917 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HD3' ' A' ' 80' ' ' LYS . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.955 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 78' ' ' ASN . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.045 ' CD2' HD11 ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HE1' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.665 HG12 ' OE1' ' A' ' 2' ' ' GLN . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.784 ' O ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 11' ' ' ILE . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -90.35 157.08 45.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 86' ' ' LEU . 5.9 Cg_endo -49.18 115.11 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.111 2.541 . . . . 0.0 112.814 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -45.88 112.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.806 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.715 ' O ' HD13 ' A' ' 90' ' ' ILE . 9.0 t0 -112.9 176.48 5.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 89' ' ' ASP . 19.8 mm -144.65 73.47 15.32 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.223 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HB2' HD22 ' A' ' 93' ' ' LEU . 53.0 Cg_endo -69.93 122.68 9.31 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.28 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.98 -26.11 42.42 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.628 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' PRO . 3.2 mm? 62.15 94.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.882 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.875 0.369 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.795 ' CD ' HG12 ' A' ' 74' ' ' VAL . 1.7 mp0 -117.02 166.44 12.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -140.22 78.51 23.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' ILE . 7.6 p-10 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.869 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.473 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD23 ' A' ' 57' ' ' LEU . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.598 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 HD13 ' HZ ' ' A' ' 70' ' ' PHE . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.076 HD11 ' CE2' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.043 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.776 ' CD1' HG13 ' A' ' 50' ' ' VAL . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.833 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.477 ' CB ' ' HA2' ' A' ' 16' ' ' GLY . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.854 HD13 ' HG3' ' A' ' 66' ' ' LYS . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 3.6 m120 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 82' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.854 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.646 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.867 HD21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.076 ' CE2' HD11 ' A' ' 25' ' ' LEU . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.795 HG12 ' CD ' ' A' ' 2' ' ' GLN . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.869 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.78 HD13 ' HA ' ' A' ' 9' ' ' THR . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.56 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.2 pp -124.1 84.19 55.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 56.0 Cg_endo -75.22 -26.98 10.06 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.535 2.157 . . . . 0.0 111.703 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -48.41 140.77 7.41 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.22 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -166.8 0.12 Allowed 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.941 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG23 ' HD2' ' A' ' 91' ' ' PRO . 29.3 mm -139.57 137.57 18.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.09 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' HD2' HG23 ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.78 132.41 23.23 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.632 2.222 . . . . 0.0 112.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.84 -31.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -159.45 88.27 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.916 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.782 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.824 0.345 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.613 ' HG3' HG11 ' A' ' 74' ' ' VAL . 2.8 mt-30 -104.91 164.03 12.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.843 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 -132.53 70.26 79.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.962 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.962 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 80' ' ' LYS . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.425 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HB3' HD23 ' A' ' 57' ' ' LEU . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG23 HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.113 HD11 ' CE1' ' A' ' 70' ' ' PHE . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.623 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 4.5 m-20 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.818 ' CE1' HD21 ' A' ' 60' ' ' LEU . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.842 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 64' ' ' THR . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.658 ' CE ' HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.838 ' O ' HD21 ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 80' ' ' LYS . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.113 ' CE1' HD11 ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG11 ' HG3' ' A' ' 2' ' ' GLN . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 78' ' ' ASN . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 82' ' ' THR . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? -61.36 164.99 7.58 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 86' ' ' LEU . 94.8 Cg_endo -79.07 137.35 13.62 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.073 2.516 . . . . 0.0 112.585 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.16 144.69 57.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.88 94.06 1.03 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 93' ' ' LEU . 4.7 tt -132.66 137.02 28.85 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD2' ' CG1' ' A' ' 90' ' ' ILE . 55.2 Cg_endo -70.01 117.07 4.88 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.6 2.2 . . . . 0.0 112.296 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.91 -22.96 4.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 90' ' ' ILE . 1.5 pp -146.17 101.85 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 110.8 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.834 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' H ' HG12 ' A' ' 74' ' ' VAL . 35.4 mm-40 -78.27 176.83 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 -129.03 84.47 62.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.778 ' CG ' HD12 ' A' ' 23' ' ' ILE . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' LYS . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.414 ' C ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.734 HD11 HD12 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.997 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.778 HD12 ' CG ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 24' ' ' THR . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.917 HD11 ' CE2' ' A' ' 70' ' ' PHE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.808 HD13 ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.755 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.726 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.623 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.658 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 5.1 mm100 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.808 ' CE2' HD13 ' A' ' 35' ' ' ILE . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.726 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 50' ' ' VAL . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.837 ' CD2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HD2' HD23 ' A' ' 60' ' ' LEU . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.848 ' HD2' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.726 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 72' ' ' PHE . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 74' ' ' VAL . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.943 ' O ' HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 67' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.739 HG12 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.58 168.57 20.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' A' ' 86' ' ' LEU . 60.1 Cg_endo -73.44 130.47 15.05 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.495 2.13 . . . . 0.0 112.333 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.93 164.35 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.672 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -69.94 162.61 27.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 89' ' ' ASP . 37.5 mm -148.6 66.58 9.11 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.29 168.08 21.99 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.583 2.189 . . . . 0.0 112.504 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.1 1.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.578 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.85 32.06 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.038 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.817 0.342 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -77.95 179.66 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 -143.15 72.47 18.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.004 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.634 HG22 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.927 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' THR . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.766 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 87' ' ' PRO . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.035 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' THR . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' OE2' ' A' ' 49' ' ' GLU . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.014 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.634 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 43' ' ' TYR . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.697 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HG2' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 35' ' ' ILE . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.738 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.602 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 47' ' ' THR . 1.7 p30 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 24' ' ' THR . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.788 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.738 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.805 ' CE1' HD21 ' A' ' 60' ' ' LEU . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.887 HD23 ' CG ' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' OE1' ' A' ' 37' ' ' GLU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 52' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 69' ' ' THR . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE1' HG11 ' A' ' 50' ' ' VAL . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.014 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HG3' HD21 ' A' ' 25' ' ' LEU . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.936 ' C ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.675 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 81' ' ' LEU . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 18' ' ' PHE . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -118.05 75.26 10.81 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.604 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 21.1 Cg_exo -64.91 -148.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 112.433 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.45 132.29 48.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.29 30.83 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.767 HD13 ' N ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -130.56 130.81 23.01 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.122 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.767 ' N ' HD13 ' A' ' 90' ' ' ILE . 55.3 Cg_endo -70.32 114.63 3.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.634 2.222 . . . . 0.0 112.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -119.87 -31.6 1.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER 61.75 63.39 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.755 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HG3' HG12 ' A' ' 74' ' ' VAL . 7.8 mt-30 -147.59 -179.78 7.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -142.56 74.27 19.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.489 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.901 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 80' ' ' LYS . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.764 ' CG2' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.046 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.88 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 ' CG ' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB2' HG22 ' A' ' 26' ' ' THR . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.884 HD11 ' HA ' ' A' ' 68' ' ' LEU . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.79 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' N ' ' A' ' 20' ' ' ASP . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HB3' HG11 ' A' ' 85' ' ' VAL . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.773 ' HA ' ' CG ' ' A' ' 87' ' ' PRO . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.581 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.591 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.009 ' CG ' HD11 ' A' ' 25' ' ' LEU . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.941 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.574 HG12 ' HG3' ' A' ' 2' ' ' GLN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' ' 74' ' ' VAL . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.682 ' HG2' HD21 ' A' ' 25' ' ' LEU . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 65' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.065 HG22 ' HD3' ' A' ' 87' ' ' PRO . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 5.8 mt -106.65 69.15 0.23 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.065 ' HD3' HG22 ' A' ' 85' ' ' VAL . 30.1 Cg_endo -62.65 -156.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.121 2.548 . . . . 0.0 112.177 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 163.82 14.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.654 ' O ' HD13 ' A' ' 90' ' ' ILE . 6.5 t0 -84.34 128.64 34.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 89' ' ' ASP . 41.1 mm -149.3 137.64 11.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 90' ' ' ILE . 53.3 Cg_endo -70.01 114.82 3.87 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.541 2.161 . . . . 0.0 112.206 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.92 33.73 2.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.73 81.07 8.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.805 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' H ' HG11 ' A' ' 74' ' ' VAL . 1.5 mm100 -70.06 150.81 46.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.787 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -124.53 82.39 59.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.484 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.96 HD11 HD13 ' A' ' 23' ' ' ILE . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.925 HD22 ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.745 ' HD3' ' CB ' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' LYS . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.731 HG23 ' CB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.949 ' HB3' ' HB3' ' A' ' 87' ' ' PRO . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.985 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD2' HD23 ' A' ' 53' ' ' LEU . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.773 ' O ' HD22 ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.96 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.925 ' N ' HD22 ' A' ' 7' ' ' ASN . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.06 HD23 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 50' ' ' VAL . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.622 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 70' ' ' PHE . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.785 ' OE2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.864 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.873 HG23 HD13 ' A' ' 25' ' ' LEU . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 44' ' ' THR . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.588 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.9 t30 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB3' HG11 ' A' ' 85' ' ' VAL . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.566 ' CB ' HD23 ' A' ' 86' ' ' LEU . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.932 ' HE2' HD23 ' A' ' 38' ' ' LEU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.956 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.858 HG23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.06 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.77 HG11 ' H ' ' A' ' 2' ' ' GLN . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 76' ' ' THR . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.731 ' CB ' HG23 ' A' ' 11' ' ' ILE . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -140.38 95.14 8.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.949 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 57.7 Cg_endo -73.55 -43.87 0.6 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.41 2.074 . . . . 0.0 112.075 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -65.27 163.27 15.69 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.995 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.59 165.33 12.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.549 HG23 ' HD2' ' A' ' 91' ' ' PRO . 3.5 mp -70.01 137.69 87.32 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD2' HG23 ' A' ' 90' ' ' ILE . 55.3 Cg_endo -69.94 134.23 27.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.63 2.22 . . . . 0.0 112.319 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -104.18 -21.71 9.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -176.19 102.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 110.956 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.826 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.831 0.348 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.651 ' CG ' HG11 ' A' ' 74' ' ' VAL . 2.0 mm100 -118.31 151.59 37.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.774 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 16.5 p30 -134.01 75.57 66.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.243 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' CA ' ' ND2' ' A' ' 30' ' ' ASN . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 23' ' ' ILE . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.766 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.587 ' HA ' HD22 ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.671 HD13 HD13 ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 17' ' ' SER . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' NZ ' HD12 ' A' ' 86' ' ' LEU . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB3' ' HB3' ' A' ' 87' ' ' PRO . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.986 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.952 ' HB3' HD23 ' A' ' 57' ' ' LEU . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 51' ' ' THR . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD13 HG23 ' A' ' 50' ' ' VAL . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.778 ' CD2' HD22 ' A' ' 25' ' ' LEU . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.039 HG22 ' HG2' ' A' ' 37' ' ' GLU . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.039 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.636 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.761 ' CE2' HD12 ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.722 HG22 ' O ' ' A' ' 47' ' ' THR . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.836 HG23 HD13 ' A' ' 25' ' ' LEU . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.699 HD22 HD22 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 1.008 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' CB ' ' HE2' ' A' ' 88' ' ' LYS . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.872 ' OG1' HG22 ' A' ' 82' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.985 HD11 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.602 HG22 ' ND2' ' A' ' 78' ' ' ASN . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.754 ' CE1' HD11 ' A' ' 35' ' ' ILE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.783 HG21 ' CE ' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.783 ' CE ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 69' ' ' THR . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.985 HD12 HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.872 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.774 HD12 HD21 ' A' ' 57' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.577 HG22 ' CD2' ' A' ' 86' ' ' LEU . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' HG22 ' A' ' 84' ' ' THR . 0.4 OUTLIER -136.5 103.02 9.48 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.897 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -75.3 -31.84 5.52 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.696 2.264 . . . . 0.0 112.093 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.29 138.02 57.93 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.823 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.08 164.72 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.061 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.556 HG23 ' HD2' ' A' ' 91' ' ' PRO . 30.2 mm -98.48 137.68 20.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.168 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 90' ' ' ILE . 52.2 Cg_endo -69.62 114.39 3.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 0.0 112.188 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.99 31.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER 69.97 37.05 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LEU . 11.3 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.041 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' CE ' HG21 ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.798 ' H ' HG11 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -69.91 -105.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -170.46 47.94 0.1 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.862 HG21 HD23 ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.991 ' HB3' HD12 ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' LYS . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.112 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.112 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.991 HD12 ' HB3' ' A' ' 7' ' ' ASN . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 6' ' ' ILE . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.498 ' CB ' ' HB ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.822 HD11 ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD11 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.582 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.781 ' CD2' HG12 ' A' ' 50' ' ' VAL . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 1.041 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.041 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 60' ' ' LEU . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HA ' ' CG ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 38' ' ' LEU . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.018 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG11 ' H ' ' A' ' 2' ' ' GLN . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.61 HG21 ' CE ' ' A' ' 1' ' ' MET . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HB2' HD11 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HE2' HG21 ' A' ' 67' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.693 ' N ' HG23 ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HD21 ' A' ' 68' ' ' LEU . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.009 HG22 ' HD3' ' A' ' 87' ' ' PRO . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt -104.39 71.37 0.18 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.009 ' HD3' HG22 ' A' ' 85' ' ' VAL . 36.4 Cg_endo -66.37 -155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.33 -0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 111.905 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.64 132.12 48.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.243 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 91' ' ' PRO . 1.3 t0 -120.91 148.42 44.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -84.68 -26.5 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 90' ' ' ILE . 84.5 Cg_endo -86.34 132.81 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.398 2.732 . . . . 0.0 112.461 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.35 32.24 7.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.537 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.26 119.92 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.939 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.779 0.324 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HG3' HG11 ' A' ' 74' ' ' VAL . 7.8 mt-30 -142.37 157.39 44.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 -134.01 77.59 61.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.99 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.652 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.972 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 80' ' ' LYS . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.983 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.983 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.989 ' HB ' HG13 ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.668 HG23 ' OE2' ' A' ' 49' ' ' GLU . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 79' ' ' PRO . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.042 ' CD1' HD23 ' A' ' 68' ' ' LEU . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.698 ' CE2' HD12 ' A' ' 35' ' ' ILE . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' HG23 ' A' ' 24' ' ' THR . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 52' ' ' LEU . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.568 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.586 HD11 ' HZ2' ' A' ' 66' ' ' LYS . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.844 ' HE2' HD11 ' A' ' 68' ' ' LEU . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.042 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 78' ' ' ASN . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 50' ' ' VAL . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.888 ' CE1' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.592 HG21 ' NZ ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.655 HD21 HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 25' ' ' LEU . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.975 HD11 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 9' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? -76.35 159.4 79.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 63' ' ' ASN . 54.8 Cg_endo -70.25 163.77 37.45 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.668 2.245 . . . . 0.0 112.345 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -64.93 167.87 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.013 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.29 160.7 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG23 ' HD2' ' A' ' 91' ' ' PRO . 4.5 mp -109.89 137.61 20.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' HD2' HG23 ' A' ' 90' ' ' ILE . 54.1 Cg_endo -69.88 147.42 62.07 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.176 . . . . 0.0 112.239 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 93' ' ' LEU . . . 105.93 -39.97 2.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.291 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 92' ' ' GLY . 1.8 tp 174.41 140.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.691 0.281 . . . . 0.0 111.038 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.652 0.263 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 2.3 mm-40 -105.51 164.28 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.69 84.34 15.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.119 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.832 ' CG ' HD13 ' A' ' 23' ' ' ILE . 11.7 p-10 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 80' ' ' LYS . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.626 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.951 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.68 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CD2' HD11 ' A' ' 83' ' ' ILE . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.991 ' HB ' HG13 ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD21 ' CG ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 28' ' ' ASN . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CG ' HD21 ' A' ' 25' ' ' LEU . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.009 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.009 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.752 HD22 ' HE3' ' A' ' 66' ' ' LYS . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 47' ' ' THR . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' HE1' HD21 ' A' ' 60' ' ' LEU . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.938 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.938 HD12 ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.435 ' HB2' ' HD3' ' A' ' 87' ' ' PRO . 11.9 t30 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.803 ' HZ3' HD11 ' A' ' 60' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.636 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.825 ' C ' HG23 ' A' ' 35' ' ' ILE . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.747 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.688 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 72' ' ' PHE . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HB2' HD11 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.85 ' O ' HG23 ' A' ' 9' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.046 HD11 ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -75.99 173.58 6.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 88.3 Cg_endo -83.83 168.39 12.43 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.44 2.094 . . . . 0.0 112.457 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.0 167.88 7.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -98.61 -171.11 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.879 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.3 mp -147.82 136.19 11.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 57.2 Cg_endo -70.97 154.78 62.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 0.0 112.344 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 155.8 -32.24 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.325 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tt -162.53 94.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.903 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.873 ' HG3' HG12 ' A' ' 74' ' ' VAL . 2.0 mt-30 -103.34 166.23 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -127.75 61.66 51.91 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.688 HD12 ' HG ' ' A' ' 25' ' ' LEU . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 80' ' ' LYS . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.674 HG23 ' CB ' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.034 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.034 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.72 ' OD1' HG22 ' A' ' 51' ' ' THR . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.864 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 81' ' ' LEU . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.947 HD11 ' CE2' ' A' ' 70' ' ' PHE . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' CD ' HG23 ' A' ' 67' ' ' THR . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.873 HD22 ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.685 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 35' ' ' ILE . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.817 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.811 HG23 ' C ' ' A' ' 21' ' ' THR . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.827 ' CE1' HD21 ' A' ' 60' ' ' LEU . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 66' ' ' LYS . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.827 HD21 ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.443 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.874 ' HG2' HD11 ' A' ' 57' ' ' LEU . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' CD ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.824 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.671 ' C ' HG23 ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.947 ' CE2' HD11 ' A' ' 35' ' ' ILE . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.088 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.873 HG12 ' HG3' ' A' ' 2' ' ' GLN . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.685 ' CG ' HD21 ' A' ' 25' ' ' LEU . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.008 HD11 ' CE1' ' A' ' 18' ' ' PHE . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 14' ' ' LYS . 1.2 mt -73.78 159.46 84.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 37.8 Cg_endo -66.93 127.48 17.01 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.437 2.091 . . . . 0.0 112.288 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.38 142.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 8.6 t70 -134.62 145.23 48.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -113.41 93.62 27.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.88 147.95 63.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.659 2.239 . . . . 0.0 112.503 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 38.98 57.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.412 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.29 60.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.963 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.738 0.304 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 4.8 mt-30 -128.65 -176.4 3.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -122.6 48.92 2.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.395 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 79' ' ' PRO . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.813 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 80' ' ' LYS . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.542 HG23 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.885 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.981 ' HB3' HD23 ' A' ' 57' ' ' LEU . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.01 HD11 HD12 ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.66 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.982 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.941 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.941 HD23 ' C ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.803 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.982 ' CE2' HG23 ' A' ' 35' ' ' ILE . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' THR . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 51' ' ' THR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.585 ' N ' HG12 ' A' ' 50' ' ' VAL . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.077 HD21 ' HE2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HD2' HG21 ' A' ' 64' ' ' THR . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 3.5 t-20 -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 1.077 ' HE2' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.648 HG22 ' OE1' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.7 HD23 ' CE1' ' A' ' 70' ' ' PHE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.855 ' N ' HD13 ' A' ' 35' ' ' ILE . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.7 ' CE1' HD23 ' A' ' 68' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 75' ' ' GLY . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 74' ' ' VAL . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.885 HG12 ' HB2' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.874 HD12 ' HE2' ' A' ' 88' ' ' LYS . 1.5 mt -94.16 161.72 28.71 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.508 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 71.2 Cg_endo -77.98 -32.66 2.46 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 122.634 2.223 . . . . 0.0 112.08 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.874 ' HE2' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -42.35 164.16 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.184 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -160.15 145.03 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.624 HG22 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mm -118.59 77.01 13.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.16 153.97 66.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.796 2.331 . . . . 0.0 112.263 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.23 42.49 41.2 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.496 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -50.18 93.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 111.037 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' HB ' ' A' ' 74' ' ' VAL . 34.9 ttp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.749 ' HB2' HG11 ' A' ' 74' ' ' VAL . 24.9 mm-40 -137.76 -179.35 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 -113.53 61.5 0.87 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HG3' HG21 ' A' ' 74' ' ' VAL . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.715 HG23 ' HB ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.705 HD13 ' HG ' ' A' ' 25' ' ' LEU . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 9' ' ' THR . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 10' ' ' SER . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.975 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' HG22 ' A' ' 51' ' ' THR . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.848 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASN . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.715 ' HB ' HG23 ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CG ' HD22 ' A' ' 25' ' ' LEU . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.052 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.023 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 37' ' ' GLU . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CE2' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 44' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HA ' HG13 ' A' ' 50' ' ' VAL . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 22' ' ' LYS . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.704 HD12 ' H ' ' A' ' 56' ' ' TYR . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' H ' HD12 ' A' ' 53' ' ' LEU . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.847 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD12 ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.472 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.834 ' CG ' HG23 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 ' HE2' ' A' ' 66' ' ' LYS . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' HD13 ' A' ' 35' ' ' ILE . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 2' ' ' GLN . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.589 ' O ' HG23 ' A' ' 9' ' ' THR . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 67' ' ' THR . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.834 HG23 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.975 HG12 ' HB2' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.5 mt -84.05 161.68 54.4 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 9.9 Cg_endo -53.58 117.93 4.35 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.554 2.169 . . . . 0.0 112.346 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -50.92 142.62 11.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.695 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 31.59 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 110.661 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' O ' HG23 ' A' ' 90' ' ' ILE . 4.3 tt -105.58 94.34 8.43 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.99 143.89 51.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.703 2.268 . . . . 0.0 112.243 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.58 22.52 23.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.543 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.02 109.92 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.868 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' CB ' ' NE2' ' A' ' 2' ' ' GLN . 1.7 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' NE2' ' CB ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -127.97 144.95 51.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -118.58 62.47 5.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.817 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.01 HD12 ' ND2' ' A' ' 7' ' ' ASN . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 1.01 ' ND2' HD12 ' A' ' 6' ' ' ILE . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 80' ' ' LYS . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.61 HD11 ' HE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.975 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.975 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.863 HD12 ' CG ' ' A' ' 7' ' ' ASN . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.759 ' HA ' HG22 ' A' ' 6' ' ' ILE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.421 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.832 HD12 HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.904 ' CD ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.943 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.943 ' CE1' HD12 ' A' ' 38' ' ' LEU . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.77 HG23 ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.539 HG22 ' OD1' ' A' ' 20' ' ' ASP . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.933 HD21 ' CD1' ' A' ' 83' ' ' ILE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD13 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 60' ' ' LEU . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.577 ' OD1' HD23 ' A' ' 86' ' ' LEU . 27.3 t30 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.904 HG23 ' CD ' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.832 HD23 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.719 HG23 ' OD1' ' A' ' 78' ' ' ASN . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.708 ' CE2' HG21 ' A' ' 50' ' ' VAL . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.719 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' HB2' HD11 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.933 ' CD1' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -119.04 91.61 43.74 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 60.2 Cg_endo -72.8 -31.17 10.64 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.098 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -64.93 123.08 18.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.72 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.644 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -97.68 31.67 2.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.332 0.587 . . . . 0.0 110.743 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 89' ' ' ASP . 38.0 mm -148.99 92.59 4.33 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.061 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 164.84 33.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.61 43.51 85.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -137.41 -159.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.765 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 93' ' ' LEU . 5.1 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.778 0.323 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 3.5 mm100 -116.45 178.58 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -133.04 68.03 78.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.507 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.859 HD22 ' H ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 80' ' ' LYS . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.017 HD11 HG23 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.045 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.045 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.612 HG22 HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.859 ' H ' HD22 ' A' ' 7' ' ' ASN . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.031 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.625 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.73 HD12 ' CE2' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.835 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.971 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.725 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.94 ' CD2' HD12 ' A' ' 38' ' ' LEU . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' THR . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG12 HG22 ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 50' ' ' VAL . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.766 HD21 ' C ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.725 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 57' ' ' LEU . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HB2' HG21 ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.571 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.936 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 25' ' ' LEU . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 1.031 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 72' ' ' PHE . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HG2' HD21 ' A' ' 25' ' ' LEU . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 9' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.473 HG23 ' OG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.017 HG23 HD11 ' A' ' 11' ' ' ILE . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.571 ' OG1' HG23 ' A' ' 65' ' ' THR . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 60' ' ' LEU . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -106.35 163.64 16.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 86' ' ' LEU . 58.8 Cg_endo -71.76 137.14 29.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.474 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.06 111.67 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.647 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -160.48 164.62 32.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 90' ' ' ILE . 5.0 tp -129.05 58.78 39.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.19 132.82 23.4 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.809 2.339 . . . . 0.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.51 -21.38 77.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 93' ' ' LEU . 5.3 tt -110.53 80.57 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 0.0 110.964 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.842 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.77 0.319 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.739 ' CG ' HG12 ' A' ' 74' ' ' VAL . 1.7 mm100 -102.19 160.34 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -132.84 73.42 75.87 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD12 ' ND2' ' A' ' 7' ' ' ASN . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.734 ' OD1' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.967 HG23 ' O ' ' A' ' 80' ' ' LYS . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 83' ' ' ILE . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.06 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.06 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.734 HG23 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' CE1' ' A' ' 72' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 28' ' ' ASN . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.057 HD13 HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.817 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.971 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.762 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.537 ' C ' ' O ' ' A' ' 46' ' ' GLY . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.9 m-20 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 45' ' ' LYS . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.762 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 59' ' ' THR . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 55' ' ' SER . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.799 ' HG2' HG21 ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.817 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 35' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.761 ' HB3' HD21 ' A' ' 25' ' ' LEU . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.896 ' CE1' HD23 ' A' ' 25' ' ' LEU . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.739 HG12 ' CG ' ' A' ' 2' ' ' GLN . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.865 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.861 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 87' ' ' PRO . 12.8 mt -92.52 164.17 23.59 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 86' ' ' LEU . 59.3 Cg_endo -72.18 170.37 19.23 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 0.0 112.404 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 167.76 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -127.19 144.92 50.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.065 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mm -102.25 93.08 3.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.38 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.62 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.78 2.32 . . . . 0.0 112.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -110.63 33.91 5.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tt 69.85 84.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.354 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.799 ' CD ' HG11 ' A' ' 74' ' ' VAL . 2.7 mp0 -140.14 154.02 46.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 7.8 p30 -121.61 55.13 5.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.28 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.676 HG21 ' CE1' ' A' ' 72' ' ' PHE . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.686 ' OD1' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.773 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.003 ' HB ' HG13 ' A' ' 50' ' ' VAL . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 28' ' ' ASN . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.534 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 ' CE1' ' A' ' 70' ' ' PHE . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.758 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.796 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.586 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.831 ' CD1' HG23 ' A' ' 50' ' ' VAL . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' HD21 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.676 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.003 HG13 ' HB ' ' A' ' 23' ' ' ILE . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.1 t30 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.758 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.899 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.753 HG23 HD21 ' A' ' 78' ' ' ASN . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' CE1' HD11 ' A' ' 35' ' ' ILE . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.799 HG11 ' CD ' ' A' ' 2' ' ' GLN . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.753 HD21 HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.773 HD11 ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 7.0 mt -78.2 159.43 75.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 61.0 Cg_endo -73.62 130.29 14.63 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.71 2.273 . . . . 0.0 112.411 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.3 160.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.86 112.51 6.34 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.884 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.12 163.32 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.32 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.74 121.21 7.91 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.043 2.495 . . . . 0.0 112.274 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.43 24.63 4.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.423 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 90' ' ' ILE . 1.7 pp -97.78 102.31 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.744 0.307 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 25' ' ' LEU . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.693 ' CG ' HD13 ' A' ' 23' ' ' ILE . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.603 HG12 HD11 ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.77 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.059 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.885 ' HB ' HD21 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 50' ' ' VAL . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' A' ' 26' ' ' THR . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD11 ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.795 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.741 ' CB ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.734 ' CD2' HD12 ' A' ' 35' ' ' ILE . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 25' ' ' LEU . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.885 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE1' HD21 ' A' ' 60' ' ' LEU . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 4.8 t-20 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 56' ' ' TYR . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.626 ' CB ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.936 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.739 ' C ' HG23 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CZ ' HD23 ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.509 HG22 ' HE3' ' A' ' 77' ' ' LYS . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 76' ' ' THR . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 69' ' ' THR . 4.8 p-10 -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.95 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.871 0.367 . . . . 0.0 110.961 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.872 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.492 ' N ' HD23 ' A' ' 81' ' ' LEU . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 83' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.987 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD2' HD23 ' A' ' 53' ' ' LEU . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.898 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.021 HD22 ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.095 HD11 ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.782 ' OE2' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.645 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.558 HE22 ' HB3' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' ND2' ' A' ' 48' ' ' ASN . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 70' ' ' PHE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 66' ' ' LYS . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.634 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.549 HG23 ' ND2' ' A' ' 78' ' ' ASN . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.095 ' CE1' HD11 ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.021 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 76' ' ' THR . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CG ' HD21 ' A' ' 25' ' ' LEU . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.808 HD21 ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 65' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.648 0.261 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.447 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.857 HD11 HG21 ' A' ' 23' ' ' ILE . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.812 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 80' ' ' LYS . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.744 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.587 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.861 ' HB ' HD21 ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 6' ' ' ILE . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.045 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 28' ' ' ASN . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 68' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.895 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.917 HD22 ' HE3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.677 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.842 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.861 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.8 ' O ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.917 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HD3' ' A' ' 80' ' ' LYS . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.955 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 78' ' ' ASN . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.045 ' CD2' HD11 ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HE1' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 75' ' ' GLY . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.784 ' O ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 11' ' ' ILE . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.671 ' ND2' HG12 ' A' ' 6' ' ' ILE . 3.2 p30 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.869 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.473 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD23 ' A' ' 57' ' ' LEU . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.598 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.573 HD13 ' ND2' ' A' ' 7' ' ' ASN . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.076 HD11 ' CE2' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.043 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.776 ' CD1' HG13 ' A' ' 50' ' ' VAL . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.833 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.477 ' CB ' ' HA2' ' A' ' 16' ' ' GLY . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.854 HD13 ' HG3' ' A' ' 66' ' ' LYS . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.4 m-80 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 82' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.854 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.646 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.867 HD21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.076 ' CE2' HD11 ' A' ' 25' ' ' LEU . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 72' ' ' PHE . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.869 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.78 HD13 ' HA ' ' A' ' 9' ' ' THR . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.56 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.2 pp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.962 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.962 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 80' ' ' LYS . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.425 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HB3' HD23 ' A' ' 57' ' ' LEU . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG23 HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.113 HD11 ' CE1' ' A' ' 70' ' ' PHE . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.623 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.8 m120 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.818 ' CE1' HD21 ' A' ' 60' ' ' LEU . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.842 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 64' ' ' THR . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.658 ' CE ' HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.838 ' O ' HD21 ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 80' ' ' LYS . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.113 ' CE1' HD11 ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 78' ' ' ASN . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 82' ' ' THR . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.778 ' CG ' HD12 ' A' ' 23' ' ' ILE . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.687 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' LYS . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.414 ' C ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.734 HD11 HD12 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.997 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.778 HD12 ' CG ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 24' ' ' THR . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.917 HD11 ' CE2' ' A' ' 70' ' ' PHE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.808 HD13 ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.755 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.726 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.623 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.658 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 18.4 mm-40 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.808 ' CE2' HD13 ' A' ' 35' ' ' ILE . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.726 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 50' ' ' VAL . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.837 ' CD2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HD2' HD23 ' A' ' 60' ' ' LEU . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.848 ' HD2' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.726 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 72' ' ' PHE . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 74' ' ' VAL . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.943 ' O ' HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 67' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.739 HG12 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.634 HG22 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.927 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' THR . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.766 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 58' ' ' ASN . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.035 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' THR . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' OE2' ' A' ' 49' ' ' GLU . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.014 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.634 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 43' ' ' TYR . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.697 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HG2' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 35' ' ' ILE . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.738 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.598 ' O ' ' CB ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 24' ' ' THR . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.788 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.738 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.805 ' CE1' HD21 ' A' ' 60' ' ' LEU . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.887 HD23 ' CG ' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.805 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 62' ' ' GLU . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' OE1' ' A' ' 37' ' ' GLU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 52' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 69' ' ' THR . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE1' HG11 ' A' ' 50' ' ' VAL . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.014 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HG3' HD21 ' A' ' 25' ' ' LEU . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.936 ' C ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.675 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 81' ' ' LEU . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 18' ' ' PHE . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.489 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.901 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 80' ' ' LYS . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.764 ' CG2' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.046 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.88 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 ' CG ' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB2' HG22 ' A' ' 26' ' ' THR . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.884 HD11 ' HA ' ' A' ' 68' ' ' LEU . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.79 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' N ' ' A' ' 20' ' ' ASP . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HB3' HG11 ' A' ' 85' ' ' VAL . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 64' ' ' THR . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.764 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.591 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.009 ' CG ' HD11 ' A' ' 25' ' ' LEU . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.941 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG22 ' OD1' ' A' ' 78' ' ' ASN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' ' 74' ' ' VAL . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.682 ' HG2' HD21 ' A' ' 25' ' ' LEU . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 65' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.88 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 5.8 mt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.484 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.96 HD11 HD13 ' A' ' 23' ' ' ILE . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.767 ' OD1' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.745 ' HD3' ' CB ' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' LYS . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.731 HG23 ' CB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.985 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD2' HD23 ' A' ' 53' ' ' LEU . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.773 ' O ' HD22 ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.96 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.767 HG22 ' OD1' ' A' ' 7' ' ' ASN . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.06 HD23 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 50' ' ' VAL . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.622 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 70' ' ' PHE . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.785 ' OE2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.864 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.873 HG23 HD13 ' A' ' 25' ' ' LEU . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 44' ' ' THR . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.547 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.588 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB3' HG11 ' A' ' 85' ' ' VAL . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.566 ' CB ' HD23 ' A' ' 86' ' ' LEU . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.932 ' HE2' HD23 ' A' ' 38' ' ' LEU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.956 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.858 HG23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.06 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' THR . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 76' ' ' THR . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.66 HD21 HG22 ' A' ' 69' ' ' THR . 12.5 p-10 -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.731 ' CB ' HG23 ' A' ' 11' ' ' ILE . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 16.5 p30 . . . . . 0 C--O 1.229 -0.025 0 CA-C-O 121.023 0.439 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' CA ' ' ND2' ' A' ' 30' ' ' ASN . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 23' ' ' ILE . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.766 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.587 ' HA ' HD22 ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.671 HD13 HD13 ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 17' ' ' SER . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' NZ ' HD12 ' A' ' 86' ' ' LEU . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.986 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.952 ' HB3' HD23 ' A' ' 57' ' ' LEU . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 51' ' ' THR . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD13 HG23 ' A' ' 50' ' ' VAL . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.778 ' CD2' HD22 ' A' ' 25' ' ' LEU . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.039 HG22 ' HG2' ' A' ' 37' ' ' GLU . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.039 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.636 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.761 ' CE2' HD12 ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.722 HG22 ' O ' ' A' ' 47' ' ' THR . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.595 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.836 HG23 HD13 ' A' ' 25' ' ' LEU . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.699 HD22 HD22 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 1.008 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.872 ' OG1' HG22 ' A' ' 82' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.985 HD11 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.602 HG22 ' ND2' ' A' ' 78' ' ' ASN . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.754 ' CE1' HD11 ' A' ' 35' ' ' ILE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.783 HG21 ' CE ' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.783 ' CE ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 69' ' ' THR . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.985 HD12 HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.872 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.774 HD12 HD21 ' A' ' 57' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.577 HG22 ' CD2' ' A' ' 86' ' ' LEU . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' HG22 ' A' ' 84' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.862 HG21 HD23 ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.991 ' HB3' HD12 ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' LYS . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.112 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.112 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.991 HD12 ' HB3' ' A' ' 7' ' ' ASN . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 6' ' ' ILE . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.498 ' CB ' ' HB ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.822 HD11 ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD11 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.1 mm-40 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.582 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.781 ' CD2' HG12 ' A' ' 50' ' ' VAL . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 1.041 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.041 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 60' ' ' LEU . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.73 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.491 ' N ' ' HG2' ' A' ' 62' ' ' GLU . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 38' ' ' LEU . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.018 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HB2' HD11 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HE2' HG21 ' A' ' 67' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.693 ' N ' HG23 ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HD21 ' A' ' 68' ' ' LEU . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.818 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.986 0.422 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.652 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.972 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 80' ' ' LYS . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.983 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.983 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.989 ' HB ' HG13 ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.668 HG23 ' OE2' ' A' ' 49' ' ' GLU . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 79' ' ' PRO . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.042 ' CD1' HD23 ' A' ' 68' ' ' LEU . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.643 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.698 ' CE2' HD12 ' A' ' 35' ' ' ILE . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' HG23 ' A' ' 24' ' ' THR . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 52' ' ' LEU . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.568 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.586 HD11 ' HZ2' ' A' ' 66' ' ' LYS . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.844 ' HE2' HD11 ' A' ' 68' ' ' LEU . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.042 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 78' ' ' ASN . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 50' ' ' VAL . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.888 ' CE1' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.592 HG21 ' NZ ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.655 HD21 HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 25' ' ' LEU . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.975 HD11 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 9' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.275 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.832 ' CG ' HD13 ' A' ' 23' ' ' ILE . 1.8 p30 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 80' ' ' LYS . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.626 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.951 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.68 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CD2' HD11 ' A' ' 83' ' ' ILE . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.991 ' HB ' HG13 ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD21 ' CG ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 28' ' ' ASN . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CG ' HD21 ' A' ' 25' ' ' LEU . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.009 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.009 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.752 HD22 ' HE3' ' A' ' 66' ' ' LYS . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 47' ' ' THR . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' HE1' HD21 ' A' ' 60' ' ' LEU . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.938 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.938 HD12 ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.803 ' HZ3' HD11 ' A' ' 60' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.636 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.825 ' C ' HG23 ' A' ' 35' ' ' ILE . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.747 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.688 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 72' ' ' PHE . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HB2' HD11 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.85 ' O ' HG23 ' A' ' 9' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.046 HD11 ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.973 0.416 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.688 HD12 ' HG ' ' A' ' 25' ' ' LEU . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 80' ' ' LYS . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.674 HG23 ' CB ' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.034 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.034 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.72 ' OD1' HG22 ' A' ' 51' ' ' THR . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.864 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 81' ' ' LEU . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.947 HD11 ' CE2' ' A' ' 70' ' ' PHE . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' CD ' HG23 ' A' ' 67' ' ' THR . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.873 HD22 ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.685 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 35' ' ' ILE . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.817 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.811 HG23 ' C ' ' A' ' 21' ' ' THR . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.827 ' CE1' HD21 ' A' ' 60' ' ' LEU . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 66' ' ' LYS . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.827 HD21 ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.874 ' HG2' HD11 ' A' ' 57' ' ' LEU . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' CD ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.824 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.671 ' C ' HG23 ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.947 ' CE2' HD11 ' A' ' 35' ' ' ILE . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.088 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 75' ' ' GLY . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.685 ' CG ' HD21 ' A' ' 25' ' ' LEU . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.008 HD11 ' CE1' ' A' ' 18' ' ' PHE . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 14' ' ' LYS . 1.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 79' ' ' PRO . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.813 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 80' ' ' LYS . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.542 HG23 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.885 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.981 ' HB3' HD23 ' A' ' 57' ' ' LEU . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.01 HD11 HD12 ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.66 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.982 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.941 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.941 HD23 ' C ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.803 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.982 ' CE2' HG23 ' A' ' 35' ' ' ILE . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' THR . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 51' ' ' THR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.585 ' N ' HG12 ' A' ' 50' ' ' VAL . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.077 HD21 ' HE2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HD2' HG21 ' A' ' 64' ' ' THR . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 1.077 ' HE2' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.648 HG22 ' OE1' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.7 HD23 ' CE1' ' A' ' 70' ' ' PHE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.855 ' N ' HD13 ' A' ' 35' ' ' ILE . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.7 ' CE1' HD23 ' A' ' 68' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 75' ' ' GLY . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 74' ' ' VAL . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.885 HG12 ' HB2' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.608 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.5 mt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HG3' HG21 ' A' ' 74' ' ' VAL . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.715 HG23 ' HB ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.705 HD13 ' HG ' ' A' ' 25' ' ' LEU . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 9' ' ' THR . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 10' ' ' SER . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.975 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' HG22 ' A' ' 51' ' ' THR . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.848 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASN . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.715 ' HB ' HG23 ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CG ' HD22 ' A' ' 25' ' ' LEU . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.052 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.023 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 37' ' ' GLU . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CE2' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 44' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HA ' HG13 ' A' ' 50' ' ' VAL . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 22' ' ' LYS . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.704 HD12 ' H ' ' A' ' 56' ' ' TYR . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' H ' HD12 ' A' ' 53' ' ' LEU . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.847 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD12 ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.834 ' CG ' HG23 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 ' HE2' ' A' ' 66' ' ' LYS . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' HD13 ' A' ' 35' ' ' ILE . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 72' ' ' PHE . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.589 ' O ' HG23 ' A' ' 9' ' ' THR . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 67' ' ' THR . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.834 HG23 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.975 HG12 ' HB2' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.5 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.814 0.34 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.01 HD12 ' ND2' ' A' ' 7' ' ' ASN . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 1.01 ' ND2' HD12 ' A' ' 6' ' ' ILE . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.731 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 80' ' ' LYS . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.61 HD11 ' HE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.975 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.975 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.863 HD12 ' CG ' ' A' ' 7' ' ' ASN . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.759 ' HA ' HG22 ' A' ' 6' ' ' ILE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.421 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.832 HD12 HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.904 ' CD ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.943 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.943 ' CE1' HD12 ' A' ' 38' ' ' LEU . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.77 HG23 ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.539 HG22 ' OD1' ' A' ' 20' ' ' ASP . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.933 HD21 ' CD1' ' A' ' 83' ' ' ILE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.6 t-20 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.642 HD13 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 60' ' ' LEU . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HD23 ' A' ' 86' ' ' LEU . 3.1 t-20 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.904 HG23 ' CD ' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.832 HD23 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.719 HG23 ' OD1' ' A' ' 78' ' ' ASN . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.708 ' CE2' HG21 ' A' ' 50' ' ' VAL . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.719 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.514 ' HB2' HD11 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.933 ' CD1' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.507 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.818 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 80' ' ' LYS . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.017 HD11 HG23 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.045 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.045 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.612 HG22 HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.031 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.625 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.73 HD12 ' CE2' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.835 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.971 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.725 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.94 ' CD2' HD12 ' A' ' 38' ' ' LEU . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' THR . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG12 HG22 ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 50' ' ' VAL . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.766 HD21 ' C ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.725 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 57' ' ' LEU . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HB2' HG21 ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.571 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.936 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 25' ' ' LEU . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 1.031 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 72' ' ' PHE . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HG2' HD21 ' A' ' 25' ' ' LEU . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 9' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.473 HG23 ' OG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.017 HG23 HD11 ' A' ' 11' ' ' ILE . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.571 ' OG1' HG23 ' A' ' 65' ' ' THR . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 60' ' ' LEU . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.938 0.399 . . . . 0.0 110.976 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.612 HD12 ' ND2' ' A' ' 7' ' ' ASN . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.734 ' OD1' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.967 HG23 ' O ' ' A' ' 80' ' ' LYS . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 83' ' ' ILE . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.06 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.06 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.734 HG23 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' CE1' ' A' ' 72' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 28' ' ' ASN . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.057 HD13 HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.817 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.971 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.762 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.568 HG22 ' ND2' ' A' ' 48' ' ' ASN . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' ND2' HG22 ' A' ' 47' ' ' THR . 1.2 m120 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 45' ' ' LYS . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.762 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 59' ' ' THR . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 55' ' ' SER . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.799 ' HG2' HG21 ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.817 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 35' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.761 ' HB3' HD21 ' A' ' 25' ' ' LEU . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.896 ' CE1' HD23 ' A' ' 25' ' ' LEU . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 75' ' ' GLY . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.865 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.861 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 12.8 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 7.8 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.874 0.368 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.676 HG21 ' CE1' ' A' ' 72' ' ' PHE . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.686 ' OD1' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.773 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.003 ' HB ' HG13 ' A' ' 50' ' ' VAL . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 28' ' ' ASN . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.534 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 ' CE1' ' A' ' 70' ' ' PHE . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.758 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.796 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.586 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.831 ' CD1' HG23 ' A' ' 50' ' ' VAL . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' HD21 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.676 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.003 HG13 ' HB ' ' A' ' 23' ' ' ILE . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.758 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.899 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.753 HG23 HD21 ' A' ' 78' ' ' ASN . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' CE1' HD11 ' A' ' 35' ' ' ILE . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 75' ' ' GLY . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.753 HD21 HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.773 HD11 ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 7.0 mt . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 12.0 mm-40 -107.58 178.6 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 57.7 p30 -124.92 49.46 3.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.292 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 82.4 Cg_endo -78.01 136.09 14.48 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.718 2.279 . . . . 0.0 111.705 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 26' ' ' THR . 2.9 m -118.92 105.87 11.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.479 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.574 HG21 ' HG ' ' A' ' 25' ' ' LEU . 1.3 pt -129.93 -176.78 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.285 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.693 ' CG ' HD13 ' A' ' 23' ' ' ILE . 2.3 p30 -39.87 168.77 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.518 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 77.2 Cg_exo -51.14 -157.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.771 2.314 . . . . 0.0 112.978 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -126.56 -1.2 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.21 140.46 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG12 HD11 ' A' ' 81' ' ' LEU . 27.0 pt -146.5 165.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.984 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.72 136.79 31.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.169 0.509 . . . . 0.0 111.848 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.81 163.21 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.086 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 10.8 tttm -70.48 140.23 51.86 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.77 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -63.5 101.29 0.32 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.823 0.821 . . . . 0.0 110.144 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.28 -37.13 1.92 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.858 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.4 9.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.552 0.692 . . . . 0.0 109.821 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.059 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 68.8 m-85 -98.9 74.95 2.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.023 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.51 152.29 45.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 5.9 t70 -34.44 114.79 0.23 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.619 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.885 ' HB ' HD21 ' A' ' 52' ' ' LEU . 2.1 m -124.33 121.44 34.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.185 0.517 . . . . 0.0 111.101 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -91.03 119.62 31.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.08 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 7' ' ' ASN . 1.9 mt -94.9 158.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 4.1 m -109.92 121.67 45.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD13 HG12 ' A' ' 50' ' ' VAL . 1.7 mp -107.75 92.46 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.202 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 5' ' ' THR . 6.2 m -69.57 109.89 5.41 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.067 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -100.05 16.15 0.42 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 124.939 3.76 . . . . 0.0 111.617 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' A' ' 26' ' ' THR . 5.0 t30 -37.16 -13.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.214 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.697 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -168.18 13.38 0.06 OUTLIER Glycine 0 C--N 1.311 -0.857 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.405 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -140.29 169.62 17.34 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.045 0.45 . . . . 0.0 111.28 -178.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.5 t -125.16 158.12 34.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 22.5 t80 -128.27 135.62 49.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.28 -55.51 2.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 171.43 168.57 33.24 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD11 ' CE1' ' A' ' 70' ' ' PHE . 1.1 mt -103.48 92.84 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 121.134 0.492 . . . . 0.0 110.024 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 37' ' ' GLU . 18.3 m -55.65 -43.86 76.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.868 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.795 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -41.46 -31.15 0.23 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pt? -135.55 85.17 2.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.769 0.795 . . . . 0.0 110.076 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.989 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.81 89.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.077 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER 8.27 -41.89 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.953 -2.385 . . . . 0.0 113.671 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.989 ' N ' ' O ' ' A' ' 39' ' ' GLN . 1.2 t -50.58 -27.72 7.33 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.741 ' CB ' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -63.75 -32.21 73.63 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.834 0.826 . . . . 0.0 110.429 178.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.734 ' CD2' HD12 ' A' ' 35' ' ' ILE . 4.1 p90 -123.87 -173.48 2.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.872 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -136.71 90.99 2.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.047 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 10.2 ttpt -68.82 163.19 24.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.576 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -156.84 73.35 0.23 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 6.6 t 10.02 107.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.793 0.437 . . . . 0.0 112.005 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 47' ' ' THR . 9.8 m-20 91.81 -14.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.39 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.1 mt-10 -151.3 165.32 34.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.376 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.728 HG12 HD13 ' A' ' 25' ' ' LEU . 1.3 p -165.58 132.41 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.081 0.467 . . . . 0.0 111.381 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 22' ' ' LYS . 2.8 t -112.48 143.02 44.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.885 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -101.48 145.29 29.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.263 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' SER . 9.8 mt -99.87 124.42 45.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.601 0.715 . . . . 0.0 112.215 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -45.6 -11.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.301 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -70.38 -47.54 60.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.469 . . . . 0.0 110.299 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.69 ' CE1' HD21 ' A' ' 60' ' ' LEU . 2.9 t80 -68.99 -59.89 2.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.104 0.954 . . . . 0.0 109.098 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -49.17 -47.6 45.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.797 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 4.8 t-20 -65.79 -28.06 68.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 35.6 m -69.99 -35.39 74.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.69 HD21 ' CE1' ' A' ' 56' ' ' TYR . 3.3 mm? -44.12 131.23 4.42 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 62' ' ' GLU . 42.2 Cg_exo -56.97 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.839 2.36 . . . . 0.0 112.655 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.1 mp0 -51.8 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.961 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.5 ' ND2' ' HE2' ' A' ' 88' ' ' LYS . 2.7 t-20 -39.09 67.83 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.32 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.789 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.1 p -95.01 146.58 24.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.311 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -101.67 78.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.626 ' CB ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -65.22 139.91 58.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 67' ' ' THR . 1.8 t -128.3 103.25 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.545 0.688 . . . . 0.0 111.774 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.936 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 1.4 mp -68.76 81.49 0.29 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.739 ' C ' HG23 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -80.47 85.93 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.864 -178.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 98.0 m-85 -69.86 106.81 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.3 100.31 1.31 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.439 0.638 . . . . 0.0 111.272 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.556 ' CZ ' HD23 ' A' ' 25' ' ' LEU . 3.4 m-85 -105.35 28.54 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.56 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.09 -7.57 21.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.802 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG13 ' HG3' ' A' ' 2' ' ' GLN . 15.9 m -126.19 45.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.916 0.388 . . . . 0.0 110.89 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -39.08 -29.75 0.1 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.93 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.509 HG22 ' HE3' ' A' ' 77' ' ' LYS . 90.2 m -39.76 -46.4 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.874 0.369 . . . . 0.0 111.214 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HE3' HG22 ' A' ' 76' ' ' THR . 1.2 ptpp? -142.58 17.5 2.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 69' ' ' THR . 4.8 p-10 -45.15 151.53 0.67 Allowed Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 6' ' ' ILE . 18.1 Cg_endo -60.63 98.47 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.51 2.14 . . . . 0.0 112.48 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -93.95 121.3 35.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.759 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD23 HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.51 85.44 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.22 0.534 . . . . 0.0 110.875 -179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.521 HG22 HG22 ' A' ' 65' ' ' THR . 0.3 OUTLIER -69.73 89.77 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.141 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.95 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.2 tt -90.93 130.75 39.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.792 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.6 119.1 32.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -104.18 106.27 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.728 HD13 ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.9 86.63 53.41 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 14' ' ' LYS . 41.6 Cg_endo -68.7 -27.82 31.56 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 122.589 2.192 . . . . 0.0 111.679 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HE2' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.15 136.27 56.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.924 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -78.98 114.63 18.08 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 1.7 mt -161.1 -62.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.408 0.623 . . . . 0.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.728 ' HG3' HD13 ' A' ' 86' ' ' LEU . 60.9 Cg_endo -76.42 167.85 24.92 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 123.801 3.001 . . . . 0.0 112.406 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.15 22.51 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.54 78.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.687 0.279 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HB2' HG11 ' A' ' 74' ' ' VAL . 7.0 mt-30 -96.84 158.0 15.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -135.48 76.31 55.81 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.961 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.2 Cg_endo -88.18 165.94 6.88 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.983 2.455 . . . . 0.0 112.322 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -121.99 176.3 5.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.989 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 79' ' ' PRO . 6.9 tp -169.97 146.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.872 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -54.65 -98.79 0.0 OUTLIER Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.26 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 72.0 Cg_endo -98.51 -167.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.506 0 CA-C-N 121.661 1.629 . . . . 0.0 112.98 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -128.07 -19.49 3.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.775 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.492 ' N ' HD23 ' A' ' 81' ' ' LEU . 37.6 t -170.77 148.5 2.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.304 0.573 . . . . 0.0 112.171 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 83' ' ' ILE . 1.9 pt -148.6 172.45 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.961 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.73 139.11 41.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.035 0.445 . . . . 0.0 111.706 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.987 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.09 149.59 3.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 3.9 ttpm? -70.16 150.06 46.89 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -61.4 103.92 0.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.932 0.872 . . . . 0.0 110.823 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.15 -37.55 2.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.41 11.85 0.3 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.403 0.62 . . . . 0.0 110.041 178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 55.1 m-85 -95.38 80.6 3.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.85 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.45 134.52 49.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD2' HD23 ' A' ' 53' ' ' LEU . 4.9 t70 -34.89 137.94 0.12 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.898 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.1 m -148.06 149.13 31.51 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.397 0.618 . . . . 0.0 111.062 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.93 169.92 9.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.064 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 50' ' ' VAL . 5.5 mt -149.31 156.03 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.789 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.472 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 m -122.85 103.73 8.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.021 HD22 ' CE1' ' A' ' 72' ' ' PHE . 1.5 mt -95.97 107.29 19.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.38 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.532 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 54.9 m -69.44 113.07 14.28 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 120.709 0.29 . . . . 0.0 110.527 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.7 Cg_endo -92.24 2.84 3.94 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.24 3.293 . . . . 0.0 113.067 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -37.19 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.781 1.232 . . . . 0.0 111.327 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.28 -23.23 25.42 Favored Glycine 0 C--N 1.306 -1.138 0 CA-C-N 113.159 -1.837 . . . . 0.0 112.41 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -101.18 170.52 8.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.998 0.428 . . . . 0.0 111.202 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.2 t -128.5 168.2 16.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.0 t80 -124.34 127.96 48.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -32.1 10.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.298 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 138.25 -173.72 22.32 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.095 HD11 ' CE1' ' A' ' 70' ' ' PHE . 34.5 mt -123.3 102.68 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.326 0.584 . . . . 0.0 110.614 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 -44.04 94.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.416 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.782 ' OE2' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -47.63 -27.19 1.77 Allowed 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.645 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -138.93 83.58 1.96 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.682 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.842 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.8 pt20 -31.29 89.23 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.254 1.026 . . . . 0.0 111.519 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 33.9 p -4.17 -41.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 111.589 -2.551 . . . . 0.0 113.303 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -51.98 -21.58 3.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.558 HE22 ' HB3' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -70.23 -26.1 63.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -121.36 -169.32 1.83 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.81 177.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 51' ' ' THR . 46.0 m -138.8 92.8 2.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.513 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.41 169.08 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.27 79.6 0.13 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.582 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' ND2' ' A' ' 48' ' ' ASN . 98.9 m 12.74 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 112.313 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.22 -11.84 0.73 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.375 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 9.2 mt-10 -146.07 166.25 26.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.98 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 70' ' ' PHE . 2.2 p -162.43 142.94 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.401 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -126.42 127.12 44.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.099 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.43 147.63 25.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.8 OUTLIER -106.84 124.09 49.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.373 0.606 . . . . 0.0 112.063 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -46.53 -9.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.373 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -70.4 -43.34 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.25 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 39.2 t80 -83.24 -49.39 9.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.475 0.655 . . . . 0.0 109.636 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.605 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.26 -39.26 66.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.205 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 26.3 t30 -65.71 -31.45 72.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.911 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 16.1 m -73.85 -26.5 60.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.05 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.634 HD22 ' CE ' ' A' ' 66' ' ' LYS . 36.7 mt -34.7 127.41 0.5 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.44 -173.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.994 2.462 . . . . 0.0 112.925 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.5 mp0 -53.76 -166.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.836 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 1.4 t-20 -38.57 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.074 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -113.04 169.87 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.607 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -125.92 73.94 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.792 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.634 ' CE ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -42.7 161.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.758 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' OE2' ' A' ' 37' ' ' GLU . 10.9 m -141.52 112.27 7.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.043 0.449 . . . . 0.0 111.236 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 HD12 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -88.0 74.06 8.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.549 HG23 ' ND2' ' A' ' 78' ' ' ASN . 23.8 m -94.32 93.99 8.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 111.334 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.095 ' CE1' HD11 ' A' ' 35' ' ' ILE . 31.4 m-85 -71.03 110.92 6.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.943 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -68.15 94.69 0.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.573 0.701 . . . . 0.0 110.197 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.021 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -95.07 19.22 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.753 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.83 28.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.022 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 2' ' ' GLN . 17.3 m -126.27 46.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.875 0.369 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 78' ' ' ASN . . . -33.6 -32.14 0.01 OUTLIER Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.547 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 74' ' ' VAL . 88.5 m -47.12 -65.95 0.48 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 0.0 110.419 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 24.85 10.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.357 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.549 ' ND2' HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -52.87 140.71 39.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.439 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.63 ' CG ' HD21 ' A' ' 25' ' ' LEU . 75.7 Cg_endo -78.79 92.18 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.769 2.313 . . . . 0.0 112.284 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.18 147.55 23.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.808 HD21 ' HG2' ' A' ' 8' ' ' PRO . 2.6 mt -130.35 88.81 2.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.168 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.865 HG22 HG22 ' A' ' 65' ' ' THR . 21.8 m -69.88 120.74 16.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.799 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.931 HD11 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -106.96 115.88 49.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.397 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -84.02 95.56 8.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.348 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -81.92 114.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.482 . . . . 0.0 110.817 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 4.6 mt -85.15 154.52 60.35 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.911 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.44 129.51 18.06 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.714 2.276 . . . . 0.0 112.337 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.404 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -42.31 140.15 1.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -158.13 153.83 26.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.907 ' O ' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -110.42 164.28 15.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.043 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 90' ' ' ILE . 53.7 Cg_endo -69.83 158.45 56.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.676 2.251 . . . . 0.0 112.239 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.76 33.05 1.77 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.907 HD11 ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.94 -157.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.782 0.325 . . . . 0.0 110.76 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.863 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mtm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.665 ' OE1' HG12 ' A' ' 74' ' ' VAL . 1.2 mp0 -136.05 146.07 46.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.5 t70 -113.9 73.16 2.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 73.4 Cg_endo -76.4 146.67 28.06 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.795 2.33 . . . . 0.0 111.77 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.447 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -124.83 167.67 14.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 111.897 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.857 HD11 HG21 ' A' ' 23' ' ' ILE . 17.1 tt -158.31 153.9 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.812 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -49.94 -80.11 0.02 OUTLIER Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 84.2 Cg_endo -104.69 -175.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.938 0 CA-C-N 119.859 0.985 . . . . 0.0 113.295 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 80' ' ' LYS . 7.1 m -150.0 8.0 0.64 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.57 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.554 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -170.31 145.92 2.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.278 0.561 . . . . 0.0 112.212 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 83' ' ' ILE . 15.8 tt -164.82 153.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.327 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -136.41 134.55 37.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.462 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.47 163.59 6.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.065 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.744 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -70.65 151.4 44.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.663 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 85' ' ' VAL . . . -62.46 102.94 0.36 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.595 0.712 . . . . 0.0 110.735 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.07 -34.63 2.78 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.768 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.53 10.04 0.4 Allowed 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.49 0.662 . . . . 0.0 110.136 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.9 m-85 -96.19 81.84 3.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -69.01 139.31 54.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.733 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.587 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -35.5 140.94 0.09 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.861 ' HB ' HD21 ' A' ' 52' ' ' LEU . 22.2 m -150.67 164.55 35.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.912 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -107.12 167.48 9.88 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.011 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.857 HG21 HD11 ' A' ' 6' ' ' ILE . 31.3 mt -151.19 116.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.784 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.06 99.44 12.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.021 0.439 . . . . 0.0 110.208 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.045 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 mt -83.68 110.5 18.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.179 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 28' ' ' ASN . 19.6 m -69.48 110.15 5.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.4 Cg_endo -94.32 4.26 2.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 124.135 3.224 . . . . 0.0 112.273 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -36.94 67.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 125.218 1.407 . . . . 0.0 111.473 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 107.1 -22.96 28.46 Favored Glycine 0 C--N 1.305 -1.151 0 CA-C-N 113.298 -1.774 . . . . 0.0 112.296 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.29 163.81 12.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.853 0.358 . . . . 0.0 110.783 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.9 t -127.06 156.95 40.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 15.3 t80 -104.35 140.54 37.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.162 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -104.43 -42.7 5.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.96 177.17 28.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.955 HD11 ' HA ' ' A' ' 68' ' ' LEU . 17.8 tt -111.63 93.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.693 0.759 . . . . 0.0 111.677 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.0 p -65.72 -32.19 73.6 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.793 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.895 ' O ' HD23 ' A' ' 38' ' ' LEU . 1.4 tt0 -53.8 -25.71 20.53 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.917 HD22 ' HE3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -148.18 92.75 2.07 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.305 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.918 ' O ' ' N ' ' A' ' 41' ' ' SER . 47.4 mm-40 -30.45 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.765 1.269 . . . . 0.0 111.614 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.543 ' O ' ' CD1' ' A' ' 43' ' ' TYR . 57.5 m 5.33 -43.7 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 111.167 -2.742 . . . . 0.0 113.495 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.918 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -47.31 -26.01 1.13 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.677 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.49 -32.62 68.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.939 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.842 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.22 -172.32 2.59 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.033 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -133.48 87.85 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.136 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.567 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.36 167.03 17.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.593 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -176.4 86.38 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.876 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 48' ' ' ASN . 4.6 t 24.5 97.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 47' ' ' THR . 6.0 t30 73.63 -1.68 2.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.489 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 46' ' ' GLY . 16.3 mt-10 -126.21 144.39 50.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.938 0.399 . . . . 0.0 111.204 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -152.72 117.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 6.8 m -113.13 123.12 49.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.308 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.861 HD21 ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.97 146.93 23.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.321 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -101.41 121.77 42.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 112.011 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.595 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -47.76 -9.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.048 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LEU . 67.5 p -70.67 -43.87 68.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.814 0.34 . . . . 0.0 110.959 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 42' ' ' GLN . 52.7 t80 -78.89 -51.82 9.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 0.0 110.386 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.8 ' O ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -56.63 -35.59 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.377 179.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.7 t30 -66.36 -23.0 66.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 60' ' ' LEU . 17.5 m -106.29 -7.46 17.76 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.8 HD22 ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -46.04 169.16 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.749 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 48.8 Cg_exo -55.99 173.35 0.43 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.693 2.262 . . . . 0.0 113.209 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.757 ' O ' ' N ' ' A' ' 64' ' ' THR . 12.3 pt-20 -68.74 -158.92 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.206 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 87' ' ' PRO . 6.0 p30 -38.09 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.46 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.757 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.7 p -139.56 178.38 7.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.554 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -105.16 91.46 3.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.178 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.917 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.0 tptt -65.52 87.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.746 HG23 ' HD3' ' A' ' 80' ' ' LYS . 41.9 m -92.45 130.31 38.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.955 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -107.09 89.55 3.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.646 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 78' ' ' ASN . 91.2 m -87.12 106.9 18.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.584 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.045 ' CD2' HD11 ' A' ' 25' ' ' LEU . 64.4 m-85 -80.28 103.61 10.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.471 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.53 99.29 1.24 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.099 0.476 . . . . 0.0 111.323 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HE1' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -95.49 25.01 4.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.171 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.32 -15.09 25.23 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.681 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.665 HG12 ' OE1' ' A' ' 2' ' ' GLN . 34.8 m -92.99 -48.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.838 0.351 . . . . 0.0 111.128 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 78.92 -57.89 4.29 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.802 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -54.06 -70.3 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.86 0.362 . . . . 0.0 111.039 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -90.5 13.68 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.511 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.34 123.77 51.14 Favored Pre-proline 0 N--CA 1.452 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.102 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 11.3 Cg_endo -56.01 99.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.537 2.158 . . . . 0.0 112.067 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.784 ' O ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -113.97 141.4 47.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 8' ' ' PRO . 1.4 mt -107.5 105.46 15.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.539 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -85.66 103.76 14.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 111.573 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 11' ' ' ILE . 1.8 mt -97.63 143.05 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.342 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.1 m -111.32 100.21 8.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.511 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.25 112.63 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' HG ' ' HA ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -90.35 157.08 45.36 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.027 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 86' ' ' LEU . 5.9 Cg_endo -49.18 115.11 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.111 2.541 . . . . 0.0 112.814 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -45.88 112.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.806 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.715 ' O ' HD13 ' A' ' 90' ' ' ILE . 9.0 t0 -112.9 176.48 5.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 89' ' ' ASP . 19.8 mm -144.65 73.47 15.32 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.223 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HB2' HD22 ' A' ' 93' ' ' LEU . 53.0 Cg_endo -69.93 122.68 9.31 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.28 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.98 -26.11 42.42 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.628 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 91' ' ' PRO . 3.2 mm? 62.15 94.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.882 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.875 0.369 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.795 ' CD ' HG12 ' A' ' 74' ' ' VAL . 1.7 mp0 -117.02 166.44 12.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -140.22 78.51 23.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 97.0 Cg_endo -87.08 157.34 8.46 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' THR . 34.1 m -143.52 110.26 5.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.861 0.362 . . . . 0.0 111.642 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.796 HG21 HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -131.35 -170.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.112 0.482 . . . . 0.0 111.723 -179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.671 ' ND2' HG12 ' A' ' 6' ' ' ILE . 3.2 p30 -47.04 173.44 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.139 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 53.0 Cg_exo -56.55 -155.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.782 2.321 . . . . 0.0 112.635 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.869 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -143.03 -2.76 1.0 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 p -130.82 128.98 41.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.112 0.482 . . . . 0.0 111.784 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -156.78 139.98 7.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.646 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.473 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -146.61 137.7 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.584 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.87 169.97 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.326 0.584 . . . . 0.0 110.558 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.8 tttt -70.1 133.94 47.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -56.26 101.26 0.05 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.903 0.859 . . . . 0.0 110.462 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.7 -37.94 1.81 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.971 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.09 10.91 0.36 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.46 0.647 . . . . 0.0 110.018 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.919 ' HB3' HD23 ' A' ' 57' ' ' LEU . 64.3 m-85 -96.13 81.23 3.33 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.194 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.598 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.78 156.11 38.93 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.961 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.2 t70 -34.72 114.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.123 0.265 . . . . 0.0 110.783 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 m -110.93 102.18 10.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.489 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' CE ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.54 162.15 28.1 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.522 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.573 HD13 ' ND2' ' A' ' 7' ' ' ASN . 32.7 mt -152.47 148.77 14.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.786 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 m -125.11 97.03 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.505 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.076 HD11 ' CE2' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -82.41 101.33 10.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.347 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 5' ' ' THR . 57.3 m -69.65 110.83 7.17 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.833 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.5 Cg_endo -91.05 3.08 4.54 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.057 3.171 . . . . 0.0 113.111 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.8 t-20 -37.5 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.8 1.24 . . . . 0.0 111.237 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.833 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.76 -27.67 8.6 Favored Glycine 0 C--N 1.307 -1.031 0 CA-C-N 113.145 -1.843 . . . . 0.0 112.263 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.55 168.84 9.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.993 0.425 . . . . 0.0 110.946 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 12.8 t -130.04 165.69 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.497 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 6.4 t80 -115.07 140.33 49.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -114.14 -37.68 4.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.863 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.61 160.45 8.32 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.698 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -96.32 96.69 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -59.92 -37.63 80.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.043 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.07 -25.92 24.17 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.99 81.21 1.78 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.45 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.964 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -32.28 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 122.483 1.135 . . . . 0.0 111.036 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.631 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 42.0 t 7.38 -43.19 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 111.46 -2.609 . . . . 0.0 113.636 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.964 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.98 -24.9 2.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.083 0.468 . . . . 0.0 110.487 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.612 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 7.5 mm-40 -63.59 -30.84 71.9 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.751 0.786 . . . . 0.0 111.127 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.776 ' CD1' HG13 ' A' ' 50' ' ' VAL . 42.1 p90 -127.29 -168.47 1.89 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.563 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.76 89.73 3.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.561 -179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.68 157.78 35.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.155 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.87 78.7 0.13 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.912 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 46' ' ' GLY . 5.0 t 14.81 100.26 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.814 0.445 . . . . 0.0 112.108 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.6 m-20 84.17 -4.75 1.07 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.305 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -142.57 163.58 32.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.989 0.423 . . . . 0.0 111.226 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.776 HG13 ' CD1' ' A' ' 43' ' ' TYR . 74.2 t -157.17 153.28 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.197 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 95.6 m -137.34 115.41 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.901 0.382 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.5 mp -69.14 133.62 48.25 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 14.9 mt -105.12 108.47 20.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.138 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.61 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.86 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 12.8 t -70.39 -45.47 65.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.119 0.485 . . . . 0.0 110.297 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.833 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -68.54 -60.99 2.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.848 0.832 . . . . 0.0 109.514 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.919 HD23 ' HB3' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -48.88 -44.44 39.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.727 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.477 ' CB ' ' HA2' ' A' ' 16' ' ' GLY . 41.9 t30 -65.55 -20.24 66.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.233 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -97.5 -19.19 18.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.854 HD13 ' HG3' ' A' ' 66' ' ' LYS . 8.1 mt -49.93 156.62 1.25 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.997 0.427 . . . . 0.0 111.02 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.28 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.983 2.456 . . . . 0.0 113.015 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.791 ' O ' ' N ' ' A' ' 64' ' ' THR . 3.4 pt-20 -68.96 -166.4 0.08 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.494 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.4 m-80 -39.13 70.37 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.115 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.791 ' N ' ' O ' ' A' ' 62' ' ' GLU . 32.7 p -125.37 142.99 51.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.851 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 82' ' ' THR . 0.7 OUTLIER -87.93 73.84 9.08 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.535 0.683 . . . . 0.0 111.579 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.854 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -66.85 115.46 6.64 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.755 178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.646 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -93.71 149.13 21.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.867 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.867 HD21 ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -119.33 83.27 2.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.839 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -93.4 119.65 32.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.225 0.536 . . . . 0.0 111.154 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.076 ' CE2' HD11 ' A' ' 25' ' ' LEU . 36.6 m-85 -79.01 115.78 18.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 5.0 t70 -68.59 84.94 0.29 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.881 0.848 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.689 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -93.54 21.88 5.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.767 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 8.92 9.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.925 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.795 HG12 ' CD ' ' A' ' 2' ' ' GLN . 18.3 m -102.38 -36.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 63.32 -75.65 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.173 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.7 m -47.09 -64.3 0.81 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' CE ' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -90.35 13.71 14.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 30.3 t-20 -68.66 114.79 24.69 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.063 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 6' ' ' ILE . 9.5 Cg_endo -55.37 98.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.732 2.288 . . . . 0.0 112.147 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.869 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.38 103.95 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.215 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.78 HD13 ' HA ' ' A' ' 9' ' ' THR . 3.9 mm? -71.44 148.91 46.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.664 0.269 . . . . 0.0 110.84 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.56 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -122.9 95.78 4.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.466 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.31 118.75 44.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.671 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -93.62 105.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.615 179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -95.06 106.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.047 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.2 pp -124.1 84.19 55.49 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 56.0 Cg_endo -75.22 -26.98 10.06 Favored 'Trans proline' 0 CA--C 1.513 -0.548 0 C-N-CA 122.535 2.157 . . . . 0.0 111.703 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -48.41 140.77 7.41 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.22 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -166.8 0.12 Allowed 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.941 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG23 ' HD2' ' A' ' 91' ' ' PRO . 29.3 mm -139.57 137.57 18.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.09 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' HD2' HG23 ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.78 132.41 23.23 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.632 2.222 . . . . 0.0 112.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.84 -31.07 0.12 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -159.45 88.27 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 0.0 110.916 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.782 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.824 0.345 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.613 ' HG3' HG11 ' A' ' 74' ' ' VAL . 2.8 mt-30 -104.91 164.03 12.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.843 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 10.9 t70 -132.53 70.26 79.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.7 Cg_endo -82.88 156.75 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.193 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -131.19 152.27 50.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.155 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 17.0 tt -148.37 163.53 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.042 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.962 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.84 -105.59 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.972 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.962 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 9.4 Cg_endo -104.59 -161.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.605 0 CA-C-N 121.908 1.717 . . . . 0.0 112.688 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 80' ' ' LYS . 9.7 m -141.88 3.76 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.314 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 m -154.5 134.73 13.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.86 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tp -154.76 145.82 13.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.95 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.425 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.62 135.28 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.112 0.482 . . . . 0.0 111.552 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.89 164.26 7.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' O ' ' OG ' ' A' ' 17' ' ' SER . 12.1 tptm -70.18 134.52 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -53.24 102.23 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.769 0.795 . . . . 0.0 110.657 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 135.29 -37.42 1.92 Allowed Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.278 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.88 10.79 0.35 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.405 0.621 . . . . 0.0 110.069 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.842 ' HB3' HD23 ' A' ' 57' ' ' LEU . 65.2 m-85 -97.0 77.9 2.77 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.814 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.64 160.25 30.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.159 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.3 t70 -34.48 114.92 0.24 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.631 0.253 . . . . 0.0 110.595 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.5 m -116.25 110.27 18.54 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.736 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 168.27 14.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 110.491 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG23 HD21 ' A' ' 7' ' ' ASN . 0.4 OUTLIER -155.57 151.37 10.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.299 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 m -125.96 98.52 5.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 72' ' ' PHE . 4.7 mt -82.9 99.22 9.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.753 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.51 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 47.6 m -69.51 109.73 5.08 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 8.5 Cg_endo -94.96 2.85 2.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.156 3.237 . . . . 0.0 113.139 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -37.81 67.59 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.792 1.237 . . . . 0.0 111.351 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.55 -24.67 14.93 Favored Glycine 0 C--N 1.308 -1.003 0 CA-C-N 113.094 -1.867 . . . . 0.0 112.486 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.92 170.09 8.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.074 0.464 . . . . 0.0 110.942 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -127.23 164.57 21.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.637 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 10.8 t80 -118.69 141.43 48.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.49 -48.46 2.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.029 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.526 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 155.19 159.91 9.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.304 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.113 HD11 ' CE1' ' A' ' 70' ' ' PHE . 5.0 mt -95.59 99.47 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.239 0.542 . . . . 0.0 111.377 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.0 t -69.37 -25.71 64.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.623 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.6 tt0 -53.7 -26.37 22.62 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.4 98.59 1.7 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.708 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.836 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.6 mp0 -31.16 89.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 122.352 1.073 . . . . 0.0 110.811 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.591 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 m -4.24 -41.78 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.552 -2.567 . . . . 0.0 113.542 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.836 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -47.58 -20.14 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.58 -32.48 71.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.825 0.821 . . . . 0.0 110.91 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 40' ' ' SER . 10.8 p90 -119.76 -169.66 1.81 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.054 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -126.1 86.66 2.56 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.396 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 4.0 ttpp -68.7 163.52 23.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.915 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.88 69.34 0.2 Allowed Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.459 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 46' ' ' GLY . 54.7 m 22.96 95.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.711 0.291 . . . . 0.0 111.367 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.8 m120 89.09 -13.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.85 159.92 34.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 23' ' ' ILE . 15.3 t -157.63 146.32 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.037 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 44' ' ' THR . 66.3 m -135.78 113.34 10.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 0.0 112.315 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 52' ' ' LEU . 7.6 mp -68.82 134.11 49.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.961 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -104.68 106.0 16.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.519 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -38.89 -17.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.025 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' LEU . 5.0 p -70.55 -46.96 62.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.7 0.286 . . . . 0.0 110.974 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.818 ' CE1' HD21 ' A' ' 60' ' ' LEU . 5.6 t80 -73.29 -57.75 3.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.866 0.841 . . . . 0.0 109.909 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.842 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.1 tp -50.5 -40.2 50.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.499 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 15.0 t-20 -65.8 -27.09 68.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.245 0.545 . . . . 0.0 109.721 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 60' ' ' LEU . 63.0 m -77.16 -27.3 53.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.17 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.1 mm? -34.54 145.95 0.16 Allowed Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HB2' HG21 ' A' ' 64' ' ' THR . 36.8 Cg_exo -57.83 179.34 0.15 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.847 2.365 . . . . 0.0 112.796 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.6 mp0 -54.89 -166.89 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.542 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.6 p-10 -38.21 72.52 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.684 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 19.9 p -113.25 163.48 14.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.38 80.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.049 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.658 ' CE ' HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.33 156.37 32.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.179 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.838 ' O ' HD21 ' A' ' 38' ' ' LEU . 76.3 m -148.08 128.69 14.14 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.644 0.259 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -97.03 90.53 5.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.286 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.585 HG23 ' HB3' ' A' ' 80' ' ' LYS . 84.5 m -105.31 101.35 10.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.188 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.113 ' CE1' HD11 ' A' ' 35' ' ' ILE . 28.9 m-85 -70.13 121.27 17.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 110.42 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.61 94.31 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 110.122 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 25' ' ' LEU . 1.2 m-85 -101.52 22.98 11.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.886 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.01 -1.53 17.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.628 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG11 ' HG3' ' A' ' 2' ' ' GLN . 17.1 m -133.99 43.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 110.798 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 78' ' ' ASN . . . -40.49 -28.15 0.18 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.146 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -39.44 -43.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -149.36 20.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 12.6 p-10 -57.76 156.28 18.8 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.439 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' CB ' ' HB ' ' A' ' 6' ' ' ILE . 11.7 Cg_endo -56.88 97.45 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.831 2.354 . . . . 0.0 112.469 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.74 129.56 44.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.495 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.671 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 pp -115.46 158.6 22.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.888 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 82' ' ' THR . 5.0 t -108.41 108.47 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -92.14 113.08 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 12' ' ' SER . 6.7 m -91.16 117.36 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.553 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.27 95.62 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.352 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.0 mm? -61.36 164.99 7.58 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HD2' ' CD1' ' A' ' 86' ' ' LEU . 94.8 Cg_endo -79.07 137.35 13.62 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.073 2.516 . . . . 0.0 112.585 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.16 144.69 57.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.88 94.06 1.03 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 93' ' ' LEU . 4.7 tt -132.66 137.02 28.85 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD2' ' CG1' ' A' ' 90' ' ' ILE . 55.2 Cg_endo -70.01 117.07 4.88 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.6 2.2 . . . . 0.0 112.296 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.91 -22.96 4.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 90' ' ' ILE . 1.5 pp -146.17 101.85 3.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 110.8 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.834 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.852 0.358 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' H ' HG12 ' A' ' 74' ' ' VAL . 35.4 mm-40 -78.27 176.83 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 11.3 p-10 -129.03 84.47 62.88 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 61.4 Cg_endo -73.67 152.89 48.49 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.646 2.231 . . . . 0.0 111.982 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 26' ' ' THR . 84.3 m -124.93 75.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.689 HG21 ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -102.59 -169.08 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.662 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.778 ' CG ' HD12 ' A' ' 23' ' ' ILE . 6.7 p30 -46.57 -177.53 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.693 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 13.4 Cg_exo -70.35 -152.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.977 2.452 . . . . 0.0 112.355 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 80' ' ' LYS . 28.5 m -142.44 -2.39 1.1 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.414 ' C ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -136.24 121.35 18.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.734 HD11 HD12 ' A' ' 83' ' ' ILE . 2.5 pp -159.19 133.74 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.429 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' CB ' ' HB ' ' A' ' 84' ' ' THR . 34.2 t -123.15 162.75 21.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 122.096 0.951 . . . . 0.0 111.773 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.997 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -172.95 149.0 1.84 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.319 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -70.84 130.23 41.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.98 103.94 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.975 0.893 . . . . 0.0 110.587 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.62 -41.54 1.46 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.744 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -77.17 19.42 0.32 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 19.4 m-85 -97.61 73.43 2.36 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.944 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.23 150.79 47.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.961 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.2 t70 -34.77 125.1 0.54 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.576 0.227 . . . . 0.0 110.709 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 3.9 m -121.56 107.99 13.07 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.28 157.52 36.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.492 0.663 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.778 HD12 ' CG ' ' A' ' 7' ' ' ASN . 4.7 mm -144.88 149.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.528 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 24' ' ' THR . 3.2 t -114.09 118.58 34.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.145 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.917 HD11 ' CE2' ' A' ' 70' ' ' PHE . 1.6 mp -106.18 90.81 3.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.287 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 5' ' ' THR . 29.6 m -69.48 110.45 6.37 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 110.686 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.815 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.16 3.32 2.92 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.228 3.285 . . . . 0.0 112.821 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 26' ' ' THR . 3.3 t-20 -37.29 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 124.963 1.305 . . . . 0.0 111.215 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.88 -27.35 9.77 Favored Glycine 0 C--N 1.307 -1.043 0 CA-C-N 113.142 -1.845 . . . . 0.0 112.169 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.37 165.69 10.89 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 4.1 t -128.18 157.94 39.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.606 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 31.6 t80 -125.84 154.18 43.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.99 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 -65.06 1.21 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 179.21 167.47 36.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.514 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.808 HD13 ' CE2' ' A' ' 43' ' ' TYR . 5.0 mp -102.64 98.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.495 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -27.63 68.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.275 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.755 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.9 OUTLIER -52.54 -27.76 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.726 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -144.36 92.75 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.463 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.883 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.37 91.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.585 1.183 . . . . 0.0 111.117 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.623 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 3.1 p -0.53 -43.29 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 111.377 -2.647 . . . . 0.0 113.28 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.883 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -49.51 -24.08 1.91 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.935 0.398 . . . . 0.0 110.295 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.658 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 18.4 mm-40 -60.38 -31.82 70.72 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 111.169 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.808 ' CE2' HD13 ' A' ' 35' ' ' ILE . 6.4 p90 -122.73 -167.55 1.6 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.287 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.63 89.13 2.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.387 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.726 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.8 159.24 32.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.264 -178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.17 71.22 0.24 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.242 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.562 ' C ' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER 11.69 103.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.626 0.37 . . . . 0.0 111.577 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.7 m-20 93.82 -12.59 0.14 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.559 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 46' ' ' GLY . 6.5 mt-10 -150.25 168.13 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 45' ' ' LYS . 8.2 p -158.73 162.45 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.927 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 50' ' ' VAL . 55.8 m -136.82 117.44 13.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.177 0.513 . . . . 0.0 111.994 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 8.6 mp -68.58 133.34 48.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.773 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 55' ' ' SER . 1.0 OUTLIER -101.45 113.85 27.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.576 0.703 . . . . 0.0 111.907 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -43.5 -14.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.319 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.3 m -70.79 -47.19 60.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.814 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.837 ' CD2' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.9 -59.88 2.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.818 0.818 . . . . 0.0 110.226 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.79 -39.87 65.83 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.574 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 16.6 t-20 -65.5 -28.01 68.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.0 -18.36 26.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.67 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -42.9 144.77 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.98 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HD2' HD23 ' A' ' 60' ' ' LEU . 72.2 Cg_exo -51.07 176.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.737 2.291 . . . . 0.0 113.107 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -57.25 -167.27 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.563 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 2.7 p-10 -38.3 71.87 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.808 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 38.9 p -120.73 165.51 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.039 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.9 77.73 1.56 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.848 ' HD2' HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -66.23 177.15 1.52 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 120.981 0.419 . . . . 0.0 110.716 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -146.86 138.0 24.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.726 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.34 74.16 2.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.388 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.2 m -69.89 98.08 1.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.886 0.374 . . . . 0.0 110.914 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 25' ' ' LEU . 50.8 m-85 -75.89 111.6 11.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -69.53 95.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.55 0.69 . . . . 0.0 110.48 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.0 m-85 -102.38 23.79 11.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.421 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.05 16.94 4.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.304 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 72' ' ' PHE . 12.0 m -109.66 -32.45 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . . . 63.62 -75.94 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.747 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' VAL . 90.1 m -48.62 -63.42 1.09 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.794 0.331 . . . . 0.0 111.234 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -86.26 10.77 13.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.294 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 74' ' ' VAL . 10.6 t30 -58.61 107.07 0.82 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' CB ' HD12 ' A' ' 6' ' ' ILE . 11.9 Cg_exo -67.9 98.44 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.448 2.098 . . . . 0.0 112.096 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.943 ' O ' HG23 ' A' ' 9' ' ' THR . 0.2 OUTLIER -98.97 116.19 30.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.282 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 67' ' ' THR . 0.8 OUTLIER -69.9 156.69 38.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.729 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' THR . 18.8 m -120.95 99.44 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.34 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.734 HD12 HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -94.89 111.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.242 0.544 . . . . 0.0 111.002 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.739 HG23 HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -98.18 107.37 19.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.051 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.739 HG12 ' CE2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -92.96 102.13 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.006 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.58 168.57 20.91 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' A' ' 86' ' ' LEU . 60.1 Cg_endo -73.44 130.47 15.05 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.495 2.13 . . . . 0.0 112.333 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.93 164.35 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.033 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.672 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -69.94 162.61 27.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 89' ' ' ASP . 37.5 mm -148.6 66.58 9.11 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.29 168.08 21.99 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.583 2.189 . . . . 0.0 112.504 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.1 1.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.578 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.85 32.06 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.038 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.817 0.342 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -77.95 179.66 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 5.0 p30 -143.15 72.47 18.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.004 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 83.5 Cg_endo -88.37 136.51 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.944 2.429 . . . . 0.0 112.335 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.634 HG22 ' OG1' ' A' ' 26' ' ' THR . 0.3 OUTLIER -99.92 134.59 42.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.563 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 79' ' ' PRO . 4.5 tp -131.08 143.23 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.622 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.927 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -62.11 -102.75 0.0 OUTLIER Pre-proline 0 CA--C 1.514 -0.434 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.264 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 48.0 Cg_endo -97.2 -166.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.306 0 CA-C-N 121.811 1.682 . . . . 0.0 113.058 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' THR . 60.2 m -142.1 -3.39 1.09 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 143.03 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.766 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.4 pt -156.26 170.31 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.872 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.22 139.43 33.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.708 0.289 . . . . 0.0 111.364 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.6 149.28 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.333 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 15' ' ' ALA . 1.5 tmmm? -70.26 150.88 45.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 87' ' ' PRO . . . -62.57 104.4 0.51 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.939 0.876 . . . . 0.0 110.595 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.49 -40.44 1.64 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.738 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.03 10.49 0.41 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.479 0.657 . . . . 0.0 109.767 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.035 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 45.1 m-85 -97.64 76.46 2.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.801 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.52 156.06 38.72 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.882 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 19' ' ' ALA . 64.2 t0 -34.11 111.33 0.11 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.824 0.345 . . . . 0.0 110.481 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 51' ' ' THR . 3.4 m -114.8 110.51 19.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.448 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 3.2 ttmp? -96.32 138.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.395 0.617 . . . . 0.0 111.089 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -117.53 156.66 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.415 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' OE2' ' A' ' 49' ' ' GLU . 11.8 m -120.02 113.71 20.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.014 HD22 ' CZ ' ' A' ' 72' ' ' PHE . 1.1 mt -108.68 98.53 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.878 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.634 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.8 m -69.48 112.34 11.7 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -97.02 14.43 0.84 Allowed 'Trans proline' 0 CA--C 1.509 -0.749 0 C-N-CA 124.93 3.753 . . . . 0.0 111.631 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.6 t-20 -37.26 -15.18 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.011 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.28 14.64 0.16 Allowed Glycine 0 C--N 1.311 -0.849 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.8 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -140.38 171.28 14.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.035 0.445 . . . . 0.0 110.914 -178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.5 t -126.27 158.72 35.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.455 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 4.7 t80 -116.51 132.65 56.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 -42.06 6.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.35 165.39 10.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 43' ' ' TYR . 4.1 mt -102.66 95.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.046 0.45 . . . . 0.0 111.261 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -66.61 -24.39 66.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.472 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.784 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.5 tt0 -49.6 -29.64 7.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -151.25 102.21 2.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.066 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.732 ' O ' ' N ' ' A' ' 41' ' ' SER . 1.1 tt0 -31.21 88.83 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.574 1.178 . . . . 0.0 110.977 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.697 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 11.2 p -10.67 -40.09 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 111.444 -2.617 . . . . 0.0 113.585 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.4 -20.64 1.16 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HG2' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -65.94 -30.29 70.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.727 0.775 . . . . 0.0 111.191 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.771 ' CE2' HD12 ' A' ' 35' ' ' ILE . 2.3 p90 -112.56 -170.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.628 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.738 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.63 92.74 3.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.331 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 66.6 tttt -69.15 164.74 21.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.361 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -150.97 65.77 0.36 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.521 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t 30.55 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.966 0.506 . . . . 0.0 112.282 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' O ' ' CB ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 157.61 -29.64 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.81 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 24' ' ' THR . 3.7 mt-10 -115.44 157.89 23.31 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.557 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.788 HG11 ' CE1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -145.56 123.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.079 0.466 . . . . 0.0 111.133 179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.738 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.2 t -117.83 126.3 52.14 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.414 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -83.34 135.08 34.85 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.807 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 55' ' ' SER . 3.8 mt -91.99 112.37 24.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.48 0.657 . . . . 0.0 111.749 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -34.76 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.225 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 m -70.9 -47.09 61.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.805 ' CE1' HD21 ' A' ' 60' ' ' LEU . 38.9 t80 -73.57 -56.89 4.44 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.887 HD23 ' CG ' ' A' ' 18' ' ' PHE . 1.3 tp -51.55 -39.04 57.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 16.5 t30 -65.8 -24.29 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.111 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 60' ' ' LEU . 94.5 m -84.42 -26.52 28.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.511 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.9 mm? -35.65 151.18 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.884 0.374 . . . . 0.0 111.592 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 36.0 Cg_exo -57.53 178.75 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.897 2.398 . . . . 0.0 112.724 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.755 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -51.11 -164.02 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.731 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 35.5 m120 -38.38 73.03 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.002 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 62' ' ' GLU . 7.2 p -107.21 170.48 7.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.596 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -121.82 71.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.662 ' O ' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -52.49 113.85 1.19 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' OE1' ' A' ' 37' ' ' GLU . 47.5 m -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.224 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 52' ' ' LEU . 34.9 mt -91.17 80.52 5.62 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 69' ' ' THR . 2.7 m -85.99 85.45 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.788 ' CE1' HG11 ' A' ' 50' ' ' VAL . 4.7 m-85 -69.53 109.21 4.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.318 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 29.4 t70 -69.35 99.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.374 0.607 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.014 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -98.34 25.68 6.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.558 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.71 12.61 6.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.714 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' A' ' 77' ' ' LYS . 17.5 m -112.13 -35.08 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 120.785 0.326 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 68.87 -71.35 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.586 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -46.7 -62.58 1.32 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -87.75 11.28 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 71' ' ' ASP . 34.6 t-20 -60.29 114.32 9.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HG3' HD21 ' A' ' 25' ' ' LEU . 30.4 Cg_endo -66.04 96.9 0.33 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.546 2.164 . . . . 0.0 112.842 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.42 106.56 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.699 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.936 ' C ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.03 154.04 20.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.262 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.675 ' N ' HD13 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -115.69 145.66 42.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.862 -178.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 81' ' ' LEU . 2.8 mm -140.32 95.43 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.761 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.5 95.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.361 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 18' ' ' PHE . 1.7 t -82.3 118.23 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -118.05 75.26 10.81 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.398 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.604 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 21.1 Cg_exo -64.91 -148.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 112.433 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.45 132.29 48.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.29 30.83 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.0 110.709 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.767 HD13 ' N ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -130.56 130.81 23.01 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.122 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.767 ' N ' HD13 ' A' ' 90' ' ' ILE . 55.3 Cg_endo -70.32 114.63 3.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.634 2.222 . . . . 0.0 112.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -119.87 -31.6 1.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.457 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER 61.75 63.39 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.755 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.574 ' HG3' HG12 ' A' ' 74' ' ' VAL . 7.8 mt-30 -147.59 -179.78 7.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -142.56 74.27 19.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 91.6 Cg_endo -81.15 138.86 11.51 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.297 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.489 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -114.18 102.55 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.971 0.415 . . . . 0.0 111.212 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -108.82 152.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.449 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.901 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -50.68 -100.38 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.953 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 12.6 Cg_endo -104.64 -162.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.193 0 CA-C-N 121.543 1.587 . . . . 0.0 113.803 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 80' ' ' LYS . 73.2 m -148.5 12.75 0.92 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.342 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -161.25 141.69 11.01 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.271 0.557 . . . . 0.0 111.92 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.764 ' CG2' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -157.83 151.66 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.138 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.98 18.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.239 0.542 . . . . 0.0 111.766 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.046 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.2 158.21 5.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.204 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ALA . 4.4 ttpt -69.41 149.44 48.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.88 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.18 104.08 0.55 Allowed 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.044 0.926 . . . . 0.0 110.598 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 131.4 -40.16 1.68 Allowed Glycine 0 N--CA 1.437 -1.258 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.547 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.01 10.5 0.41 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.561 0.696 . . . . 0.0 109.778 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 24.1 m-85 -96.44 80.35 3.15 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.18 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.97 142.6 54.62 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.809 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' N ' ' HB2' ' A' ' 54' ' ' ALA . 14.3 t70 -34.55 130.85 0.36 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.675 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 54.4 m -120.91 162.38 19.96 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.56 164.29 18.42 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.288 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' VAL . 4.8 mt -154.21 155.76 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.7 m -127.14 92.1 3.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.626 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.009 HD11 ' CG ' ' A' ' 70' ' ' PHE . 2.6 mt -78.99 101.54 7.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 5' ' ' THR . 56.3 m -69.44 110.5 6.44 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.349 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -98.5 13.57 0.7 Allowed 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 111.785 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB2' HG22 ' A' ' 26' ' ' THR . 6.0 t30 -37.66 -14.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.91 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . -161.92 12.56 0.13 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.092 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -141.9 171.19 14.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.011 0.434 . . . . 0.0 111.004 -178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.69 158.72 37.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 5.3 t80 -110.63 134.57 52.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.942 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -106.45 -36.14 6.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 140.29 153.02 5.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.884 HD11 ' HA ' ' A' ' 68' ' ' LEU . 5.6 tt -98.54 102.04 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.937 0.875 . . . . 0.0 111.114 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 p -57.19 -44.65 83.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.637 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.755 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.99 -24.15 0.99 Allowed 'General case' 0 N--CA 1.425 -1.715 0 O-C-N 122.31 -0.244 . . . . 0.0 110.762 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -137.63 71.91 1.41 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.842 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.947 ' O ' ' N ' ' A' ' 41' ' ' SER . 6.4 mp0 -32.62 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.44 1.114 . . . . 0.0 110.769 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 14.08 -47.35 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 111.519 -2.582 . . . . 0.0 113.764 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.947 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.61 -26.16 5.03 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.113 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -67.07 -30.09 70.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.7 0.762 . . . . 0.0 111.447 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.79 ' CZ ' HG22 ' A' ' 35' ' ' ILE . 6.5 p90 -138.13 -162.77 1.35 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.339 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 1.6 m -142.27 95.56 2.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.866 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.59 168.38 13.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.244 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -161.31 69.03 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.166 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.526 ' C ' ' O ' ' A' ' 46' ' ' GLY . 78.5 m 19.71 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' LEU . 4.2 m-20 86.1 -8.04 0.76 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.526 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.61 162.52 32.06 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -148.42 148.27 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 71.4 m -135.68 109.5 8.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 111.871 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.4 141.89 54.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.796 178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -107.25 106.12 16.43 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.629 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' N ' ' A' ' 20' ' ' ASP . . . -35.48 -21.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' LEU . 98.3 p -70.7 -45.01 65.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -68.1 -60.79 2.22 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.776 0.798 . . . . 0.0 109.331 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.8 tp -46.39 -47.6 18.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.378 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -65.82 -23.74 66.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.971 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.8 m -81.0 -27.98 35.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.784 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HB3' HG11 ' A' ' 85' ' ' VAL . 9.0 mp -35.79 144.07 0.25 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 111.926 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 52.0 Cg_exo -55.35 -175.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.76 2.307 . . . . 0.0 112.113 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.773 ' HA ' ' CG ' ' A' ' 87' ' ' PRO . 24.9 mp0 -51.2 -172.49 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.649 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.581 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.1 m120 -38.92 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.828 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 62' ' ' GLU . 22.1 p -115.48 165.65 12.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.425 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -115.27 74.33 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.358 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.591 ' O ' ' HB ' ' A' ' 83' ' ' ILE . 17.2 tptt -65.78 104.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.161 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 11.0 t -90.81 123.93 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.067 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.55 107.88 20.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.807 HG23 ' CG ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -110.56 125.56 53.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.812 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.009 ' CG ' HD11 ' A' ' 25' ' ' LEU . 28.3 m-85 -86.44 119.01 26.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.289 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.81 84.26 0.31 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.758 0.79 . . . . 0.0 110.462 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.941 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -91.72 19.28 6.57 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.652 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.06 12.93 7.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.434 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.574 HG12 ' HG3' ' A' ' 2' ' ' GLN . 17.9 m -105.18 -36.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.782 0.325 . . . . 0.0 110.968 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . 69.74 -68.32 0.6 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.85 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -60.51 -61.69 2.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.801 0.334 . . . . 0.0 111.226 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.44 10.66 14.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' OD1' HG22 ' A' ' 74' ' ' VAL . 1.2 m-20 -53.15 115.51 7.68 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.682 ' HG2' HD21 ' A' ' 25' ' ' LEU . 29.7 Cg_endo -63.74 95.85 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.549 2.166 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.809 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -116.42 163.71 15.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.673 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 68' ' ' LEU . 2.0 pp -150.4 128.26 11.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.531 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 65' ' ' THR . 1.7 t -80.49 111.68 17.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.835 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -96.62 119.49 44.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 109.858 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -99.34 106.32 18.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.242 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.065 HG22 ' HD3' ' A' ' 87' ' ' PRO . 3.7 p -93.45 119.16 40.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.327 0.585 . . . . 0.0 110.687 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 5.8 mt -106.65 69.15 0.23 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.887 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.065 ' HD3' HG22 ' A' ' 85' ' ' VAL . 30.1 Cg_endo -62.65 -156.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.121 2.548 . . . . 0.0 112.177 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 163.82 14.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.654 ' O ' HD13 ' A' ' 90' ' ' ILE . 6.5 t0 -84.34 128.64 34.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 89' ' ' ASP . 41.1 mm -149.3 137.64 11.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 90' ' ' ILE . 53.3 Cg_endo -70.01 114.82 3.87 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.541 2.161 . . . . 0.0 112.206 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.92 33.73 2.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.73 81.07 8.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.805 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' H ' HG11 ' A' ' 74' ' ' VAL . 1.5 mm100 -70.06 150.81 46.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.787 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -124.53 82.39 59.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . 4.2 Cg_exo -76.98 153.33 32.51 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.295 2.663 . . . . 0.0 111.684 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.484 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -117.57 145.84 44.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.144 0.497 . . . . 0.0 111.326 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.96 HD11 HD13 ' A' ' 23' ' ' ILE . 7.8 tp -140.89 141.1 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.767 ' OD1' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -45.38 -82.72 0.0 OUTLIER Pre-proline 0 CA--C 1.501 -0.921 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.745 ' HD3' ' CB ' ' A' ' 7' ' ' ASN . 32.2 Cg_endo -103.65 -173.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.616 0 CA-C-N 120.114 1.077 . . . . 0.0 113.68 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 80' ' ' LYS . 24.2 m -152.76 14.04 0.54 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.9 t -167.6 142.66 3.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 0.0 112.077 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.731 HG23 ' CB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -168.29 160.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.804 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.495 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -153.43 135.72 14.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.147 0.499 . . . . 0.0 111.394 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.985 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.22 164.88 7.29 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.596 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 ttmt -70.34 149.64 47.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.949 ' HB3' ' HB3' ' A' ' 87' ' ' PRO . . . -62.4 103.81 0.44 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.771 0.796 . . . . 0.0 110.637 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.71 -35.78 2.58 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.568 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.92 8.18 0.57 Allowed 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.493 0.663 . . . . 0.0 110.127 178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.985 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 57.3 m-85 -96.94 82.9 3.3 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.333 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.21 137.27 54.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' OD2' HD23 ' A' ' 53' ' ' LEU . 6.8 t70 -34.57 128.76 0.43 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.773 ' O ' HD22 ' A' ' 52' ' ' LEU . 28.1 m -139.15 130.36 26.74 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 111.033 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -89.85 121.58 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.224 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.96 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.42 156.59 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.016 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.767 HG22 ' OD1' ' A' ' 7' ' ' ASN . 5.6 t -115.6 114.28 24.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.06 HD23 ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -102.55 104.77 15.2 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.987 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.72 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.8 m -69.82 112.25 11.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.064 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 15.1 Cg_endo -91.69 4.15 3.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.043 3.162 . . . . 0.0 112.129 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.6 t30 -37.08 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 125.22 1.408 . . . . 0.0 111.577 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 111.63 -26.57 11.61 Favored Glycine 0 C--N 1.307 -1.081 0 CA-C-N 113.222 -1.808 . . . . 0.0 112.376 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -108.78 162.04 14.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.782 0.325 . . . . 0.0 110.809 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -120.9 155.57 33.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.933 0.397 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 50' ' ' VAL . 18.0 t80 -108.75 141.35 40.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.066 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.5 -42.39 3.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.622 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.52 160.92 9.9 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.685 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.051 HD11 ' CE2' ' A' ' 70' ' ' PHE . 20.8 mt -99.64 99.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.744 0.783 . . . . 0.0 109.721 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.3 t -62.25 -41.0 98.04 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.221 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.785 ' OE2' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -46.51 -25.87 0.76 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.1 pp -136.09 85.42 2.15 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.506 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.937 ' O ' ' N ' ' A' ' 41' ' ' SER . 29.1 mt-30 -31.14 87.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.395 1.093 . . . . 0.0 111.317 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' LEU . 56.5 p 6.33 -42.63 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 111.706 -2.497 . . . . 0.0 113.698 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.46 -27.6 2.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.264 0.554 . . . . 0.0 109.852 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -56.92 -33.75 67.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.676 0.751 . . . . 0.0 111.573 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -121.82 -171.76 2.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.452 -178.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -132.36 91.14 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.431 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.864 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.54 163.51 23.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.134 -177.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.19 83.57 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.519 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 61.3 m 11.27 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.0 OUTLIER 88.57 -8.74 0.49 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.553 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -146.09 164.02 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 111.553 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.873 HG23 HD13 ' A' ' 25' ' ' LEU . 1.5 t -162.55 127.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.321 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 44' ' ' THR . 4.3 t -108.99 134.77 51.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.654 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -92.27 145.04 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD23 ' OD2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -110.97 124.18 51.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.46 0.648 . . . . 0.0 112.226 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -47.03 -9.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.399 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 53' ' ' LEU . 63.2 p -70.27 -45.1 67.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.987 0.422 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.588 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 17.6 t80 -77.03 -57.23 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.955 0.883 . . . . 0.0 109.058 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.3 tp -48.69 -40.68 29.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.76 -26.0 67.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 110.504 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -84.83 -25.99 27.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.503 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB3' HG11 ' A' ' 85' ' ' VAL . 6.4 mt -37.55 157.39 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 111.561 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.01 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.052 2.502 . . . . 0.0 112.516 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.8 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.2 pt-20 -70.22 -170.6 0.38 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.339 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.566 ' CB ' HD23 ' A' ' 86' ' ' LEU . 10.9 p-10 -39.57 68.8 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.95 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.8 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.4 p -114.61 149.51 36.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.446 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -85.6 79.17 9.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.515 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.932 ' HE2' HD23 ' A' ' 38' ' ' LEU . 6.9 tptm -65.59 116.15 6.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.51 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.471 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 9.9 t -105.17 124.53 49.7 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.92 0.391 . . . . 0.0 111.646 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.956 HD23 ' CZ ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -85.75 102.74 13.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.701 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.858 HG23 ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -106.24 97.08 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.99 -178.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.051 ' CE2' HD11 ' A' ' 35' ' ' ILE . 52.6 m-85 -74.75 113.02 11.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -69.42 100.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.508 0.67 . . . . 0.0 111.1 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.06 ' CE2' HD23 ' A' ' 25' ' ' LEU . 1.1 m-85 -99.42 24.5 8.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.99 -9.56 24.36 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.77 HG11 ' H ' ' A' ' 2' ' ' GLN . 16.3 m -134.04 50.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.705 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -38.71 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.454 -0.122 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.1 m -39.89 -45.55 1.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.839 0.352 . . . . 0.0 111.161 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 76' ' ' THR . 6.6 mtmp? -140.46 14.04 2.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.66 HD21 HG22 ' A' ' 69' ' ' THR . 12.5 p-10 -48.78 152.38 1.78 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.422 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.679 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 19.4 Cg_endo -60.73 98.48 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.422 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -115.98 136.25 53.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HG ' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -114.81 156.91 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.621 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -118.31 93.59 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.958 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.731 ' CB ' HG23 ' A' ' 11' ' ' ILE . 14.0 tt -99.35 120.43 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.536 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.446 ' OG1' HG23 ' A' ' 65' ' ' THR . 22.6 m -96.06 119.21 34.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 2.7 p -106.43 132.11 54.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -140.38 95.14 8.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.289 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.949 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 57.7 Cg_endo -73.55 -43.87 0.6 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 C-N-CA 122.41 2.074 . . . . 0.0 112.075 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -65.27 163.27 15.69 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.995 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.59 165.33 12.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.549 HG23 ' HD2' ' A' ' 91' ' ' PRO . 3.5 mp -70.01 137.69 87.32 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD2' HG23 ' A' ' 90' ' ' ILE . 55.3 Cg_endo -69.94 134.23 27.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.63 2.22 . . . . 0.0 112.319 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -104.18 -21.71 9.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -176.19 102.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.705 0.288 . . . . 0.0 110.956 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.826 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.831 0.348 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.651 ' CG ' HG11 ' A' ' 74' ' ' VAL . 2.0 mm100 -118.31 151.59 37.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.774 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 16.5 p30 -134.01 75.57 66.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.243 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' CA ' ' ND2' ' A' ' 30' ' ' ASN . 88.8 Cg_endo -93.78 149.35 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.145 2.563 . . . . 0.0 111.973 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -99.61 162.8 12.8 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.752 HD13 ' HB2' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -155.3 150.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 23' ' ' ILE . 3.4 p30 -66.15 -164.85 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.848 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.766 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 36.6 Cg_exo -61.89 -166.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.72 1.613 . . . . 0.0 111.946 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.587 ' HA ' HD22 ' A' ' 81' ' ' LEU . 5.4 m -147.73 -0.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.01 120.09 20.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 112.099 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.671 HD13 HD13 ' A' ' 83' ' ' ILE . 1.3 tt -144.97 135.08 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.61 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -134.2 137.87 44.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 17' ' ' SER . . . -171.1 168.77 6.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.238 0.542 . . . . 0.0 110.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' NZ ' HD12 ' A' ' 86' ' ' LEU . 11.3 tptt -70.12 155.27 40.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB3' ' HB3' ' A' ' 87' ' ' PRO . . . -63.45 91.58 0.06 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.006 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.37 -25.24 4.86 Favored Glycine 0 C--O 1.218 -0.903 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.986 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -66.55 3.74 0.92 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.25 178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.952 ' HB3' HD23 ' A' ' 57' ' ' LEU . 95.3 m-85 -98.55 82.91 2.92 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.075 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.658 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.26 159.3 31.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.402 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 51' ' ' THR . 49.2 t0 -33.92 112.85 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.622 0.249 . . . . 0.0 110.544 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 m -114.22 103.74 11.4 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 162.08 28.76 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.38 0.61 . . . . 0.0 110.607 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 7' ' ' ASN . 4.4 mt -151.1 151.3 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.808 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -117.32 117.85 30.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD13 HG23 ' A' ' 50' ' ' VAL . 1.5 mp -113.55 88.2 2.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.849 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.58 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 52.9 m -68.69 111.67 8.95 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 120.82 0.343 . . . . 0.0 111.069 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.836 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.0 Cg_endo -91.61 3.21 4.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.256 3.304 . . . . 0.0 112.964 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 26' ' ' THR . 1.4 t-20 -37.3 67.75 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.599 1.16 . . . . 0.0 111.2 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.836 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.43 -31.04 5.95 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.04 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -104.19 164.9 11.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.292 -0.454 . . . . 0.0 110.381 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.521 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.3 t -125.61 156.03 39.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.778 ' CD2' HD22 ' A' ' 25' ' ' LEU . 4.6 t80 -121.7 135.86 54.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.047 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' CD1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER -96.24 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 178.16 170.14 39.93 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.73 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.039 HG22 ' HG2' ' A' ' 37' ' ' GLU . 2.1 mt -102.5 101.51 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.987 0.422 . . . . 0.0 110.381 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 m -56.88 -43.57 81.4 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.884 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.039 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -45.25 -28.39 0.79 Allowed 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.048 0.451 . . . . 0.0 110.013 179.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -145.03 82.4 1.66 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.615 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.959 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.7 mm100 -32.37 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.107 0.956 . . . . 0.0 110.712 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 18.0 m 6.92 -41.87 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 111.614 -2.539 . . . . 0.0 113.758 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.63 -27.22 4.37 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.166 0.508 . . . . 0.0 109.88 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.636 ' HG3' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -60.77 -33.12 72.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.144 0.973 . . . . 0.0 110.728 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.761 ' CE2' HD12 ' A' ' 35' ' ' ILE . 11.8 p90 -124.19 -170.6 2.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.764 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 48.4 m -133.08 93.29 3.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.728 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' CE ' ' CD2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -68.98 168.09 14.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 48' ' ' ASN . . . -152.52 67.74 0.32 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.511 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.722 HG22 ' O ' ' A' ' 47' ' ' THR . 97.7 m 23.32 39.24 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.187 0.595 . . . . 0.0 112.486 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.595 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER 160.59 -19.34 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.097 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 24' ' ' THR . 1.4 mt-10 -133.5 166.76 21.81 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.168 0.509 . . . . 0.0 111.305 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.836 HG23 HD13 ' A' ' 25' ' ' LEU . 2.8 t -136.54 137.17 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.118 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.61 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 41.6 m -121.11 108.14 13.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.049 0.452 . . . . 0.0 111.3 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.699 HD22 HD22 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -69.25 132.4 46.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.993 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.7 OUTLIER -103.67 110.36 22.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.474 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -40.83 -16.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 6.2 p -70.55 -46.74 62.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.022 0.439 . . . . 0.0 110.622 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 1.008 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.88 -61.14 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.024 0.916 . . . . 0.0 109.973 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.952 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.5 tp -50.33 -34.88 25.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 10.4 t-20 -65.75 -37.7 87.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.549 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.44 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.817 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 56' ' ' TYR . 1.4 mm? -40.84 151.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.863 0.363 . . . . 0.0 111.424 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' LEU . 38.3 Cg_exo -57.17 -163.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.832 2.355 . . . . 0.0 112.569 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.78 ' O ' ' N ' ' A' ' 64' ' ' THR . 10.8 pt-20 -70.03 -168.9 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' CB ' ' HE2' ' A' ' 88' ' ' LYS . 17.5 t30 -39.5 69.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.12 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.78 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.1 p -121.12 145.28 47.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.872 ' OG1' HG22 ' A' ' 82' ' ' THR . 1.1 t -92.31 85.48 5.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.573 0.701 . . . . 0.0 111.417 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 22.0 tptt -65.68 92.22 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t -79.35 129.61 34.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.504 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.985 HD11 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -101.95 96.71 7.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.265 0.226 . . . . 0.0 111.266 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.602 HG22 ' ND2' ' A' ' 78' ' ' ASN . 24.3 m -99.07 99.8 10.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.754 0.311 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.754 ' CE1' HD11 ' A' ' 35' ' ' ILE . 8.5 m-85 -69.75 112.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.304 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -69.49 100.52 1.42 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.28 0.562 . . . . 0.0 110.795 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -91.98 21.41 4.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.733 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.09 5.02 17.91 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.479 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.783 HG21 ' CE ' ' A' ' 77' ' ' LYS . 8.9 m -121.28 -45.25 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 110.835 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 78' ' ' ASN . . . 77.88 -36.28 1.67 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.673 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 71.3 m -53.18 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.715 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.783 ' CE ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -86.19 9.7 16.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.193 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 69' ' ' THR . 30.7 t-20 -44.46 136.0 4.31 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.752 ' HB2' HD13 ' A' ' 6' ' ' ILE . 8.4 Cg_endo -85.2 86.55 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.835 2.356 . . . . 0.0 112.346 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -99.1 108.41 21.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.14 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.985 HD12 HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -94.74 170.29 9.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.872 HG22 ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -126.54 117.88 23.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.774 HD12 HD21 ' A' ' 57' ' ' LEU . 1.2 mm -103.66 98.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.577 HG22 ' CD2' ' A' ' 86' ' ' LEU . 13.8 m -76.13 87.85 3.02 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -92.86 121.8 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' HG22 ' A' ' 84' ' ' THR . 0.4 OUTLIER -136.5 103.02 9.48 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.268 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.897 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 71.5 Cg_endo -75.3 -31.84 5.52 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.696 2.264 . . . . 0.0 112.093 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' HE2' ' CB ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -65.29 138.02 57.93 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.823 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.08 164.72 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.061 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.556 HG23 ' HD2' ' A' ' 91' ' ' PRO . 30.2 mm -98.48 137.68 20.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.168 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' A' ' 90' ' ' ILE . 52.2 Cg_endo -69.62 114.39 3.66 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 0.0 112.188 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.99 31.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER 69.97 37.05 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LEU . 11.3 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.041 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' CE ' HG21 ' A' ' 76' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.798 ' H ' HG11 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -69.91 -105.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -170.46 47.94 0.1 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.705 0.288 . . . . 0.0 111.54 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 73.6 Cg_endo -74.07 145.51 35.46 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.467 2.111 . . . . 0.0 111.751 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 26' ' ' THR . 23.7 m -126.07 80.68 1.93 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.267 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.862 HG21 HD23 ' A' ' 25' ' ' LEU . 3.9 pt -116.43 -170.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.397 0.617 . . . . 0.0 112.476 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.991 ' HB3' HD12 ' A' ' 23' ' ' ILE . 3.2 p30 -39.69 167.08 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.255 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 48.9 Cg_exo -56.23 -151.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.643 2.229 . . . . 0.0 112.434 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' LYS . 4.0 m -135.87 -0.33 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.094 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -167.55 140.64 3.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.364 0.602 . . . . 0.0 112.304 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.703 HD11 ' CD1' ' A' ' 83' ' ' ILE . 3.1 pt -156.16 174.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.244 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.74 141.08 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.593 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.112 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.54 147.48 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.545 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 5.5 tmtt? -70.42 150.12 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.818 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -64.59 103.99 0.75 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.778 0.799 . . . . 0.0 109.555 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 123.99 -40.0 2.04 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.51 10.59 0.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.578 0.704 . . . . 0.0 109.406 177.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.112 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 41.4 m-85 -96.0 80.0 3.28 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.49 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -68.34 140.21 55.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 19' ' ' ALA . 6.8 t70 -34.57 130.4 0.38 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.47 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 m -126.73 153.25 45.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 121.484 0.659 . . . . 0.0 111.412 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.44 154.62 22.36 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.991 HD12 ' HB3' ' A' ' 7' ' ' ASN . 29.0 mm -143.8 152.54 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.809 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.4 m -121.39 106.24 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 6' ' ' ILE . 3.4 mt -81.41 84.61 6.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.498 ' CB ' ' HB ' ' A' ' 5' ' ' THR . 77.0 m -69.52 107.84 2.62 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 120.722 0.296 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.82 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.8 Cg_endo -95.32 5.41 2.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 124.424 3.416 . . . . 0.0 112.6 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -37.14 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.029 1.331 . . . . 0.0 111.32 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.82 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 113.61 -27.06 9.6 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 113.24 -1.8 . . . . 0.0 112.205 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -107.99 164.85 11.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.836 0.351 . . . . 0.0 110.723 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.9 t -124.18 156.79 36.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.498 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 34' ' ' GLY . 22.7 t80 -113.89 149.49 35.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.183 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.62 -41.65 3.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.58 179.43 28.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.343 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.822 HD11 ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -117.48 87.32 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.026 0.441 . . . . 0.0 109.982 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 58.5 m -62.95 -29.86 71.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.867 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 67' ' ' THR . 3.0 tt0 -51.82 -27.34 12.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD11 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.78 88.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.957 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.958 ' O ' ' N ' ' A' ' 41' ' ' SER . 10.1 mm-40 -31.92 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.328 1.061 . . . . 0.0 111.188 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.582 ' HA ' ' CE1' ' A' ' 43' ' ' TYR . 85.3 p 6.68 -43.74 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 111.64 -2.527 . . . . 0.0 113.47 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.958 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -49.2 -24.89 1.93 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.966 0.413 . . . . 0.0 110.338 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 25.5 mm-40 -59.54 -32.76 70.62 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.85 0.834 . . . . 0.0 111.1 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.781 ' CD2' HG12 ' A' ' 50' ' ' VAL . 12.1 p90 -132.24 -170.67 2.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -117.98 81.63 1.7 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.624 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.19 143.67 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.02 -179.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -157.32 80.93 0.16 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.839 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.586 ' C ' ' O ' ' A' ' 46' ' ' GLY . 92.7 m 8.15 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.491 0.317 . . . . 0.0 111.574 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 47' ' ' THR . 5.1 m-20 91.99 -3.74 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.289 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.63 154.09 42.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.137 0.494 . . . . 0.0 111.571 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 ' CD2' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -149.16 129.01 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.754 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.443 ' HB ' ' HB ' ' A' ' 44' ' ' THR . 16.5 m -121.39 111.18 17.0 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' THR . 7.6 mp -68.95 136.41 52.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.303 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 55' ' ' SER . 12.5 mt -109.15 108.02 18.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.311 0.577 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 18' ' ' PHE . . . -36.11 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.87 -47.58 58.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 1.041 ' CE1' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.82 -61.43 2.07 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.9 0.857 . . . . 0.0 109.914 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD23 ' CD1' ' A' ' 18' ' ' PHE . 1.8 tp -49.55 -46.21 48.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.222 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 31.2 t30 -65.92 -28.73 69.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 m -76.54 -26.13 54.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.764 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.041 HD21 ' CE1' ' A' ' 56' ' ' TYR . 2.8 mm? -43.13 149.8 0.51 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.902 0.382 . . . . 0.0 111.143 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 60' ' ' LEU . 10.2 Cg_endo -53.66 -165.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.958 2.438 . . . . 0.0 112.381 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HA ' ' CG ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -64.28 -169.2 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.463 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 2.4 m-20 -38.21 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.063 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.73 ' N ' ' O ' ' A' ' 62' ' ' GLU . 21.7 p -118.88 170.71 8.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.763 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -118.71 75.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.757 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE3' HD23 ' A' ' 38' ' ' LEU . 17.9 tptt -66.18 104.2 1.13 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.973 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.693 HG23 ' N ' ' A' ' 82' ' ' THR . 19.9 m -97.83 135.21 39.9 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.634 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.018 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -98.82 87.48 3.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.994 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -77.16 93.79 3.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.748 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.822 ' CE2' HD11 ' A' ' 35' ' ' ILE . 44.3 m-85 -69.61 99.86 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.211 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -69.02 100.3 1.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.131 0.491 . . . . 0.0 110.857 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' HE2' HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -92.55 24.63 3.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.161 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.98 -16.59 26.8 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.491 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG11 ' H ' ' A' ' 2' ' ' GLN . 35.4 m -89.67 -52.54 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.623 0.249 . . . . 0.0 111.167 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 75.62 -47.26 2.09 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.308 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.61 HG21 ' CE ' ' A' ' 1' ' ' MET . 95.8 m -41.19 -61.79 0.95 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.834 0.35 . . . . 0.0 111.41 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -128.01 29.72 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 6.2 p-10 -49.27 139.26 13.9 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HB2' HD11 ' A' ' 6' ' ' ILE . 19.1 Cg_endo -61.1 90.86 0.1 OUTLIER 'Trans proline' 0 CA--C 1.525 0.05 0 C-N-CA 122.821 2.347 . . . . 0.0 112.449 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HE2' HG21 ' A' ' 67' ' ' THR . 1.2 ptmm? -99.56 129.43 45.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.569 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -103.36 97.11 7.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.441 -179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.693 ' N ' HG23 ' A' ' 67' ' ' THR . 15.1 t -73.7 107.63 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HD21 ' A' ' 68' ' ' LEU . 1.5 mt -97.55 123.35 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.027 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -92.06 98.95 11.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.533 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.009 HG22 ' HD3' ' A' ' 87' ' ' PRO . 1.5 p -84.26 115.4 26.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.028 0.442 . . . . 0.0 110.242 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 5.9 mt -104.39 71.37 0.18 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.124 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.009 ' HD3' HG22 ' A' ' 85' ' ' VAL . 36.4 Cg_endo -66.37 -155.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.33 -0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 111.905 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.64 132.12 48.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.243 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 91' ' ' PRO . 1.3 t0 -120.91 148.42 44.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -84.68 -26.5 0.38 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 90' ' ' ILE . 84.5 Cg_endo -86.34 132.81 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.398 2.732 . . . . 0.0 112.461 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.35 32.24 7.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.537 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.26 119.92 6.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.939 -179.919 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.779 0.324 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HG3' HG11 ' A' ' 74' ' ' VAL . 7.8 mt-30 -142.37 157.39 44.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.622 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 3.3 p-10 -134.01 77.59 61.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.99 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 85.0 Cg_endo -90.42 150.31 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.139 2.559 . . . . 0.0 112.266 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -105.12 145.08 31.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.198 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.652 ' CB ' ' HB3' ' A' ' 79' ' ' PRO . 6.1 tp -145.18 147.14 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.716 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.972 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -66.8 -112.65 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.964 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 40.1 Cg_endo -97.8 -165.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.102 0 CA-C-N 122.145 1.802 . . . . 0.0 113.487 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 80' ' ' LYS . 51.5 m -154.22 13.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.377 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 127.13 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 83' ' ' ILE . 5.1 tt -155.47 159.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.69 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -148.61 134.75 19.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.281 0.562 . . . . 0.0 112.05 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.983 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.42 169.86 6.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.578 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.35 141.39 52.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.761 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.751 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -60.18 101.96 0.15 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.596 0.712 . . . . 0.0 110.389 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 127.16 -33.08 3.42 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.986 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.36 6.78 0.71 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.677 0.751 . . . . 0.0 110.043 179.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.983 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 36.9 m-85 -97.09 85.93 3.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.915 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.661 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 158.27 32.65 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.497 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 10.2 t70 -33.95 111.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.777 0.323 . . . . 0.0 110.515 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 51' ' ' THR . 1.1 m -105.13 165.05 11.36 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.375 0.607 . . . . 0.0 110.613 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.24 147.06 52.39 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.35 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.989 ' HB ' HG13 ' A' ' 50' ' ' VAL . 1.6 mt -139.29 157.97 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.27 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.668 HG23 ' OE2' ' A' ' 49' ' ' GLU . 1.7 m -120.42 112.35 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 79' ' ' PRO . 1.8 mt -114.4 97.45 6.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -69.61 117.17 50.49 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.714 0.293 . . . . 0.0 111.086 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.2 Cg_endo -90.48 2.93 4.91 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.057 3.171 . . . . 0.0 112.716 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.51 67.41 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 124.983 1.313 . . . . 0.0 111.171 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.66 -30.15 6.3 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.186 -1.824 . . . . 0.0 112.018 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.91 167.42 9.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.063 0.459 . . . . 0.0 110.395 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.9 t -131.34 157.74 42.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 8.0 t80 -111.39 130.49 55.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.071 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.75 -26.93 13.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.388 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 127.34 172.62 13.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.559 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.042 ' CD1' HD23 ' A' ' 68' ' ' LEU . 5.0 mt -102.09 98.5 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.17 0.51 . . . . 0.0 109.812 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -44.31 89.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.06 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -45.89 -28.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.643 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.52 89.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.981 177.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.905 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.71 91.76 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 122.325 1.059 . . . . 0.0 111.152 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.579 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 1.3 m 1.94 -42.72 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.279 -2.692 . . . . 0.0 113.462 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.905 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -46.71 -25.05 0.65 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.76 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -56.15 -33.56 65.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.86 0.838 . . . . 0.0 110.909 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.698 ' CE2' HD12 ' A' ' 35' ' ' ILE . 28.4 p90 -121.94 -173.7 2.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.937 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 87.8 m -128.83 90.58 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.457 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 1.7 ptmt -69.27 168.46 14.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.713 -1.13 . . . . 0.0 111.474 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -154.03 70.01 0.29 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.7 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 48' ' ' ASN . 10.0 t 28.37 44.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.1 OUTLIER 153.1 -39.03 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.25 0.547 . . . . 0.0 110.346 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' HG23 ' A' ' 24' ' ' THR . 2.2 mt-10 -109.1 161.36 15.26 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.291 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -138.11 131.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.014 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 21' ' ' THR . 41.6 m -116.94 116.36 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.369 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 52' ' ' LEU . 5.9 mp -69.19 140.93 54.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.632 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -106.83 98.44 8.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.343 0.592 . . . . 0.0 111.254 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -36.72 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.948 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' LEU . 8.8 t -70.71 -45.74 64.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 0.0 111.589 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.568 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 8.9 t80 -72.46 -57.67 3.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.866 0.841 . . . . 0.0 110.373 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HB2' ' A' ' 18' ' ' PHE . 3.1 tt -54.33 -35.03 62.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.79 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 16' ' ' GLY . 28.2 t30 -65.16 -25.42 67.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.903 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.83 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.815 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.586 HD11 ' HZ2' ' A' ' 66' ' ' LYS . 7.6 mt -41.39 155.04 0.23 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 110.912 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.55 177.25 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.921 2.414 . . . . 0.0 113.08 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.5 mp0 -56.14 -167.1 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.473 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -38.32 71.67 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.966 -178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.774 ' N ' ' O ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -111.72 154.55 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.139 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.98 89.1 7.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.394 0.616 . . . . 0.0 111.305 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.844 ' HE2' HD11 ' A' ' 68' ' ' LEU . 3.5 tptm -65.58 78.96 0.07 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.259 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 1.5 m -90.92 96.33 10.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.042 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -69.62 101.36 1.62 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.618 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.655 HG23 HD21 ' A' ' 78' ' ' ASN . 65.0 m -94.92 94.95 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.943 ' CE2' HG11 ' A' ' 50' ' ' VAL . 45.4 m-85 -75.96 105.74 7.17 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.68 96.51 0.97 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 111.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.888 ' CE1' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -97.51 25.41 5.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.544 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.25 -8.57 24.25 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.624 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.592 HG21 ' NZ ' ' A' ' 77' ' ' LYS . 14.0 m -129.95 48.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.912 0.386 . . . . 0.0 110.425 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 78' ' ' ASN . . . -33.95 -34.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.175 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' VAL . 75.6 m -39.91 -51.51 2.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.69 0.281 . . . . 0.0 111.482 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -130.99 11.54 5.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.535 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.655 HD21 HG23 ' A' ' 69' ' ' THR . 0.1 OUTLIER -42.46 164.86 0.11 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.305 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 25' ' ' LEU . 1.2 Cg_endo -79.9 93.0 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 112.511 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' THR . 53.1 mtpt -95.68 150.45 20.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.084 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.975 HD11 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -133.22 115.43 14.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.298 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 9' ' ' THR . 1.5 t -91.06 116.4 28.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.019 HG23 HG23 ' A' ' 11' ' ' ILE . 7.2 mt -112.06 152.02 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.445 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -109.49 95.58 5.71 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.578 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -89.0 97.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.653 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 1.2 mm? -76.35 159.4 79.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.06 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 63' ' ' ASN . 54.8 Cg_endo -70.25 163.77 37.45 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.668 2.245 . . . . 0.0 112.345 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -64.93 167.87 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 111.013 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.29 160.7 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG23 ' HD2' ' A' ' 91' ' ' PRO . 4.5 mp -109.89 137.61 20.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' HD2' HG23 ' A' ' 90' ' ' ILE . 54.1 Cg_endo -69.88 147.42 62.07 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.176 . . . . 0.0 112.239 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 93' ' ' LEU . . . 105.93 -39.97 2.66 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.291 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 92' ' ' GLY . 1.8 tp 174.41 140.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.691 0.281 . . . . 0.0 111.038 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.652 0.263 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 2.3 mm-40 -105.51 164.28 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.69 84.34 15.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.119 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 61.0 Cg_endo -73.15 143.34 35.65 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.699 2.266 . . . . 0.0 111.79 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -129.02 119.03 23.54 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.452 -179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 79' ' ' PRO . 8.9 pt -151.72 -170.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.454 0.645 . . . . 0.0 112.26 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.832 ' CG ' HD13 ' A' ' 23' ' ' ILE . 1.8 p30 -39.84 167.7 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.97 -1.013 . . . . 0.0 112.336 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 40.2 Cg_exo -57.35 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.008 2.472 . . . . 0.0 112.709 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 80' ' ' LYS . 8.6 m -147.2 4.8 0.82 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.869 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 p -143.26 132.3 22.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 83' ' ' ILE . 2.8 tt -163.5 146.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.24 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.626 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.6 134.78 25.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.388 0.614 . . . . 0.0 112.05 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.951 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -171.65 161.08 6.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.037 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.3 152.23 44.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.865 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -61.36 103.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.847 0.832 . . . . 0.0 111.406 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.78 -33.54 2.94 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.68 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -68.55 6.55 0.8 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.503 0.668 . . . . 0.0 110.433 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.046 ' CD2' HD11 ' A' ' 83' ' ' ILE . 83.0 m-85 -100.42 79.32 2.11 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.98 157.67 34.54 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.834 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 19' ' ' ALA . 7.0 t70 -33.79 117.91 0.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -125.88 122.9 37.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.359 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -83.82 170.31 14.25 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.273 0.559 . . . . 0.0 110.964 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.991 ' HB ' HG13 ' A' ' 50' ' ' VAL . 8.2 mt -157.06 161.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.711 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 6.7 t -111.51 117.25 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD21 ' CG ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -98.0 74.65 2.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.761 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 28' ' ' ASN . 2.3 m -69.12 109.28 4.09 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.835 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.799 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.0 Cg_endo -94.64 5.28 2.51 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.165 3.243 . . . . 0.0 112.625 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.1 t30 -37.22 67.09 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 125.05 1.34 . . . . 0.0 111.645 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.799 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 116.46 -28.13 7.66 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 113.111 -1.859 . . . . 0.0 112.47 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.632 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -107.32 167.31 10.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.855 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.526 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.6 t -123.7 156.78 35.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.203 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CG ' HD21 ' A' ' 25' ' ' LEU . 11.7 t80 -116.91 141.68 47.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.181 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.75 -38.84 4.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.21 161.16 8.81 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.533 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.009 HG22 ' HG2' ' A' ' 37' ' ' GLU . 1.3 mt -100.78 99.56 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.446 ' C ' ' N ' ' A' ' 38' ' ' LEU . 4.1 p -58.87 -37.27 76.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.096 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.009 ' HG2' HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -42.88 -30.25 0.39 Allowed 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.752 HD22 ' HE3' ' A' ' 66' ' ' LYS . 1.1 pt? -145.53 95.7 2.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.257 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.818 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.8 mt-30 -31.16 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.184 0.993 . . . . 0.0 111.634 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 20.4 t -5.61 -41.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 111.715 -2.493 . . . . 0.0 113.28 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -57.67 -17.25 13.86 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.814 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.33 -16.74 62.45 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.372 0.606 . . . . 0.0 112.196 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -122.16 -172.63 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.784 178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -120.09 81.35 1.73 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.403 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.71 160.22 32.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.469 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' GLU . . . -163.61 65.82 0.24 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 47' ' ' THR . 12.1 t 11.33 59.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.826 0.45 . . . . 0.0 111.678 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 1.6 t30 148.29 -16.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.733 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.1 mt-10 -150.06 162.38 40.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 23' ' ' ILE . 1.3 p -156.45 136.23 3.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.5 m -127.58 112.81 15.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -69.49 144.95 53.07 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.03 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 6.0 mt -108.32 112.15 24.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.537 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -42.88 -14.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.532 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.9 t -70.71 -46.58 62.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.672 0.272 . . . . 0.0 111.206 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' HE1' HD21 ' A' ' 60' ' ' LEU . 5.9 t80 -73.18 -56.07 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.688 0.756 . . . . 0.0 110.101 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.938 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.94 -35.92 67.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.247 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 20.5 t30 -65.44 -27.62 68.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 110.356 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -22.48 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.938 HD12 ' HG ' ' A' ' 57' ' ' LEU . 18.2 mt -38.86 156.79 0.12 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.149 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 -175.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.79 2.327 . . . . 0.0 112.686 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 4.4 pt-20 -65.8 -165.26 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.355 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.435 ' HB2' ' HD3' ' A' ' 87' ' ' PRO . 10.1 t-20 -38.8 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.938 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 3.3 p -114.94 146.14 41.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -88.62 85.6 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.882 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.803 ' HZ3' HD11 ' A' ' 60' ' ' LEU . 2.2 tptt -65.46 118.23 9.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.636 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 7.8 m -107.74 121.13 44.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.904 -0.135 . . . . 0.0 110.856 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -93.85 84.01 4.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.527 0.203 . . . . 0.0 111.466 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.825 ' C ' HG23 ' A' ' 35' ' ' ILE . 23.7 m -94.86 102.94 14.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.747 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m-85 -73.58 114.82 12.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.864 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -68.58 88.21 0.34 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.785 0.802 . . . . 0.0 110.7 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.688 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.45 21.01 6.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.645 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.29 18.55 3.44 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.295 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 72' ' ' PHE . 34.1 m -113.54 -31.7 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 62.94 -76.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.743 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' VAL . 85.4 m -46.91 -63.18 1.1 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.71 11.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 37.1 t-20 -65.47 112.2 7.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HB2' HD11 ' A' ' 6' ' ' ILE . 10.7 Cg_endo -56.14 98.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 122.618 2.212 . . . . 0.0 112.277 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.85 ' O ' HG23 ' A' ' 9' ' ' THR . 12.3 mmtt -93.8 122.61 36.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.297 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -95.37 140.29 30.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -118.26 85.44 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.197 0.522 . . . . 0.0 110.925 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.046 HD11 ' CD2' ' A' ' 18' ' ' PHE . 8.3 tt -103.0 116.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -94.92 121.34 36.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.309 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -101.76 109.95 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.81 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -75.99 173.58 6.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.381 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 88.3 Cg_endo -83.83 168.39 12.43 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.44 2.094 . . . . 0.0 112.457 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.0 167.88 7.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.99 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -98.61 -171.11 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.879 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.3 mp -147.82 136.19 11.22 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 90' ' ' ILE . 57.2 Cg_endo -70.97 154.78 62.8 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.63 2.22 . . . . 0.0 112.344 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 155.8 -32.24 0.62 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.325 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tt -162.53 94.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.903 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.873 ' HG3' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -103.34 166.23 10.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -127.75 61.66 51.91 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 93.8 Cg_endo -85.86 153.82 10.0 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.812 2.342 . . . . 0.0 112.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -136.7 164.3 28.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.688 HD12 ' HG ' ' A' ' 25' ' ' LEU . 4.4 tt -154.36 161.5 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.921 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.45 -102.12 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.74 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 37.5 Cg_endo -103.43 -169.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 CA-C-N 121.66 1.628 . . . . 0.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 80' ' ' LYS . 40.2 m -149.27 7.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 t -150.35 132.91 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.171 0.51 . . . . 0.0 112.241 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.674 HG23 ' CB ' ' A' ' 83' ' ' ILE . 2.4 tt -162.26 158.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.054 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.461 ' N ' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -152.56 135.51 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 111.761 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.034 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -171.04 168.75 6.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.168 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.09 136.53 50.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.636 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -55.95 102.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.875 0.845 . . . . 0.0 110.22 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.19 -36.26 2.17 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.172 -1.377 . . . . 0.0 110.388 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.08 8.62 0.53 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.86 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.034 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 30.5 m-85 -97.75 81.16 2.86 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.237 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.95 148.35 51.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.72 ' OD1' HG22 ' A' ' 51' ' ' THR . 56.3 t0 -34.32 120.58 0.46 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.836 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.864 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.1 m -133.47 133.68 42.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.224 0.535 . . . . 0.0 110.811 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -96.51 142.19 28.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.434 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 81' ' ' LEU . 1.3 mt -117.9 156.69 19.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.421 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 5.3 m -120.45 105.01 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.088 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.0 mt -95.44 110.47 22.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.715 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 5' ' ' THR . 54.5 m -69.46 110.76 6.93 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.812 ' O ' ' N ' ' A' ' 29' ' ' GLY . 9.9 Cg_endo -94.45 3.61 2.76 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.108 3.206 . . . . 0.0 112.714 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -37.51 67.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.999 1.32 . . . . 0.0 111.59 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 108.94 -22.19 26.04 Favored Glycine 0 C--N 1.306 -1.118 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.578 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -100.48 168.44 9.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.966 0.412 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.7 t -129.12 158.33 39.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.642 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 9.5 t80 -117.26 135.4 53.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.87 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.26 -38.82 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 144.81 168.43 12.73 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.429 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.947 HD11 ' CE2' ' A' ' 70' ' ' PHE . 3.3 mt -103.39 93.28 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.73 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -65.76 -26.2 67.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.084 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' CD ' HG23 ' A' ' 67' ' ' THR . 1.7 tt0 -51.54 -27.34 10.55 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.873 HD22 ' CE ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -148.98 98.17 2.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.0 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.755 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -31.04 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 122.379 1.085 . . . . 0.0 111.137 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 72.4 p -9.07 -40.39 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 111.593 -2.548 . . . . 0.0 113.41 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.755 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.37 -23.11 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.685 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -59.66 -31.45 69.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.753 0.787 . . . . 0.0 111.195 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 35' ' ' ILE . 10.9 p90 -118.46 -169.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.343 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -124.51 90.57 3.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.111 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.817 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.41 140.8 55.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.121 -178.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -147.5 78.57 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.889 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.538 ' C ' ' O ' ' A' ' 46' ' ' GLY . 36.0 m 8.88 108.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.898 0.479 . . . . 0.0 112.145 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' THR . 2.4 m-20 89.05 -13.16 0.38 Allowed 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.102 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.92 163.7 33.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.052 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -158.03 125.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.811 HG23 ' C ' ' A' ' 21' ' ' THR . 28.0 m -114.04 124.02 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.07 145.45 30.18 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.832 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' SER . 60.8 mt -107.77 116.65 32.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.602 0.715 . . . . 0.0 112.026 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -44.78 -11.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.668 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' LEU . 41.1 m -70.31 -45.65 65.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.827 ' CE1' HD21 ' A' ' 60' ' ' LEU . 23.5 t80 -77.09 -55.24 5.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.701 0.762 . . . . 0.0 109.335 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.874 HD11 ' HG2' ' A' ' 66' ' ' LYS . 2.7 tp -50.03 -41.5 47.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.959 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 22.6 t-20 -65.6 -22.66 66.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.555 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.7 m -89.39 -25.03 21.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.561 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.827 HD21 ' CE1' ' A' ' 56' ' ' TYR . 11.2 mt -41.27 153.32 0.25 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -52.0 -176.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 0.0 112.919 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.7 pt-20 -65.12 -165.12 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.392 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.443 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -38.93 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.161 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.9 p -114.69 165.95 12.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 88.96 4.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.874 ' HG2' HD11 ' A' ' 57' ' ' LEU . 19.6 tptp -65.12 80.03 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.179 0.514 . . . . 0.0 110.547 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.759 HG23 ' CD ' ' A' ' 37' ' ' GLU . 4.7 t -88.21 113.84 24.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.405 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.824 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -96.49 95.58 8.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.821 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.671 ' C ' HG23 ' A' ' 35' ' ' ILE . 22.2 m -88.79 100.72 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.754 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.947 ' CE2' HD11 ' A' ' 35' ' ' ILE . 26.2 m-85 -74.61 107.97 7.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.056 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.1 99.7 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.512 0.672 . . . . 0.0 111.594 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.088 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -99.41 23.02 9.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.612 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.13 6.03 12.1 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.774 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.873 HG12 ' HG3' ' A' ' 2' ' ' GLN . 22.4 m -105.91 -40.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 75.01 -77.53 1.14 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.773 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -46.21 -61.83 1.61 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.841 0.353 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HD2' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.3 11.31 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.374 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.1 t-20 -57.37 120.3 38.96 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.685 ' CG ' HD21 ' A' ' 25' ' ' LEU . 28.8 Cg_endo -64.53 98.09 0.28 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.457 2.105 . . . . 0.0 112.216 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -99.82 141.9 32.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.444 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -121.45 109.75 15.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.287 . . . . 0.0 111.158 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -93.75 107.99 19.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.981 0.42 . . . . 0.0 111.095 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.008 HD11 ' CE1' ' A' ' 18' ' ' PHE . 15.5 tt -113.62 121.38 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.488 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.78 114.73 14.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -101.2 98.13 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.853 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 14' ' ' LYS . 1.2 mt -73.78 159.46 84.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 37.8 Cg_endo -66.93 127.48 17.01 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.437 2.091 . . . . 0.0 112.288 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.38 142.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 14' ' ' LYS . 8.6 t70 -134.62 145.23 48.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -113.41 93.62 27.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.98 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.88 147.95 63.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.659 2.239 . . . . 0.0 112.503 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 38.98 57.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.412 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.675 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.29 60.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.963 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.738 0.304 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.45 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 4.8 mt-30 -128.65 -176.4 3.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -122.6 48.92 2.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.395 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.6 Cg_endo -76.56 144.37 25.23 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.663 2.242 . . . . 0.0 112.043 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' THR . 3.1 m -124.23 100.92 6.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.593 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 79' ' ' PRO . 3.7 pt -127.63 -169.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.505 0.669 . . . . 0.0 112.371 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.813 ' CG ' HD13 ' A' ' 23' ' ' ILE . 3.2 p30 -39.21 159.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.218 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 11.7 Cg_endo -55.78 -157.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.958 2.439 . . . . 0.0 112.334 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 80' ' ' LYS . 61.8 m -139.58 7.0 2.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.53 131.96 13.78 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.542 HG23 HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -159.45 150.99 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.214 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.6 137.54 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 111.622 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.97 164.25 7.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.6 148.49 48.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.885 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -62.66 103.57 0.44 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 110.615 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 129.72 -36.58 2.33 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.327 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.3 9.02 0.5 Allowed 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.515 0.674 . . . . 0.0 110.12 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.981 ' HB3' HD23 ' A' ' 57' ' ' LEU . 74.6 m-85 -99.04 75.84 2.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.306 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.35 158.29 33.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.158 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 21.1 t70 -34.38 113.37 0.17 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.464 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 95.55 5.72 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -70.4 112.01 6.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.305 0.574 . . . . 0.0 110.697 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.01 HD11 HD12 ' A' ' 81' ' ' LEU . 2.2 mt -93.69 155.87 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.211 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 m -112.18 120.44 41.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 32' ' ' PHE . 1.7 mp -108.75 88.0 2.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.3 m -69.9 109.51 4.87 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-O 120.739 0.304 . . . . 0.0 110.266 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.811 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -93.7 3.57 3.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.074 3.183 . . . . 0.0 112.942 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.36 67.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.968 1.307 . . . . 0.0 111.405 -178.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.65 -25.67 11.72 Favored Glycine 0 C--N 1.306 -1.105 0 CA-C-N 113.094 -1.866 . . . . 0.0 112.584 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -109.58 166.55 10.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.876 0.369 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 2.7 t -128.53 163.73 24.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 13.8 t80 -114.24 145.57 41.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.119 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' ASP . 3.3 t-20 -110.47 -51.34 2.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.813 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.66 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 152.78 148.99 5.02 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.331 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.982 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -94.48 84.12 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 122.517 1.151 . . . . 0.0 110.094 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 37' ' ' GLU . 10.6 p -63.42 -24.23 67.75 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.729 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.941 ' C ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -44.68 -32.7 1.58 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.941 HD23 ' C ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -140.58 99.36 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.101 177.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.795 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mt-30 -30.52 94.89 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.634 1.207 . . . . 0.0 111.427 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.803 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 4.4 t -7.32 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.232 -2.713 . . . . 0.0 113.497 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.55 -22.66 0.79 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.775 0.321 . . . . 0.0 110.895 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.649 ' HB2' ' CG ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.617 0.722 . . . . 0.0 111.026 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.982 ' CE2' HG23 ' A' ' 35' ' ' ILE . 47.7 p90 -122.34 -167.42 1.56 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.261 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 56.0 m -134.17 92.8 2.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.465 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HG2' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -69.12 162.89 26.02 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.027 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -164.54 76.81 0.15 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.003 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' THR . 15.1 t 9.93 104.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.771 0.428 . . . . 0.0 112.112 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 0.6 OUTLIER 87.55 -7.85 0.6 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.704 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -151.59 168.21 25.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 51' ' ' THR . 47.5 t -157.13 166.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.016 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.585 ' N ' HG12 ' A' ' 50' ' ' VAL . 21.9 m -143.69 116.0 8.5 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.794 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt -69.0 136.83 53.08 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -103.21 107.82 18.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.926 -179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -43.04 -14.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.502 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.0 m -70.72 -47.14 61.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 0.0 111.062 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CG ' ' HB2' ' A' ' 42' ' ' GLN . 7.1 t80 -73.4 -58.57 3.22 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.822 0.82 . . . . 0.0 109.718 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 ' HB3' ' A' ' 18' ' ' PHE . 3.5 tp -48.35 -40.98 27.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.287 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 36.0 t30 -66.13 -28.4 68.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 56' ' ' TYR . 23.2 m -69.72 -39.0 77.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.644 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.077 HD21 ' HE2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -36.66 139.7 0.45 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.915 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HD2' HG21 ' A' ' 64' ' ' THR . 13.7 Cg_exo -69.08 -158.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.853 2.369 . . . . 0.0 112.301 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.776 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -54.13 -164.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.464 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -39.14 68.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.507 -178.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -92.91 159.7 15.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.278 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -112.1 72.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.792 0.33 . . . . 0.0 111.572 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 1.077 ' HE2' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -53.36 105.35 0.13 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.303 0.573 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.648 HG22 ' OE1' ' A' ' 37' ' ' GLU . 21.3 m -101.56 113.38 26.45 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.018 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.7 HD23 ' CE1' ' A' ' 70' ' ' PHE . 4.3 tp -95.51 76.15 3.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.643 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.855 ' N ' HD13 ' A' ' 35' ' ' ILE . 22.9 m -80.84 93.51 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.773 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.7 ' CE1' HD23 ' A' ' 68' ' ' LEU . 27.5 m-85 -69.86 107.45 3.55 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.929 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' ASN . 4.8 t70 -69.47 91.38 0.57 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.506 0.669 . . . . 0.0 110.249 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.5 m-85 -94.32 25.05 4.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.411 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.11 -17.98 19.76 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.766 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 75' ' ' GLY . 32.0 m -83.82 -51.37 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 120.677 0.275 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 73.76 -60.17 2.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.338 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.2 m -48.64 -66.01 0.47 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.884 0.373 . . . . 0.0 111.589 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -107.93 22.53 15.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.731 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 74' ' ' VAL . 22.3 p-10 -54.65 134.25 64.38 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 120.719 0.295 . . . . 0.0 110.701 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 6' ' ' ILE . 29.7 Cg_exo -60.19 98.36 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.372 2.048 . . . . 0.0 112.547 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -96.98 119.91 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.524 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.01 HD12 HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -81.21 102.38 10.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.572 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 11' ' ' ILE . 18.5 m -77.69 123.28 26.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 110.395 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 66' ' ' LYS . 3.2 mt -124.53 135.71 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.701 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.52 96.55 6.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.885 HG12 ' HB2' ' A' ' 15' ' ' ALA . 10.6 t -90.9 127.03 43.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.236 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.874 HD12 ' HE2' ' A' ' 88' ' ' LYS . 1.5 mt -94.16 161.72 28.71 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.187 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.508 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 71.2 Cg_endo -77.98 -32.66 2.46 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 C-N-CA 122.634 2.223 . . . . 0.0 112.08 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.874 ' HE2' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -42.35 164.16 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.184 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -160.15 145.03 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.624 HG22 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mm -118.59 77.01 13.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.16 153.97 66.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.796 2.331 . . . . 0.0 112.263 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.23 42.49 41.2 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.496 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -50.18 93.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 111.037 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' HB ' ' A' ' 74' ' ' VAL . 34.9 ttp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.825 0.345 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.749 ' HB2' HG11 ' A' ' 74' ' ' VAL . 24.9 mm-40 -137.76 -179.35 5.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 17.0 p30 -113.53 61.5 0.87 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HG3' HG21 ' A' ' 74' ' ' VAL . 37.3 Cg_endo -65.2 126.5 16.48 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.775 2.316 . . . . 0.0 111.705 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.715 HG23 ' HB ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -105.29 125.17 50.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.22 0.533 . . . . 0.0 112.053 -178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.705 HD13 ' HG ' ' A' ' 25' ' ' LEU . 8.2 tp -127.05 151.49 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.96 -84.7 0.02 OUTLIER Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 59.2 Cg_endo -103.83 -178.01 0.1 Allowed 'Trans proline' 0 N--CA 1.424 -2.562 0 CA-C-N 120.445 1.195 . . . . 0.0 113.488 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 9' ' ' THR . 97.3 m -147.9 5.84 0.78 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.75 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.631 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -170.48 137.27 1.38 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.429 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 10' ' ' SER . 3.0 pt -162.64 171.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.394 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.62 137.6 22.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.038 0.446 . . . . 0.0 111.591 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.028 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.88 157.46 5.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.48 145.73 50.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.203 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.975 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -63.17 103.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.918 0.866 . . . . 0.0 110.189 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 133.07 -39.37 1.74 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.735 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -69.32 8.15 0.65 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.552 0.691 . . . . 0.0 109.644 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.028 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 83.1 m-85 -99.27 77.88 2.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.571 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -67.93 146.5 53.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.118 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' HG22 ' A' ' 51' ' ' THR . 29.5 t70 -34.2 126.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.833 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.848 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.6 m -136.55 136.8 39.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.674 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -103.96 115.79 31.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.99 -179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD13 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -89.72 159.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.984 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASN . 27.3 m -116.07 108.38 16.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -93.47 91.49 7.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.434 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.715 ' HB ' HG23 ' A' ' 5' ' ' THR . 91.6 m -69.38 111.13 7.73 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-O 121.174 0.511 . . . . 0.0 111.104 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.823 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.3 Cg_endo -93.36 4.72 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.364 3.376 . . . . 0.0 113.081 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB2' HG22 ' A' ' 26' ' ' THR . 1.2 t30 -36.91 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.826 1.251 . . . . 0.0 111.622 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.823 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.26 -29.84 6.54 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.301 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.608 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -105.41 164.0 12.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.702 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 4.6 t -117.88 154.39 31.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.161 0.505 . . . . 0.0 110.654 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CG ' HD22 ' A' ' 25' ' ' LEU . 12.1 t80 -115.9 144.09 44.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.131 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -111.25 -53.96 2.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 159.85 154.78 7.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.194 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.052 HG23 ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -92.25 80.79 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 122.704 1.24 . . . . 0.0 110.439 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 37' ' ' GLU . 4.5 m -61.92 -20.09 63.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.958 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.023 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -44.28 -34.97 2.1 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 37' ' ' GLU . 4.7 mt -134.23 98.66 4.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.103 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.854 ' O ' ' N ' ' A' ' 41' ' ' SER . 2.1 mp0 -31.61 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.662 1.22 . . . . 0.0 111.514 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 40.1 p -2.66 -39.13 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 111.154 -2.748 . . . . 0.0 113.902 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -50.87 -24.81 3.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.11 0.481 . . . . 0.0 110.173 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.37 -28.06 67.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.017 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 1.052 ' CE2' HG23 ' A' ' 35' ' ' ILE . 10.8 p90 -134.43 -172.39 3.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.051 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 44' ' ' THR . 6.5 t -137.24 95.73 3.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.056 0.932 . . . . 0.0 109.624 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HA ' HG13 ' A' ' 50' ' ' VAL . 1.5 ttpp -68.72 165.11 20.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.347 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.6 71.87 0.23 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.582 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.525 ' C ' ' O ' ' A' ' 46' ' ' GLY . 98.7 m 15.83 103.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.5 m-20 89.41 -15.55 0.29 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' GLY . 1.3 mt-10 -143.68 167.48 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.524 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 45' ' ' LYS . 14.7 t -159.29 157.16 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 22' ' ' LYS . 41.4 m -138.99 118.47 12.89 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.203 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.44 144.64 27.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.913 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.704 HD12 ' H ' ' A' ' 56' ' ' TYR . 1.4 pp -109.56 118.43 36.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.531 0.682 . . . . 0.0 112.213 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -42.12 -14.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.926 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -70.63 -44.78 66.49 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.43 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' H ' HD12 ' A' ' 53' ' ' LEU . 7.7 t80 -79.92 -52.09 8.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.62 0.724 . . . . 0.0 109.69 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.847 ' HG ' HD12 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -55.36 -40.37 71.2 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.833 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 39.2 t30 -65.57 -24.98 67.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.77 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.8 m -84.41 -23.88 29.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD12 ' HG ' ' A' ' 57' ' ' LEU . 23.8 mt -39.75 153.44 0.19 Allowed Pre-proline 0 CA--C 1.529 0.161 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.89 175.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.644 2.23 . . . . 0.0 112.669 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.788 ' O ' ' N ' ' A' ' 64' ' ' THR . 2.3 mp0 -55.96 -168.17 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.277 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.472 ' CB ' ' HD3' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -38.5 71.89 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.734 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.788 ' N ' ' O ' ' A' ' 62' ' ' GLU . 4.6 p -117.12 144.33 44.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.509 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -86.34 93.07 9.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.24 0.543 . . . . 0.0 111.679 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.834 ' CG ' HG23 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -65.35 147.31 53.67 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.793 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.1 m -138.82 125.83 21.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD13 ' HE2' ' A' ' 66' ' ' LYS . 1.7 tp -95.27 83.91 3.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.188 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' HD13 ' A' ' 35' ' ' ILE . 35.5 m -85.29 91.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.859 ' HB3' HD21 ' A' ' 25' ' ' LEU . 37.8 m-85 -69.95 112.06 6.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' ND2' ' A' ' 78' ' ' ASN . 39.7 t0 -69.15 96.07 0.79 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.559 0.695 . . . . 0.0 110.819 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -95.74 24.56 5.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.51 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.66 15.91 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.611 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 2' ' ' GLN . 24.0 m -115.85 -31.98 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.66 0.267 . . . . 0.0 110.889 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 67.94 -72.11 0.29 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.8 m -47.94 -63.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.763 0.316 . . . . 0.0 111.12 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -87.1 10.5 16.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.336 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 20.5 t-20 -52.7 113.19 4.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.543 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 28.7 Cg_endo -63.52 84.35 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.572 2.181 . . . . 0.0 112.023 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.589 ' O ' HG23 ' A' ' 9' ' ' THR . 10.0 pttp -104.1 122.2 44.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.146 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 67' ' ' THR . 2.4 pp -99.55 160.88 13.96 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' SER . 22.8 m -127.7 98.13 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.055 0.455 . . . . 0.0 111.383 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.834 HG23 ' CG ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -100.64 122.66 52.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.68 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 5.5 m -86.69 121.27 28.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.975 HG12 ' HB2' ' A' ' 15' ' ' ALA . 1.7 t -105.6 117.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.028 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 14' ' ' LYS . 2.5 mt -84.05 161.68 54.4 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.635 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 9.9 Cg_endo -53.58 117.93 4.35 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.554 2.169 . . . . 0.0 112.346 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -50.92 142.62 11.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.695 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.43 31.59 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 110.661 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' O ' HG23 ' A' ' 90' ' ' ILE . 4.3 tt -105.58 94.34 8.43 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.99 143.89 51.14 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.703 2.268 . . . . 0.0 112.243 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.58 22.52 23.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.543 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.02 109.92 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.868 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -127.97 144.95 51.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -118.58 62.47 5.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.817 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 36.2 Cg_endo -65.35 129.18 22.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.51 2.14 . . . . 0.0 111.599 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -125.72 139.66 53.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.882 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.01 HD12 ' ND2' ' A' ' 7' ' ' ASN . 2.5 pt -157.63 -170.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.287 0.565 . . . . 0.0 111.521 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 1.01 ' ND2' HD12 ' A' ' 6' ' ' ILE . 2.9 p30 -51.87 -171.78 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.048 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' CD ' ' HB2' ' A' ' 7' ' ' ASN . 22.6 Cg_exo -66.61 -159.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.508 2.138 . . . . 0.0 113.034 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 80' ' ' LYS . 26.2 m -144.27 10.37 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.753 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 82' ' ' THR . 5.0 p -143.35 127.28 17.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 111.638 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.61 HD11 ' HE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -153.45 154.57 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.558 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.43 136.29 11.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 111.459 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.975 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -170.94 165.32 7.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.337 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.4 ttmm -70.69 131.11 43.39 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HA ' HG12 ' A' ' 85' ' ' VAL . . . -54.35 102.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.896 0.855 . . . . 0.0 110.259 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 136.16 -39.82 1.61 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.709 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -70.02 10.57 0.4 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.538 0.685 . . . . 0.0 109.834 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.975 ' CZ ' ' HB3' ' A' ' 13' ' ' ALA . 65.4 m-85 -98.05 76.91 2.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.382 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.75 160.29 30.65 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 25.4 t70 -34.01 110.41 0.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 0.0 110.45 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 52' ' ' LEU . 1.7 m -111.03 102.38 10.85 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.6 159.66 32.99 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.632 0.729 . . . . 0.0 110.88 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.863 HD12 ' CG ' ' A' ' 7' ' ' ASN . 6.8 mm -146.9 159.28 9.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.559 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 23' ' ' ILE . 26.4 m -122.44 111.11 16.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 0.0 111.564 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.759 ' HA ' HG22 ' A' ' 6' ' ' ILE . 3.0 mt -90.06 90.04 7.95 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' THR . 1.1 m -69.45 108.47 3.21 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.197 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 10.9 Cg_endo -94.29 4.46 2.75 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.085 3.19 . . . . 0.0 112.966 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.421 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.9 OUTLIER -37.11 67.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.994 1.317 . . . . 0.0 111.4 -178.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.57 -27.39 8.87 Favored Glycine 0 C--N 1.307 -1.048 0 CA-C-N 113.12 -1.855 . . . . 0.0 112.716 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -112.28 167.26 10.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.982 0.42 . . . . 0.0 111.141 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.478 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 3.7 t -126.15 157.63 37.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.566 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.607 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 21.2 t80 -108.83 149.87 28.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -110.86 -35.56 5.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.903 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.554 ' CA ' ' CZ ' ' A' ' 32' ' ' PHE . . . 141.63 -175.01 22.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.832 HD12 HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -115.9 94.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.98 0.419 . . . . 0.0 109.993 179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -66.6 -22.24 66.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.127 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.904 ' CD ' HG23 ' A' ' 67' ' ' THR . 0.4 OUTLIER -60.31 -25.93 66.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.943 HD12 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -146.71 89.38 1.83 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.849 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.846 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -31.77 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.706 1.241 . . . . 0.0 111.509 -178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 12.0 t -1.5 -43.12 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 111.046 -2.797 . . . . 0.0 113.464 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.846 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -48.45 -23.47 0.97 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.997 0.427 . . . . 0.0 110.674 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -61.38 -29.74 70.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.298 0.571 . . . . 0.0 111.734 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.943 ' CE1' HD12 ' A' ' 38' ' ' LEU . 1.7 p90 -127.83 -170.72 2.29 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.36 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.54 89.54 3.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.31 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 5.3 mtpp -69.14 168.68 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.802 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.6 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -172.22 79.85 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.548 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.6 ' C ' ' O ' ' A' ' 46' ' ' GLY . 1.3 t 10.76 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.889 0.376 . . . . 0.0 110.965 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 85.38 7.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 -178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 46' ' ' GLY . 34.3 mt-10 -139.99 140.32 36.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.744 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.77 HG23 ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -140.26 121.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.919 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.539 HG22 ' OD1' ' A' ' 20' ' ' ASP . 19.1 m -117.12 111.91 20.15 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 8.0 mp -67.88 132.74 47.92 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 55' ' ' SER . 33.0 mt -101.03 104.52 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.782 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -37.01 -19.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.996 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 53' ' ' LEU . 1.2 p -70.66 -49.49 46.8 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.186 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 42' ' ' GLN . 23.2 t80 -71.88 -57.24 4.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.78 0.8 . . . . 0.0 109.612 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.933 HD21 ' CD1' ' A' ' 83' ' ' ILE . 2.7 tp -48.36 -43.7 33.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.558 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.6 t-20 -65.69 -25.1 67.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.059 0.456 . . . . 0.0 110.168 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 56' ' ' TYR . 79.4 m -78.8 -30.56 45.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.66 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD13 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -38.04 139.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 111.097 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HD2' HD13 ' A' ' 60' ' ' LEU . 77.2 Cg_exo -49.89 -173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.812 2.341 . . . . 0.0 112.602 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 64' ' ' THR . 8.7 pt-20 -54.96 -169.22 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HD23 ' A' ' 86' ' ' LEU . 3.1 t-20 -39.3 69.69 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.878 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.795 ' N ' ' O ' ' A' ' 62' ' ' GLU . 24.2 p -106.47 144.52 33.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.11 82.26 8.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.2 tptp -65.61 96.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.789 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.904 HG23 ' CD ' ' A' ' 37' ' ' GLU . 9.3 t -97.9 120.07 37.65 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.832 HD23 HD12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.76 90.07 8.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.718 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.719 HG23 ' OD1' ' A' ' 78' ' ' ASN . 2.9 m -87.9 100.31 12.79 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.708 ' CE2' HG21 ' A' ' 50' ' ' VAL . 37.0 m-85 -76.23 99.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -71.09 96.8 1.38 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 110.244 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.525 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.69 20.08 3.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.21 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.18 -1.59 24.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.263 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 75' ' ' GLY . 35.0 m -103.79 -47.84 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 120.735 0.302 . . . . 0.0 111.024 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 85.42 -45.25 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.689 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.7 m -59.7 -63.36 1.33 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.813 0.34 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -86.33 9.87 16.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.719 ' OD1' HG23 ' A' ' 69' ' ' THR . 0.7 OUTLIER -45.69 100.17 0.23 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.433 . . . . 0.0 110.995 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' HB2' HD11 ' A' ' 6' ' ' ILE . 11.2 Cg_exo -69.85 98.31 0.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.472 2.115 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.759 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 ttpm? -84.45 162.14 20.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.276 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -134.93 89.12 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.019 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -69.96 82.25 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.056 0.455 . . . . 0.0 112.093 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.933 ' CD1' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.07 125.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.46 178.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.64 125.44 42.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.222 0.534 . . . . 0.0 112.29 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -105.99 104.91 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.463 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -119.04 91.61 43.74 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.744 0.306 . . . . 0.0 111.321 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 60.2 Cg_endo -72.8 -31.17 10.64 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.098 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -64.93 123.08 18.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.72 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.644 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -97.68 31.67 2.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.332 0.587 . . . . 0.0 110.743 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 89' ' ' ASP . 38.0 mm -148.99 92.59 4.33 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.061 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 164.84 33.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.676 2.251 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.61 43.51 85.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -137.41 -159.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.765 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 93' ' ' LEU . 5.1 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.778 0.323 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 3.5 mm100 -116.45 178.58 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -133.04 68.03 78.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.1 Cg_exo -67.38 124.75 12.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.948 2.432 . . . . 0.0 112.035 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.507 ' CB ' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -119.17 141.88 48.46 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.105 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 79' ' ' PRO . 8.4 tp -145.52 158.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.176 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.818 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.34 -84.27 0.03 OUTLIER Pre-proline 0 CA--C 1.504 -0.789 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 7' ' ' ASN . 35.3 Cg_endo -105.85 -178.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.732 0 CA-C-N 120.384 1.173 . . . . 0.0 113.42 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 80' ' ' LYS . 49.1 m -140.94 1.91 1.7 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.197 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 p -169.21 122.39 0.78 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.0 0.429 . . . . 0.0 112.065 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.017 HD11 HG23 ' A' ' 83' ' ' ILE . 2.5 pp -131.39 169.89 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -154.34 137.65 15.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.771 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.045 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.61 146.13 2.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.793 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.34 140.19 52.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 103.87 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.024 0.916 . . . . 0.0 110.496 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 132.05 -42.33 1.4 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.406 -177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -79.56 21.98 0.48 Allowed 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.045 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 1.9 m-85 -97.06 76.61 2.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.112 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ASP . . . -69.37 142.98 53.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.176 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' ALA . 5.7 t70 -34.82 134.18 0.24 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.137 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 6.3 m -126.31 103.47 7.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.818 0.342 . . . . 0.0 111.642 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD3' ' CG2' ' A' ' 51' ' ' THR . 0.0 OUTLIER -69.91 165.74 21.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.241 0.543 . . . . 0.0 110.507 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.612 HG22 HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -156.71 148.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.489 -179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 9.2 m -125.04 104.79 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.666 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.031 HD22 ' CE1' ' A' ' 72' ' ' PHE . 2.9 mt -88.93 100.51 13.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 28' ' ' ASN . 3.0 m -69.27 110.81 6.9 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.424 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.808 ' O ' ' N ' ' A' ' 29' ' ' GLY . 12.8 Cg_endo -91.73 4.03 4.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.101 3.201 . . . . 0.0 112.782 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.625 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.7 OUTLIER -37.57 67.26 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.938 1.295 . . . . 0.0 111.444 -178.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.808 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 114.21 -27.28 9.13 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 113.047 -1.888 . . . . 0.0 112.213 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -103.31 169.86 8.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.97 0.414 . . . . 0.0 110.873 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 3.4 t -128.28 158.66 37.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 5.3 t80 -112.04 140.31 46.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.38 -38.49 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.58 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 166.35 10.96 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.582 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.73 HD12 ' CE2' ' A' ' 43' ' ' TYR . 1.3 mt -100.67 88.95 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -64.63 -25.82 68.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.835 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.2 tt0 -52.88 -26.56 15.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.971 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -143.19 89.39 2.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.045 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.913 ' O ' ' N ' ' A' ' 41' ' ' SER . 8.9 tt0 -31.89 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.558 1.17 . . . . 0.0 111.282 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.714 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 0.3 OUTLIER 7.08 -45.62 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 111.271 -2.695 . . . . 0.0 113.588 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.913 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -50.46 -21.55 1.52 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.838 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.725 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 3.4 mm100 -67.84 -26.43 66.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.199 0.523 . . . . 0.0 111.758 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.94 ' CD2' HD12 ' A' ' 38' ' ' LEU . 6.3 p90 -133.5 -171.65 2.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.618 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.439 ' OG1' ' CD2' ' A' ' 53' ' ' LEU . 93.3 m -126.31 88.85 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.989 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -68.22 169.36 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.706 -178.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -166.38 69.61 0.19 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.621 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' THR . 11.5 t 17.23 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.591 0.356 . . . . 0.0 111.498 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 25' ' ' LEU . 3.0 m-20 90.66 -11.51 0.29 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.762 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 46' ' ' GLY . 2.5 mt-10 -141.66 165.78 26.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG12 HG22 ' A' ' 23' ' ' ILE . 7.5 p -163.72 155.97 2.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 50' ' ' VAL . 98.5 m -137.91 118.63 14.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.543 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 68' ' ' LEU . 6.2 mt -69.59 137.85 52.67 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.766 HD21 ' C ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -107.84 121.95 45.79 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.817 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.576 ' O ' ' CB ' ' A' ' 58' ' ' ASN . . . -41.13 -16.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.612 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 53' ' ' LEU . 46.6 p -70.57 -46.76 62.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.725 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -68.97 -59.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.778 0.799 . . . . 0.0 110.114 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -54.37 -39.05 66.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.556 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.576 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 24.7 t30 -65.39 -27.56 68.64 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.902 0.382 . . . . 0.0 110.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 83.1 m -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.323 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 57' ' ' LEU . 1.9 mt -42.19 139.66 1.74 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HB2' HG21 ' A' ' 64' ' ' THR . 75.3 Cg_exo -49.67 177.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.785 2.323 . . . . 0.0 112.763 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -56.72 -163.3 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.263 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.1 OUTLIER -38.54 72.5 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.862 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.777 ' N ' ' O ' ' A' ' 62' ' ' GLU . 28.6 p -115.94 165.22 13.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.006 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.571 HG23 ' OG1' ' A' ' 84' ' ' THR . 0.4 OUTLIER -125.5 73.29 1.31 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.936 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 tttt -65.74 178.61 1.0 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.825 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 81' ' ' LEU . 6.0 m -149.85 138.39 20.74 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.319 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.12 80.52 3.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.503 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.9 m -78.89 98.48 6.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.88 0.371 . . . . 0.0 111.378 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 25' ' ' LEU . 9.0 m-30 -76.55 102.74 6.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.292 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.2 93.13 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.577 0.704 . . . . 0.0 110.969 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 1.031 ' CE1' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -93.43 22.39 5.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.687 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 55.34 14.4 6.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.557 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 72' ' ' PHE . 35.3 m -115.68 -34.24 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 78' ' ' ASN . . . 69.64 -70.54 0.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.67 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.2 m -49.85 -64.73 0.72 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -89.29 12.4 16.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.232 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -63.58 119.57 55.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.934 0.397 . . . . 0.0 110.619 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HG2' HD21 ' A' ' 25' ' ' LEU . 44.3 Cg_endo -67.69 97.25 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.562 2.175 . . . . 0.0 112.58 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 9' ' ' THR . 1.6 ttpt -111.26 137.04 49.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.707 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -113.63 161.74 17.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.473 HG23 ' OG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.68 107.06 13.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.684 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.017 HG23 HD11 ' A' ' 11' ' ' ILE . 4.3 mm -84.9 111.78 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.782 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.571 ' OG1' HG23 ' A' ' 65' ' ' THR . 4.7 m -96.5 97.51 9.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.13 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 60' ' ' LEU . 44.3 t -85.58 132.03 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -106.35 163.64 16.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.906 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 86' ' ' LEU . 58.8 Cg_endo -71.76 137.14 29.27 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.474 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -65.06 111.67 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.647 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -160.48 164.62 32.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 90' ' ' ILE . 5.0 tp -129.05 58.78 39.56 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.19 132.82 23.4 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.809 2.339 . . . . 0.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.51 -21.38 77.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.488 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 93' ' ' LEU . 5.3 tt -110.53 80.57 1.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 0.0 110.964 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.842 179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.77 0.319 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.739 ' CG ' HG12 ' A' ' 74' ' ' VAL . 1.7 mm100 -102.19 160.34 14.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -132.84 73.42 75.87 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 98.3 Cg_endo -86.76 155.38 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.842 2.361 . . . . 0.0 112.278 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' THR . 68.4 m -138.52 118.4 13.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.366 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD12 ' ND2' ' A' ' 7' ' ' ASN . 1.3 pt -144.34 -177.73 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.0 112.313 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.734 ' OD1' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -48.32 -176.04 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.921 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 7' ' ' ASN . 36.8 Cg_exo -61.72 -154.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.924 2.416 . . . . 0.0 113.426 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.967 HG23 ' O ' ' A' ' 80' ' ' LYS . 54.1 m -145.22 11.48 1.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.943 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.95 125.09 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 83' ' ' ILE . 22.2 pt -150.78 159.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.559 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.14 143.72 27.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.06 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.57 159.91 7.0 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.629 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -70.36 148.09 48.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.309 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . . . -63.06 103.22 0.44 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.847 0.832 . . . . 0.0 110.487 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.23 -37.34 2.3 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.088 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.17 11.38 0.32 Allowed 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.342 0.591 . . . . 0.0 109.758 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.06 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.6 m-85 -97.44 74.08 2.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.039 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.79 158.07 35.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.099 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 34.7 t0 -34.5 115.26 0.25 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 110.452 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.9 m -113.23 98.16 6.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -69.27 136.68 52.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.328 0.585 . . . . 0.0 110.336 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.734 HG23 ' OD1' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -128.53 150.13 33.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.109 -179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.426 ' HA ' ' CG ' ' A' ' 49' ' ' GLU . 7.1 m -115.36 115.44 26.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' CE1' ' A' ' 72' ' ' PHE . 4.1 mp -104.67 92.87 4.46 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.639 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 28' ' ' ASN . 13.0 m -69.33 110.99 7.28 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-O 120.617 0.246 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.809 ' O ' ' N ' ' A' ' 29' ' ' GLY . 11.1 Cg_endo -92.47 3.99 3.63 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.16 3.24 . . . . 0.0 112.94 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 26' ' ' THR . 2.6 t30 -37.52 67.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.763 1.29 . . . . 0.0 111.367 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 117.85 -29.65 6.47 Favored Glycine 0 C--N 1.308 -0.984 0 CA-C-N 113.177 -1.829 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -102.07 167.86 9.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.546 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -122.32 164.99 16.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 70' ' ' PHE . 6.5 t80 -123.72 140.27 53.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -110.53 -39.88 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.637 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . 142.86 166.9 11.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.73 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.057 HD13 HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -98.01 93.89 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 120.857 0.361 . . . . 0.0 110.302 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.68 -15.6 62.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.817 ' OE1' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -59.47 -30.75 68.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -143.01 90.21 2.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.896 178.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.939 ' O ' ' N ' ' A' ' 41' ' ' SER . 5.5 mt-30 -31.51 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.44 1.114 . . . . 0.0 111.55 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 43' ' ' TYR . 17.3 m 6.17 -43.0 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 111.547 -2.569 . . . . 0.0 113.673 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.939 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -51.01 -23.37 2.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.203 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -65.88 -29.73 70.22 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.485 0.659 . . . . 0.0 110.961 179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.971 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 6.7 p90 -132.16 -171.32 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.762 ' HB ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -124.47 86.02 2.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.332 179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HA ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.89 156.64 38.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.148 -178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -159.89 85.89 0.12 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.821 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.568 HG22 ' ND2' ' A' ' 48' ' ' ASN . 57.9 m 5.44 109.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' ND2' HG22 ' A' ' 47' ' ' THR . 1.2 m120 87.99 -9.36 0.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.357 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 50' ' ' VAL . 5.2 mt-10 -151.73 165.94 32.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 111.309 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 45' ' ' LYS . 1.5 t -159.7 135.85 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.762 HG22 ' HB ' ' A' ' 44' ' ' THR . 1.3 t -115.46 121.42 42.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.019 0.437 . . . . 0.0 111.532 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 43' ' ' TYR . 1.1 mt -69.29 138.62 54.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.7 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.6 OUTLIER -105.6 110.2 22.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.39 0.614 . . . . 0.0 111.695 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' ALA . . . -44.21 -12.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.47 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 59' ' ' THR . 0.3 OUTLIER -70.75 -46.91 62.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.706 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 34.2 t80 -73.01 -59.2 2.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.86 0.838 . . . . 0.0 109.627 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.9 tp -50.37 -40.47 49.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.2 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 29.7 t30 -65.89 -31.08 71.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 55' ' ' SER . 72.3 p -80.36 -25.94 38.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.477 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 6.1 mt -37.86 134.78 0.82 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.799 ' HG2' HG21 ' A' ' 64' ' ' THR . 10.1 Cg_endo -51.96 -170.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.031 2.488 . . . . 0.0 112.729 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.766 ' O ' ' N ' ' A' ' 64' ' ' THR . 5.9 pm0 -56.97 -165.46 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.357 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 6.0 p30 -38.83 71.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.274 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -98.41 163.2 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.74 69.9 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.995 0.426 . . . . 0.0 111.405 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -56.8 164.4 1.54 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.59 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.817 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.4 m -151.1 133.1 15.15 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.057 HD11 HD13 ' A' ' 35' ' ' ILE . 8.9 tp -102.64 77.35 1.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 97.4 m -92.19 94.71 9.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.583 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.761 ' HB3' HD21 ' A' ' 25' ' ' LEU . 49.3 m-85 -69.94 110.68 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -68.6 101.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.668 0.747 . . . . 0.0 111.061 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.896 ' CE1' HD23 ' A' ' 25' ' ' LEU . 1.7 m-30 -101.86 15.58 28.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.253 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.95 4.88 23.08 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.902 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.739 HG12 ' CG ' ' A' ' 2' ' ' GLN . 33.7 m -96.2 -46.82 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 120.607 0.242 . . . . 0.0 110.787 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 72.82 -61.04 1.67 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.289 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.6 m -54.38 -69.9 0.11 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.763 0.316 . . . . 0.0 111.414 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' CE ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -87.63 13.24 10.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.096 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -55.73 118.86 21.65 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.387 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 5.5 Cg_exo -73.34 99.03 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.168 1.912 . . . . 0.0 112.16 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.967 ' O ' HG23 ' A' ' 9' ' ' THR . 6.4 pttm -111.69 116.29 30.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.252 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD11 HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -96.63 114.11 25.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 111.842 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 m -69.48 111.66 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 111.357 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.865 ' CD1' HD11 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -97.19 113.64 32.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.543 179.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 112.55 24.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.018 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.861 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 p -103.73 123.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.755 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 87' ' ' PRO . 12.8 mt -92.52 164.17 23.59 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.917 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 86' ' ' LEU . 59.3 Cg_endo -72.18 170.37 19.23 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 0.0 112.404 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 167.76 7.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -127.19 144.92 50.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.065 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mm -102.25 93.08 3.6 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.38 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 114.62 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.78 2.32 . . . . 0.0 112.402 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -110.63 33.91 5.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tt 69.85 84.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.354 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.799 ' CD ' HG11 ' A' ' 74' ' ' VAL . 2.7 mp0 -140.14 154.02 46.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 7.8 p30 -121.61 55.13 5.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.28 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' ' ND2' ' A' ' 30' ' ' ASN . 71.7 Cg_endo -76.92 143.47 23.23 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.598 2.199 . . . . 0.0 111.51 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 26' ' ' THR . 8.0 m -134.36 95.62 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.777 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.676 HG21 ' CE1' ' A' ' 72' ' ' PHE . 2.5 pt -114.24 173.37 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.307 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.686 ' OD1' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -39.52 167.96 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.404 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 7' ' ' ASN . 93.2 Cg_exo -45.02 172.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.482 2.122 . . . . 0.0 112.485 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -116.47 6.59 13.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.773 -179.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' THR . 0.7 OUTLIER -161.29 135.39 6.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.773 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.2 pt -154.14 164.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.361 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -141.15 138.02 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.98 0.419 . . . . 0.0 111.449 -179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.07 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -170.55 146.81 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.739 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -70.29 143.02 52.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG12 ' A' ' 85' ' ' VAL . . . -55.95 103.97 0.12 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.067 0.937 . . . . 0.0 110.592 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 18' ' ' PHE . . . 128.99 -39.88 1.79 Allowed Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.781 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.86 14.43 0.28 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.35 0.595 . . . . 0.0 109.584 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.07 ' CE1' ' HB3' ' A' ' 13' ' ' ALA . 38.7 m-85 -97.14 75.75 2.62 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.07 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . . . -68.82 155.35 40.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.992 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 22.4 t70 -34.52 112.05 0.13 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.785 0.326 . . . . 0.0 110.686 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 52' ' ' LEU . 1.3 m -108.75 101.65 10.76 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.622 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -69.57 156.72 38.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.612 0.72 . . . . 0.0 110.611 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.003 ' HB ' HG13 ' A' ' 50' ' ' VAL . 21.2 mt -144.5 147.61 19.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.071 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.71 ' O ' HG23 ' A' ' 24' ' ' THR . 5.8 t -124.52 98.96 5.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 111.599 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 49' ' ' GLU . 0.5 OUTLIER -81.11 97.32 7.5 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.39 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 28' ' ' ASN . 56.4 m -70.0 111.16 8.24 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' O ' ' N ' ' A' ' 29' ' ' GLY . 13.8 Cg_endo -90.71 2.37 4.86 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.91 3.074 . . . . 0.0 113.117 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.534 ' HB2' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -37.41 67.44 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 124.695 1.198 . . . . 0.0 111.242 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.821 ' N ' ' O ' ' A' ' 27' ' ' PRO . . . 112.6 -26.8 10.49 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 113.129 -1.851 . . . . 0.0 112.457 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -111.5 167.55 10.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.471 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 3.8 t -131.89 158.2 41.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.863 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CZ ' ' HA2' ' A' ' 34' ' ' GLY . 32.5 t80 -122.52 155.1 36.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.682 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -117.03 -67.87 0.96 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA2' ' CZ ' ' A' ' 32' ' ' PHE . . . -173.58 170.84 44.0 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.605 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 ' CE1' ' A' ' 70' ' ' PHE . 3.4 mt -105.76 96.78 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.254 0.55 . . . . 0.0 110.211 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 p -64.34 -30.16 71.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.401 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.758 ' OE1' HG22 ' A' ' 67' ' ' THR . 1.0 OUTLIER -51.79 -27.23 11.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.796 HD11 ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -147.84 93.99 2.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.826 178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.862 ' O ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -31.54 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.459 1.123 . . . . 0.0 111.225 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.586 ' HA ' ' CE2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -2.7 -42.33 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 111.344 -2.662 . . . . 0.0 113.239 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -49.29 -24.04 1.66 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.961 0.41 . . . . 0.0 110.317 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' HB3' ' CG ' ' A' ' 56' ' ' TYR . 1.5 mm100 -60.39 -29.75 69.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 0.0 111.283 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.831 ' CD1' HG23 ' A' ' 50' ' ' VAL . 26.0 p90 -124.44 -169.26 1.94 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.064 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' HD21 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -121.87 87.62 2.79 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.706 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -68.88 160.08 31.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.828 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 47' ' ' THR . . . -169.72 78.74 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.027 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.534 ' C ' ' O ' ' A' ' 46' ' ' GLY . 94.1 m 15.61 99.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.616 0.367 . . . . 0.0 111.943 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 47' ' ' THR . 1.6 m-20 84.04 -3.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.676 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.7 mt-10 -140.96 160.73 39.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.155 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.003 HG13 ' HB ' ' A' ' 23' ' ' ILE . 2.1 p -162.01 150.94 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.371 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' THR . 51.7 m -137.61 120.14 16.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 7.6 mp -68.47 131.78 45.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.58 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' SER . 5.0 mt -101.93 108.5 19.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.784 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' PHE . . . -37.69 -18.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.16 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -70.16 -48.77 55.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 0.0 110.511 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 42' ' ' GLN . 1.6 t80 -69.89 -60.58 2.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.077 0.941 . . . . 0.0 109.317 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.825 HD23 ' HB3' ' A' ' 18' ' ' PHE . 2.1 tp -45.76 -44.46 13.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.757 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 2.4 t-20 -65.69 -27.17 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.51 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 56' ' ' TYR . 20.9 m -80.17 -26.11 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 56' ' ' TYR . 8.2 mt -38.58 156.45 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.147 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 -174.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.947 2.431 . . . . 0.0 113.154 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.778 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -70.29 -165.02 0.09 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.426 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 9.0 p-10 -38.78 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.164 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.778 ' N ' ' O ' ' A' ' 62' ' ' GLU . 49.2 p -125.1 165.54 18.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.456 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -119.76 83.28 2.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -66.02 172.99 3.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.966 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.758 HG22 ' OE1' ' A' ' 37' ' ' GLU . 22.8 m -145.62 133.37 21.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.785 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.899 HD23 ' CD1' ' A' ' 35' ' ' ILE . 0.6 OUTLIER -95.83 75.9 3.17 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.529 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.753 HG23 HD21 ' A' ' 78' ' ' ASN . 2.7 m -69.99 89.69 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.335 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' CE1' HD11 ' A' ' 35' ' ' ILE . 65.5 m-85 -69.92 106.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.405 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -69.2 100.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HG21 ' A' ' 6' ' ' ILE . 1.3 m-85 -101.23 28.61 5.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.209 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.97 -22.06 13.38 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.671 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.799 HG11 ' CD ' ' A' ' 2' ' ' GLN . 29.6 m -102.3 -48.3 10.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 111.243 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' N ' HG23 ' A' ' 74' ' ' VAL . . . 77.26 -57.96 3.66 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.195 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.5 m -51.29 -65.9 0.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.773 0.321 . . . . 0.0 111.29 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -89.24 12.72 15.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.753 HD21 HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.74 156.78 90.31 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.8 Cg_exo -75.03 96.16 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.5 2.133 . . . . 0.0 112.274 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -85.72 106.53 17.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.775 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.773 HD11 ' CD1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -84.46 87.73 7.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.341 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.0 t -69.09 114.54 7.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.134 0.492 . . . . 0.0 111.506 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HD21 ' A' ' 57' ' ' LEU . 1.4 tt -104.42 120.73 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.625 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.5 m -92.06 104.67 17.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.436 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -88.15 104.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.545 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 7.0 mt -78.2 159.43 75.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 86' ' ' LEU . 61.0 Cg_endo -73.62 130.29 14.63 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.71 2.273 . . . . 0.0 112.411 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.3 160.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.86 112.51 6.34 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.884 ' O ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.12 163.32 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.32 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 90' ' ' ILE . 53.9 Cg_endo -69.74 121.21 7.91 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.043 2.495 . . . . 0.0 112.274 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.43 24.63 4.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.423 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 90' ' ' ILE . 1.7 pp -97.78 102.31 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 stop_ save_